Identifying MOB2 Binding Partners: A Comprehensive Guide to Yeast Two-Hybrid Screening

Abstract

This article provides a detailed methodological and conceptual framework for using yeast two-hybrid (Y2H) screening to identify and characterize binding partners of the MOB2 protein, a key adaptor in Hippo and Hippo-like signaling pathways. Aimed at researchers and drug development professionals, the content covers foundational MOB2 biology, state-of-the-art Y2H protocols—including high-throughput batch screening and optimized bait/prey vector design—and rigorous validation strategies using orthogonal assays like proximity labeling and split-protein systems. It further addresses critical troubleshooting for false positives/negatives and explores the translational potential of discovered interactions in diseases such as cancer, offering a complete roadmap from initial screen to functional insight.

MOB2 in Cell Signaling: Unraveling Its Biological Context and Interaction Potential

The Mps one binder (MOB) family constitutes a group of highly conserved eukaryotic kinase adaptor proteins, first identified in a yeast two-hybrid screen for interactors of Mps1p kinase [1]. MOB proteins are universally distributed, found in at least 41 out of 43 sequenced eukaryotic genomes, underscoring their fundamental biological importance [2]. These proteins are characterized as non-catalytic signal transducers that physically associate with and regulate serine/threonine kinases, thereby controlling essential cellular processes from yeast to humans [3] [4].

Historically, research in budding yeast (Saccharomyces cerevisiae) and fission yeast (Schizosaccharomyces pombe) revealed that MOB proteins are crucial regulators of mitotic exit and cell morphogenesis [2] [1]. In multicellular organisms, MOBs have expanded in number and function, playing central roles in tissue homeostasis, morphogenesis, and tumor suppression [3]. The MOB family has undergone functional diversification through gene expansion, with fungi typically possessing two MOB genes, while mammals express up to six distinct MOB proteins [2] [1].

Classification and Structural Characteristics

MOB Family Classes

MOB proteins are phylogenetically classified into four distinct classes in animals, with some species containing sub-isotypes within these classes [3] [5]. The table below summarizes the classification and key characteristics of human MOB proteins.

Table 1: Classification and Characteristics of Human MOB Proteins

Class	Protein Names	Key Interacting Kinases	Reported Functions
Class I	MOB1A, MOB1B	LATS1/2, NDR1/2	Core component of Hippo signaling, tumor suppression, mitotic exit [3] [4] [1]
Class II	MOB2	NDR1/2	Cell morphogenesis, DNA damage response, competes with MOB1 for NDR binding [6] [7]
Class III	MOB3A, MOB3B, MOB3C	MST1	Apoptosis regulation; MOB3A (Phocein) associates with STRIPAK [1] [7]
Class IV	MOB4/Phocein	MST3/4, STRIPAK complex	Component of STRIPAK complex, antagonizes Hippo signaling [3] [4]

Conserved Structural Fold

MOB proteins are generally single-domain proteins, averaging 210-240 amino acids in length [5]. Despite sequence divergence between classes, they share a conserved tertiary structure known as the Mob family fold. As revealed by the crystal structure of human MOB1A, the core of this fold consists of a four-helix bundle stabilized by a zinc atom [8]. This structure creates conserved surfaces for protein-protein interactions, particularly with partner kinases [4] [8].

The N-terminal helix of the bundle is solvent-exposed and forms an evolutionarily conserved surface with a strong negative electrostatic potential [8]. Conditional mutant alleles of S. cerevisiae MOB1 target this surface, reducing its net negative charge and impairing function. This suggests that MOB proteins may regulate their target kinases through electrostatic interactions mediated by these conserved charged surfaces [8].

Conserved Biological Functions Across Eukaryotes

Regulation of Cell Division and Mitotic Exit

The founding function of MOB proteins lies in regulating cell cycle progression, particularly mitotic exit and cytokinesis [2] [1]. In both S. cerevisiae and S. pombe, Mob1p associates with the Dbf2p/Sid2p kinases and is essential for the Mitotic Exit Network (MEN) and Septation Initiation Network (SIN), respectively [2] [1]. These pathways ensure the correct transition from mitosis to cytokinesis and the proper initiation of septum formation [3]. Depletion of Mob1 in either yeast leads to failure in cytokinesis, resulting in multinucleated cells and ploidy defects [2].

Control of Cell Morphogenesis and Polarity

MOB proteins simultaneously coordinate cell cycle progression with cell polarity and morphogenesis [2]. In yeast, Mob2p forms a complex with the Cbk1p/Orb6p kinases, regulating polarized growth and cellular morphology throughout the cell cycle [1]. This function is conserved in higher eukaryotes, where MOB proteins contribute to processes requiring precise morphological control, including neurite outgrowth, photoreceptor morphology, and neuromuscular junction development [7].

Roles in Multicellular Organisms: Hippo Signaling and Beyond

In metazoans, MOB proteins have been integrated into more complex signaling pathways, most notably the Hippo tumor suppressor pathway [3] [4]. The canonical Hippo pathway comprises a core kinase cascade where MOB1 functions as a crucial adaptor. When activated, Hippo/MST kinases phosphorylate and activate MOB1 in complex with Warts/LATS kinases, which in turn phosphorylate the YAP/TAZ transcriptional co-activators, preventing their nuclear translocation and inhibiting proliferation-associated gene expression [3].

Beyond Hippo signaling, MOB proteins participate in alternative regulatory networks. MOB4/Phocein is a component of the STRIPAK complex (Striatin-Interacting Phosphatase and Kinase), which includes protein phosphatase PP2A and regulates processes including vesicular trafficking, microtubule dynamics, and morphogenesis [3] [4]. Interestingly, the STRIPAK complex can antagonize Hippo signaling, creating a balance of regulatory inputs [4].

Genome Stability and DNA Damage Response

Recent research has uncovered a role for MOB2 in the DNA damage response (DDR) [6] [7]. MOB2 promotes DDR signaling, cell survival, and cell cycle arrest following exogenously induced DNA damage [6]. Under normal growth conditions, MOB2 prevents the accumulation of endogenous DNA damage and subsequent p53/p21-dependent G1/S cell cycle arrest [6]. Mechanistically, MOB2 interacts with RAD50, facilitating recruitment of the MRE11-RAD50-NBS1 (MRN) DNA damage sensor complex and activated ATM to damaged chromatin [6]. This function appears to be independent of NDR kinase signaling, expanding the functional repertoire of MOB proteins beyond kinase regulation [7].

Experimental Protocols for MOB2 Binding Partner Research

Yeast Two-Hybrid Screening for MOB2 Interactors

The Yeast Two-Hybrid (Y2H) system is a powerful method for identifying novel protein-protein interactions. Below is a detailed protocol for screening a cDNA library to identify MOB2 binding partners, adapted from methodologies used in recent studies [6] [9].

Table 2: Key Research Reagents for Yeast Two-Hybrid Screening

Reagent Category	Specific Examples	Function in Experimental Workflow
Yeast Strains	Y2HGold, Y190	Reporter strains with complementary auxotrophic and chromogenic markers [9]
Vectors	pGBKT7 (bait), pGADT7 (prey)	GAL4-based vectors for expressing DNA-Binding Domain and Activation Domain fusions [9]
cDNA Libraries	Normalized universal human tissue cDNA library	Source of "prey" genes for identifying novel binding partners [6]
Selection Media	SD/-Trp, SD/-Leu, SD/-Trp/-Leu/-His + 3-AT	Selective media for screening interacting protein pairs [9]

Bait Vector Construction and Validation

• Amplify the coding sequence of MOB2 using gene-specific primers with appropriate restriction sites.
• Clone MOB2 into the pGBKT7 bait vector downstream of the DNA-Binding Domain using standard molecular biology techniques. Verify the construct by sequencing.
• Transform the pGBKT7-MOB2 bait construct into the Y2HGold yeast strain and plate on SD/-Trp medium to select for transformants.
• Test for autoactivation by streaking positive colonies on high-stringency media (SD/-Trp/-His/-Ade with X-α-Gal). A bait with no autoactivation will not turn blue or grow on this medium, confirming suitability for library screening [9].

Library Screening and Validation

• Transform the cDNA library cloned into the pGADT7 prey vector into Y2HGold yeast already containing the pGBKT7-MOB2 bait.
• Plate transformation mixtures on high-stringency selection media (SD/-Trp/-Leu/-His/-Ade with X-α-Gal) to select for interacting clones. Incubate at 30°C for 3-7 days.
• Isolate positive colonies and sequence the prey plasmids to identify potential interacting partners.
• Confirm interactions by co-transforming the isolated prey plasmids with the original pGBKT7-MOB2 bait and empty pGBKT7 control into fresh yeast cells. Repeat plating on selective media to verify specific interaction with MOB2 [9].

Functional Validation of MOB2 in DNA Damage Response

Based on findings that MOB2 plays a role in DDR, the following protocol can be used to validate its functional significance [6].

MOB2 Knockdown and DNA Damage Assessment

• Transfert cells with MOB2-specific siRNAs or non-targeting control siRNAs using appropriate transfection reagents.
• 48-72 hours post-transfection, treat cells with DNA damaging agents such as doxorubicin (topoisomerase II poison) or expose to ionizing radiation.
• Assess DNA damage by immunofluorescence staining for γH2AX foci or perform comet assays to detect DNA strand breaks.
• Analyze cell cycle profiles by flow cytometry to detect G1/S arrest. Monitor activation of the p53/p21 pathway by immunoblotting.
• Evaluate cell survival using clonogenic assays following DNA damage induction.

Interaction with MRN Complex

• Co-immunoprecipitation: Immunoprecipitate endogenous MOB2 from cell lysates and probe for co-precipitating RAD50 to confirm physical interaction.
• Chromatin fractionation: Isolate chromatin fractions from cells with and without DNA damage treatment. Monitor recruitment of MOB2, RAD50, and activated ATM to chromatin.
• Functional rescue: Express siRNA-resistant wild-type MOB2 in MOB2-depleted cells to confirm rescue of DDR defects.

Visualization of MOB Protein Functions and Signaling Pathways

MOB Protein Functions in Signaling Pathways

Diagram 1: MOB Protein Functions in Key Signaling Pathways. This diagram illustrates the roles of different MOB proteins in Hippo signaling (MOB1), STRIPAK complex (MOB4), and DNA Damage Response (MOB2). MOB proteins serve as adaptors that either activate or inhibit these crucial cellular pathways [3] [6] [4].

Experimental Workflow for Y2H Screening of MOB2 Partners

Diagram 2: Experimental Workflow for Yeast Two-Hybrid Screening of MOB2 Partners. This workflow outlines the key steps in identifying novel MOB2 binding partners, from bait construction to final validation of protein-protein interactions [6] [9].

The MOB protein family represents a conserved group of kinase adaptors that have evolved from regulating fundamental cell cycle processes in yeast to controlling complex signaling networks in multicellular organisms. Their classification into four structural classes reflects functional diversification, with different MOB isoforms participating in distinct yet interconnected cellular pathways including Hippo signaling, STRIPAK complex regulation, and DNA damage response. The experimental protocols outlined here, particularly yeast two-hybrid screening followed by functional validation, provide robust methodologies for expanding our understanding of MOB2 interactions and functions. Continued research on MOB proteins promises to yield important insights into cell cycle regulation, tissue homeostasis, and cancer biology, with potential applications in therapeutic development.

MOB2's Role in Hippo and Hippo-Like Intracellular Signaling Pathways

MOB2 is a member of the highly conserved monopolar spindle-one-binder (MOB) family of proteins, which function as critical regulatory adaptors in key cellular signaling pathways [10]. Unlike their catalytic counterparts, MOB proteins act as globular scaffold proteins without enzymatic activity, serving as signal transducers in essential intracellular pathways [10]. MOB2 belongs to Class II of the four MOB protein classes identified in animals and has been implicated in diverse cellular processes including cell survival, cell cycle progression, responses to DNA damage, and cell motility [11] [5].

The Hippo signaling pathway represents a crucial evolutionarily conserved mechanism that restricts tissue growth and regulates organ size [5]. MOB2 functions within this network primarily through its interactions with Nuclear Dbf2-related (NDR) kinases, positioning it as a significant regulator of both Hippo and Hippo-like signaling pathways that coordinate cellular morphogenesis and proliferation [5]. This application note details the molecular functions of MOB2 and provides standardized protocols for investigating MOB2-binding partners, with particular emphasis on yeast two-hybrid screening methodologies.

Molecular Functions and Binding Characteristics of MOB2

MOB2 as a Regulator of NDR Kinases

MOB2 exerts its primary cellular functions through direct interaction with NDR1/2 kinases (also known as STK38 and STK38L in mammals) [11] [5]. This interaction places MOB2 within a Hippo-like signaling pathway that runs parallel to the canonical Hippo pathway and is dedicated to regulating cell morphology and polarity [5]. Structural analyses reveal that MOB proteins share a conserved globular Mob/Phocein domain that forms the NDR kinase binding surface, with MOB2 specifically competing with MOB1 for binding to the same N-terminal regulatory domain of NDR1/2 [11] [5].

The functional outcome of MOB2 binding to NDR kinases appears context-dependent. Multiple studies indicate that MOB2 functions as an inhibitor of NDR kinase activity by competing with the activating MOB1 protein [11]. This competitive inhibition model positions MOB2 as a negative regulator of NDR1/2, in contrast to MOB1 which serves as a co-activator of both NDR and LATS kinases in the canonical Hippo pathway [5]. The balance between MOB1 and MOB2 binding thus determines the activity state of NDR kinases and consequently modulates downstream signaling outputs.

Table 1: MOB2 Protein Interactions and Functional Consequences

Interaction Partner	Interaction Type	Functional Consequence	Biological Process
NDR1/STK38	Direct binding	Inhibition of NDR1 kinase activity	Cell morphogenesis, neuronal development
NDR2/STK38L	Direct binding	Inhibition of NDR2 kinase activity	Cell polarity, migration
MOB1	Competition	Modulation of NDR kinase activation	Hippo pathway regulation
LATS1/2	No binding reported	Indirect regulation via YAP	Cell proliferation, migration

MOB2 in Cellular Processes and Disease Contexts

Research across multiple model systems has established MOB2's involvement in fundamental cellular processes, particularly in neuronal development and cancer biology. In neuronal systems, MOB2 insufficiency disrupts neuronal migration during cortical development, leading to periventricular nodular heterotopia where neurons fail to reach their appropriate positions in the cerebral cortex [12]. This function appears conserved in C. elegans, where the MOB-2 homolog functions with the NDR kinase SAX-1 to promote dendrite pruning during neuronal remodeling [13].

In cancer contexts, MOB2 demonstrates tumor-suppressive properties in hepatocellular carcinoma (HCC), where its overexpression inhibits cell migration and invasion [11]. Mechanistically, MOB2 regulates the alternative interaction of MOB1 with NDR1/2 and LATS1, resulting in increased phosphorylation of LATS1 and MOB1. This leads to subsequent inactivation of YAP (Yes-associated protein) and consequently inhibition of cell motility [11]. The regulation of YAP activity connects MOB2 to the core Hippo signaling pathway despite its primary association with the NDR kinase branch.

Table 2: MOB2-Associated Phenotypes Across Model Systems

Model System	Experimental Manipulation	Observed Phenotype	Reference
Human HCC cells (SMMC-7721)	MOB2 knockout	Promoted migration and invasion, decreased YAP phosphorylation	[11]
Human HCC cells (SMMC-7721)	MOB2 overexpression	Inhibited migration and invasion, increased YAP phosphorylation	[11]
Developing mouse cortex	Mob2 knockdown	Disrupted neuronal migration, periventricular heterotopia	[12]
C. elegans (IL2 neurons)	MOB-2 loss of function	Defective dendrite branch elimination	[13]

Yeast Two-Hybrid Screening for MOB2 Binding Partners

Principles of Yeast Two-Hybrid Screening

The yeast two-hybrid (Y2H) system is a powerful molecular biology technique used to discover protein-protein interactions (PPIs) by testing for physical binding between two proteins [14]. The foundational principle relies on the modular nature of transcription factors, typically the Gal4 protein from Saccharomyces cerevisiae, which can be separated into two functional domains: the DNA-binding domain (DBD) and the activation domain (AD) [15] [14]. When these domains are brought into proximity through interaction between proteins fused to each domain, they reconstitute a functional transcription factor that drives expression of reporter genes [14].

For investigating MOB2 interactions, Y2H screening offers distinct advantages, including sensitivity to weak or transient interactions, applicability to high-throughput formats, and the ability to screen cDNA libraries against a MOB2 bait protein [15] [14]. The methodology has been successfully employed to characterize interactions within signaling pathways, including those involving MOB family proteins and their kinase partners [10] [5].

Protocol: Yeast Two-Hybrid Screening to Identify MOB2-Binding Partners

Reagents and Equipment

• Yeast Strains: AH109 or other appropriate Y2H reporter strains with auxotrophic markers (HIS3, ADE2) under GAL promoter control [15]
• Plasmids: pGBKT7 (bait vector) and pGADT7 (prey vector) or equivalent Y2H vectors [15]
• Media: Synthetic Dropout (SD) medium lacking appropriate amino acids for selection (-Trp, -Leu, -His, -Ade) [15]
• Small Molecules: 3-Amino-1,2,4-triazole (3-AT) for increasing stringency in HIS3 selection [14]
• MOB2 Constructs: Human MOB2 cDNA (UniProtKB: Q70IA6) for bait construction [10]

Step-by-Step Procedure

Bait and Prey Construction (4-5 days)

• Amplify MOB2 coding sequence using PCR with appropriate restriction sites.
• Digest both MOB2 PCR product and pGBKT7 bait vector with restriction enzymes.
• Ligate MOB2 into the multiple cloning site of pGBKT7 to create a Gal4 DBD-MOB2 fusion.
• Transform ligation product into E. coli, select on kanamycin plates, and verify constructs by sequencing.
• For prey construction, prepare a cDNA library from tissues or cell lines of interest (e.g., neural tissues) cloned into pGADT7 vector.

Yeast Transformation and Mating (3-4 days)

• Transform the Gal4 DBD-MOB2 bait construct into AH109 yeast strain using lithium acetate method.
• Select transformed yeast on SD medium lacking tryptophan (-Trp) to maintain bait plasmid.
• Transform prey library into Y187 yeast strain and select on SD medium lacking leucine (-Leu).
• Mate bait and prey strains by combining equal volumes of each culture in rich medium (YPDA) overnight at 30°C.

Selection and Interaction Screening (5-7 days)

• Plate mated yeast cultures on high-stringency selection media (SD/-Trp/-Leu/-His/-Ade).
• Include controls: empty bait vector with prey library (negative control), known interactors (positive control).
• Incubate plates at 30°C for 3-5 days until colonies appear.
• For quantitative assessment, perform β-galactosidase filter assays to confirm interactions.

Interaction Confirmation and Analysis (7-10 days)

• Isolate prey plasmids from positive yeast colonies by plasmid rescue.
• Sequence isolated prey plasmids to identify interacting proteins.
• Retransform purified prey plasmids with MOB2 bait to confirm interaction specificity.
• Validate biologically relevant interactions using complementary methods (co-immunoprecipitation, biophysical assays).

Figure 1: Experimental workflow for yeast two-hybrid screening to identify MOB2-binding partners

Technical Considerations and Optimization

Successful implementation of Y2H screening for MOB2 interactions requires attention to several technical aspects. First, verification of bait autoactivation is essential—the Gal4 DBD-MOB2 fusion should not autonomously activate reporter genes in the absence of a prey protein [15]. Second, yeast permeability to potential small molecules can be enhanced using engineered strains; the ABC9Δ yeast strain with deleted ABC transporter genes improves detection of protein-protein interaction inhibitors by preventing efflux of small molecules [15]. Third, selection stringency should be optimized using 3-AT titration for the HIS3 reporter to reduce false positives [14].

For MOB2 specifically, researchers should consider potential competition with MOB1 when screening for NDR kinase interactions. Including controls with MOB1 can help distinguish MOB2-specific interactors. Additionally, given MOB2's role in neuronal development, cDNA libraries from neural tissues may yield particularly relevant binding partners [12].

Complementary Methods for MOB2 Interaction Studies

Proximity-Dependent Biotin Identification (BioID)

BioID represents a powerful complementary approach to Y2H for mapping MOB2 protein interactions in live cells [16]. This method utilizes a promiscuous biotin ligase (BirA*) fused to MOB2, which biotinylates proximate proteins in living cells. These biotinylated proteins can then be captured and identified using streptavidin affinity purification followed by mass spectrometry [16].

Protocol Overview:

• Fuse MOB2 to BirA* R118G mutant using appropriate mammalian expression vector.
• Transfect fusion construct into HeLa or HEK293 cells and culture with biotin supplementation.
• Harvest cells after 24 hours and lyse under denaturing conditions.
• Capture biotinylated proteins using streptavidin beads.
• Identify interacting proteins using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Recent BioID studies have revealed novel aspects of MOB protein interactions, including a unique association between MOB3C and the RNase P complex, highlighting the potential of this method for uncovering unexpected functional relationships [16].

Fluorescent Two-Hybrid (F2H) Assay

The fluorescent two-hybrid assay provides a visually tractable method for confirming MOB2 interactions in mammalian cells [17]. This approach detects co-localization of fluorescently tagged proteins at defined subcellular locations, offering real-time visualization of protein-protein interaction dynamics.

Key Steps:

• Fuse MOB2 to a fluorescent protein (e.g., GFP) and potential partners to a complementary fluorescent tag (e.g., RFP).
• Co-transfect constructs into mammalian cells and culture for 24-48 hours.
• Image live cells using fluorescence microscopy and quantify co-localization.
• Assess interaction disruption using specific inhibitors or competing peptides.

Research Reagent Solutions for MOB2 Studies

Table 3: Essential Research Reagents for MOB2 Investigation

Reagent Category	Specific Examples	Function/Application	Source/Reference
Expression Plasmids	pGBKT7-MOB2, pGADT7-NDR1	Y2H bait and prey constructs	[15] [14]
Antibodies	Anti-MOB2, Anti-NDR1, Anti-pYAP	Protein detection and validation	[11] [12]
Cell Lines	HEK293, HeLa, SMMC-7721	Functional assays and interaction studies	[11] [16]
Yeast Strains	AH109, Y187, ABC9Δ	Y2H screening with enhanced permeability	[15]
Critical Chemicals	3-AT, Nutlin-3, Doxycycline	Selection modulation, pathway inhibition	[15] [14]

MOB2 in Hippo Signaling Pathway Context

MOB2's positioning within the broader Hippo signaling network reveals its unique regulatory functions. While the canonical Hippo pathway centers on MST1/2 kinases activating LATS1/2 kinases with MOB1 co-activation, leading to YAP/TAZ phosphorylation and inhibition, MOB2 operates primarily through the parallel NDR kinase pathway [5]. This Hippo-like pathway regulates cellular morphogenesis rather than proliferation and is conserved from yeast to mammals.

Figure 2: MOB2 in Hippo and Hippo-like signaling pathways. MOB2 primarily regulates the NDR kinase branch, with competitive binding with MOB1 determining signaling output.

The interplay between MOB2 and MOB1 creates a regulatory node that integrates signals from both Hippo pathway branches. MOB2's competitive relationship with MOB1 for NDR kinase binding suggests a mechanism for fine-tuning cellular responses to morphogenetic and proliferative cues [5]. This balanced regulation has implications for developmental processes and disease states, particularly in neurological disorders and cancer where proper cellular positioning and growth control are essential [11] [12].

MOB2 represents a significant regulatory component within Hippo and Hippo-like intracellular signaling pathways, primarily through its interactions with NDR kinases. The yeast two-hybrid system provides a powerful methodological approach for identifying novel MOB2-binding partners, with optimized protocols enabling comprehensive mapping of its interaction network. Combined with complementary techniques such as BioID and fluorescent two-hybrid assays, researchers can obtain a detailed understanding of MOB2's molecular functions and regulatory mechanisms. These insights contribute to elucidating MOB2's roles in development and disease, potentially revealing new therapeutic targets for conditions involving disrupted cellular growth and migration.

MOB kinase activator 2 (MOB2) is a member of the highly conserved Mps one binder (Mob) family of adaptor proteins, which function as essential regulatory partners in intracellular signaling pathways [4]. MOB2 plays a critical role in regulating the Nuclear Dbf2-Related (NDR) family of serine-threonine kinases, which are central components of the Hippo and Hippo-like signaling pathways that control fundamental processes including cell cycle progression, cell shape, tissue growth, and morphogenesis [4] [18]. As a non-catalytic scaffold protein, MOB2 functions as an allosteric activator and adaptor that contributes to the assembly of multiprotein NDR kinase activation complexes, thereby modulating key cellular functions from yeast to humans [4].

The study of MOB2-protein interactions is crucial for understanding its role in cellular homeostasis and disease. MOB2 dysfunction has been implicated in various pathological conditions, highlighting its importance as a research target [4]. The yeast two-hybrid (Y2H) system has emerged as a powerful genetic tool for identifying and characterizing MOB2 binding partners, providing invaluable insights into its molecular functions [19] [20]. This Application Note details experimental frameworks and protocols for investigating MOB2 interactors using Y2H-based approaches, with emphasis on technical considerations for researchers studying NDR kinase signaling networks.

MOB2 Characterization and Classification

Structural and Functional Properties

MOB proteins adopt a conserved globular fold with a core consisting of a four alpha-helix bundle, known as the "Mob family fold" [4]. This structure provides distinct surfaces for binding to NDR kinases or upstream regulatory kinases. Animal Mob proteins have expanded into four classes (I-IV) through evolutionary diversification, with MOB2 belonging to Class II of this family [4]. Unlike Class I Mobs (MOB1A/B) that are established core components of Hippo signaling, Class II Mobs like MOB2 exhibit more specialized functions and regulatory properties within Hippo-like signaling pathways [4].

MOB2 is expressed ubiquitously across human tissues with low tissue specificity, showing detectable expression in all tissues examined according to the Human Protein Atlas [21]. It clusters with non-specific signal transduction proteins and is classified as intracellular in its subcellular localization [21]. The widespread expression pattern suggests MOB2 participates in fundamental cellular processes across multiple tissue types.

MOB2 in NDR Kinase Signaling Pathways

MOB2 functions as a key regulatory partner for Tricornered-like NDR kinases (STK38/STK38L in mammals) in the Hippo-like signaling pathway, which operates parallel to the canonical Hippo pathway and primarily regulates cell and tissue morphogenesis rather than growth control [4]. The effect of MOB2 binding to Tricornered-like kinases appears complex, with studies reporting both activating and inhibitory roles depending on cellular context [4]. MOB2 can compete with Class I Mob proteins for binding to Tricornered-like kinases, suggesting a potential mechanism for fine-tuning NDR kinase activity through relative Mob availability [4].

Table 1: Mob Family Protein Classification and Characteristics

Mob Class	Representative Members	Primary Kinase Partners	Cellular Functions
Class I	MOB1A, MOB1B	Warts/LATS kinases [4]	Hippo signaling, growth control, cell division [4]
Class II	MOB2	Tricornered/STK38/STK38L kinases [4]	Hippo-like signaling, cell morphogenesis, neuronal development [13] [4]
Class III	MOB3	Not well characterized [4]	Unknown, potentially specialized functions [4]
Class IV	MOB4/Phocein	STRIPAK complex [4]	PP2A phosphatase regulation, Hippo pathway antagonism [4]

Yeast Two-Hybrid Screening for MOB2 Interactors

Fundamental Principles of Y2H Screening

The yeast two-hybrid system is a powerful molecular biology technique for detecting protein-protein interactions (PPIs) in vivo [19] [14]. Pioneered by Stanley Fields and Ok-Kyu Song in 1989, the method is based on the modular nature of transcription factors, typically using the Gal4 protein from Saccharomyces cerevisiae, which can be split into two separate fragments: the DNA-binding domain (BD) and activation domain (AD) [19] [14]. The core principle involves fusing a "bait" protein (e.g., MOB2) to the BD and "prey" proteins to the AD. If the bait and prey proteins interact, they reconstruct a functional transcription factor that drives expression of reporter genes, enabling yeast survival on selective media or producing a detectable color reaction [19] [14].

The Y2H system offers several advantages for studying MOB2 interactions: it occurs in vivo within a eukaryotic cellular environment, can detect weak or transient interactions through reporter gene amplification, and can be adapted for high-throughput screening of complex libraries [19]. Recent advancements have addressed previous limitations, such as yeast cell permeability to small molecules, through engineered strains like ABC9Δ that lack nine ABC transporter genes, enabling more effective screening of interaction inhibitors [15].

Y2H Screening Methodologies for MOB2 Research

Library Screening Approach

The library screening approach identifies novel MOB2 binding partners from pooled cDNA libraries [20]. This method is particularly valuable when prior knowledge of potential interactors is limited. The general workflow involves:

• Library Construction: Create a cDNA library from relevant tissues or cell lines, cloning cDNA fragments into a prey vector containing the Gal4 AD [14] [20]. For MOB2 studies, libraries from neuronal tissues or developing organisms may be particularly relevant given MOB2's role in neuronal remodeling [13].

• Bait Vector Construction: Clone MOB2 into a bait vector containing the Gal4 BD [14].

• Transformation: Co-transform the bait and prey vectors into appropriate yeast reporter strains (e.g., AH109, Y187) [14] [15].

• Selection: Plate transformed yeast on selective media lacking specific nutrients (e.g., histidine, adenine) to identify colonies where interaction-activated reporter genes enable growth [14] [15].

• Interaction Validation: Sequence positive clones and validate interactions through secondary assays [14].

This approach can identify unknown binding partners but typically requires sequencing of positive clones and may yield higher false-positive rates compared to matrix approaches [20].

Matrix/Array Screening Approach

The matrix approach systematically tests interactions between MOB2 and a defined set of potential protein partners arrayed in multiwell plates [20]. This method is ideal for:

• Testing MOB2 against known NDR kinase family members and related signaling proteins
• Validating interactions suggested by proteomic studies
• Systematic mapping of MOB2 interactions within specific signaling pathways

The matrix approach offers higher reproducibility and lower false-positive rates than library screening, as the identity and position of each prey protein are predetermined [20]. However, it is restricted to the specific ORFs included in the array and may miss novel interactors not represented in the predefined set [20].

Advanced Y2H Techniques for MOB2 Interaction Mapping

Next-Generation Sequencing Enhanced Y2H

Recent innovations have integrated next-generation sequencing (NGS) with Y2H screening to create quantitative, high-resolution interaction mapping techniques. QIS-Seq (Quantitative Interactor Screening with Sequencing) provides quantitative measurements of enrichment for each interactor relative to its frequency in the library, enabling statistical evaluation of interaction strength and specificity [22]. This approach is particularly valuable for distinguishing specific MOB2 interactions from non-specific "sticky" partners.

DoMY-Seq (Protein Domain mapping using Yeast 2 Hybrid-Next Generation Sequencing) offers high-resolution mapping of interaction interfaces by creating a library of fragments derived from an ORF of interest and enriching for interacting fragments using Y2H selection [23]. For MOB2 research, this technique can precisely identify which protein domains mediate interactions with NDR kinases and other binding partners, providing mechanistic insights into MOB2 function.

Specialized Y2H Systems for Membrane-Associated Complexes

As some MOB2 interactions may occur in specific cellular compartments, specialized Y2H variants have been developed. The split-ubiquitin yeast two-hybrid system is designed for membrane-associated bait proteins and may be appropriate for studying MOB2 interactions that occur at cellular membranes [22]. This technique has been successfully used to identify interactors of membrane-associated proteins in Arabidopsis, demonstrating its utility for compartment-specific interaction mapping [22].

Experimental Protocol: Y2H Screening for MOB2 Binding Partners

Phase 1: Bait Vector Construction and Validation

Step 1: Primer Design and Amplification

• Design gene-specific primers with appropriate restriction sites for MOB2 amplification
• Include sequences for in-frame fusion with Gal4 DNA-binding domain
• Amplify MOB2 coding sequence via PCR using high-fidelity DNA polymerase

Step 2: Vector Ligation and Transformation

• Digest both PCR product and bait vector (e.g., pGBKT7) with restriction enzymes
• Purify digested fragments and ligate using T4 DNA ligase
• Transform ligation product into competent E. coli cells and plate on selective media
• Isolate plasmid DNA from resulting colonies and verify insertion by sequencing

Step 3: Bait Functionality and Autoactivation Testing

• Transform validated MOB2 bait vector into yeast reporter strain (e.g., AH109)
• Plate on selective media lacking tryptophan (-Trp) to select for bait-containing cells
• Test for autoactivation by plating on media lacking histidine (-His) and adenine (-Ade)
• If autoactivation occurs, consider using lower-stringency selection or truncated bait

Phase 2: Library Screening and Interaction Detection

Step 4: Library Transformation and Mating

• For library screening, transform prey library into mating-compatible yeast strain (e.g., Y187)
• Mate bait-containing yeast with prey library-containing yeast by combining cultures
• Alternatively, co-transform bait and prey libraries directly into same yeast strain

Step 5: Selection of Interactors

• Plate mated yeast on high-stringency selective media (-Trp, -Leu, -His, -Ade)
• Include appropriate controls: empty bait vector, known non-interacting proteins
• Incubate plates at 30°C for 3-7 days until colonies appear
• Pick positive colonies and restreak on fresh selective media to confirm phenotype

Step 6: Interaction Validation and Identification

• Isolate prey plasmids from positive yeast colonies
• Transform isolated plasmids into E. coli for amplification
• Sequence prey inserts using vector-specific primers
• Identify interacting proteins through database searches (BLAST)
• Confirm interactions through secondary assays (co-IP, BiFC)

Table 2: Troubleshooting Common Issues in MOB2 Y2H Screening

Problem	Potential Causes	Solutions
Bait autoactivation	MOB2 has intrinsic transcriptional activity	Use truncated MOB2 constructs; lower-stringency selection; different bait vector [15]
No interactions detected	Poor expression; improper localization; weak interactions	Verify bait expression (Western); try different screening conditions; use sensitive reporter genes [20]
High background	Non-specific interactions; insufficient selection	Optimize 3-AT concentration; include more stringent selection; use dual reporter systems [14]
Inconsistent results	Experimental variability; plasmid loss	Standardize protocols; include controls; ensure selective pressure maintenance [20]

MOB2-NDR Kinase Signaling Pathway

The diagram below illustrates the core signaling pathway involving MOB2 and its NDR kinase partners, highlighting key molecular relationships and regulatory mechanisms.

MOB2 Signaling and Regulatory Network

Research Reagent Solutions for MOB2-NDR Kinase Studies

Table 3: Essential Research Reagents for MOB2 Interaction Studies

Reagent Category	Specific Examples	Applications and Functions
Yeast Two-Hybrid Systems	Gal4-based (pGBKT7/pGADT7); Split-ubiquitin system	Detect protein-protein interactions; study membrane-associated complexes [14] [22]
Yeast Strains	AH109, Y187, ABC9Δ (engineered for permeability)	Reporter strains for interaction detection; enhanced compound permeability for inhibitor studies [15]
MOB2 Constructs	Full-length MOB2; Domain-specific variants; Tagged versions (HA, FLAG, GFP)	Bait protein for interaction screens; functional domain mapping; localization studies [4]
NDR Kinase Constructs	SAX-1 (C. elegans); Tricornered (Drosophila); STK38/STK38L (mammalian)	Known MOB2 binding partners for validation; pathway mapping [13] [4] [18]
Selection Agents	3-Amino-1,2,4-triazole (3-AT); Aureobasidin A	Control background; increase stringency; additional selection pressure [14]
Interaction Inhibitors	Kinase inhibitors; Small molecule libraries	Characterize MOB2-kinase interactions; identify potential therapeutic compounds [15]

Key Findings from MOB2 Interaction Studies

MOB2 in Neuronal Remodeling

Recent research using C. elegans has revealed MOB2's essential role in neuronal remodeling through its interaction with the NDR kinase SAX-1. In this model, MOB2 (encoded by sax-2) forms a complex with SAX-1 and MOB-2 to promote dendrite pruning during stress-induced developmental transitions [13]. This complex demonstrates branch-specific elimination of dendritic arbors, with SAX-1/MOB2 required for removing secondary and tertiary branches but not quaternary branches, revealing unexpected specificity in the pruning process [13]. The interaction between MOB2 and SAX-1 regulates membrane dynamics through endocytosis during neuronal remodeling, highlighting the functional significance of this partnership in cellular morphogenesis [13].

MOB2 in Hippo-like Signaling Pathways

MOB2 functions as a key regulatory partner for Tricornered-like NDR kinases (STK38/STK38L in mammals) in the Hippo-like signaling pathway, which operates parallel to the canonical Hippo pathway and primarily regulates cell and tissue morphogenesis rather than growth control [4]. The effect of MOB2 binding to Tricornered-like kinases appears complex, with studies reporting both activating and inhibitory roles depending on cellular context [4]. MOB2 can compete with Class I Mob proteins for binding to Tricornered-like kinases, suggesting a potential mechanism for fine-tuning NDR kinase activity through relative Mob availability [4].

Table 4: Quantitative Data from MOB2 Functional Studies

Experimental System	Observed Phenotype	Genetic Requirements	Biological Process
C. elegans IL2 dendrite remodeling [13]	Defective secondary/tertiary branch elimination	SAX-1/NDR, SAX-2/MOB2, MOB-2	Stress-induced dendrite pruning
C. elegans neuronal development [13]	Impaired dendrite elimination specificity	RABI-1/Rabin8, RAB-11.2 with SAX-1	Developmental neuronal remodeling
Signaling pathway studies [4]	Altered NDR kinase activity	MOB2 competition with Class I Mobs	Hippo-like pathway regulation

MOB2 represents a crucial adaptor protein that regulates NDR kinase function in fundamental cellular processes, particularly in neuronal development and cellular morphogenesis. The yeast two-hybrid system provides a powerful platform for identifying novel MOB2 binding partners and characterizing their functional relationships. Recent technical advances, including next-generation sequencing integration and specialized systems for membrane-associated proteins, have significantly enhanced the resolution and applicability of Y2H for MOB2 research.

Future investigations should leverage these advanced Y2H methodologies to comprehensively map the MOB2 interactome under different physiological conditions, identify context-dependent interactions, and discover small molecule modulators of MOB2-protein interactions. These approaches will continue to illuminate the multifaceted roles of MOB2 in cellular signaling and its potential implications for therapeutic development in neurological disorders and cancer.

MOB kinase activator 2 (MOB2) is an evolutionarily conserved adaptor protein belonging to the seven-member MOB family, which function as critical regulators of intracellular signaling pathways [4]. As a non-catalytic scaffold protein, MOB2 mediates its biological effects primarily through protein-protein interactions (PPIs), positioning it as a key node in cellular homeostasis [24]. Recent research has established compelling connections between disrupted MOB2 function and human diseases, particularly cancer, highlighting its role as a potential tumor suppressor [25]. The identification and characterization of MOB2 binding partners is therefore essential for understanding its mechanism of action in both normal physiology and disease states. Yeast two-hybrid (Y2H) screening methodologies provide powerful tools for mapping these interactions, offering insights that could inform therapeutic strategies targeting MOB2-mediated pathways [15] [26].

MOB2 Protein Structure and Classification

MOB2 is classified as a Class II MOB protein based on phylogenetic analysis [4]. Structurally, it shares the conserved Mob family fold—a globular structure with a core consisting of a four alpha-helix bundle [4]. Unlike Class I MOB proteins (MOB1A/B) that activate both Warts/LATS and Tricornered/STK38 classes of Nuclear Dbf2-related (NDR) kinases, MOB2 exhibits binding specificity primarily for the NDR1/2 kinases and does not interact with LATS1/2 kinases [25] [4]. This selective binding capacity underscores MOB2's unique functional role in specific signaling cascades distinct from the canonical Hippo pathway.

MOB2 as a Tumor Suppressor: Evidence from Cancer Studies

Expression and Clinical Significance in Glioblastoma

Substantial clinical evidence demonstrates MOB2's role as a tumor suppressor in glioblastoma (GBM). Immunohistochemical analyses reveal that MOB2 expression is markedly decreased or undetectable in GBM patient samples compared to low-grade gliomas and normal brain tissues [25]. Bioinformatic analyses of The Cancer Genome Atlas (TCGA) data consistently show significant downregulation of MOB2 mRNA in GBM samples compared to lower-grade gliomas and normal brain tissues [25]. This reduced expression carries clinical significance, as Kaplan-Meier survival analyses indicate that low MOB2 expression correlates significantly with poor prognosis in glioma patients [25].

Table 1: MOB2 Expression in Glioma Patient Samples

Sample Type	MOB2 Protein Level	MOB2 mRNA Level	Clinical Correlation
Normal brain tissue	High	High	N/A
Low-grade glioma (WHO I-II)	Moderate to high	Moderate	Better prognosis
Glioblastoma (WHO IV)	Low to undetectable	Significantly downregulated	Poor survival

Functional Role in Cancer Phenotypes

Functional studies provide compelling mechanistic insights into MOB2's tumor suppressive activities. Ectopic MOB2 expression suppresses malignant phenotypes in GBM cells, including clonogenic growth, migration, and invasion, while MOB2 depletion enhances these phenotypes [25]. In vivo studies using chick chorioallantoic membrane (CAM) and mouse xenograft models confirm that MOB2 overexpression reduces tumor invasion and growth, establishing its functional significance in cancer progression [25].

MOB2 Interaction Partners and Signaling Pathways

Protein-Protein Interaction Landscape

Recent proximity-dependent biotin identification (BioID) screens have substantially expanded our understanding of the MOB2 interactome, revealing over 200 interactions with at least 70% representing previously unreported associations [24]. This comprehensive mapping reliably recalls MOB2's established interaction with NDR kinases (STK38 and STK38L) while identifying novel potential partners that illuminate MOB2's diverse cellular functions [24].

Table 2: Key MOB2 Protein-Protein Interactions and Functional Consequences

Interaction Partner	Interaction Type/ Domain	Functional Consequence	Experimental Evidence
NDR1/2 (STK38/STK38L)	Direct binding	Regulation of cell cycle, morphogenesis	Y2H, BioID, co-IP [24] [25] [4]
RAD50	DNA damage response domain	Homologous recombination repair	Genetic and cellular assays [27]
FAK/Akt pathway components	Indirect via integrin signaling	Suppression of migration and invasion	Phosphoprotein arrays, IB analysis [25]
PKA signaling components	cAMP-dependent interaction	Regulation of cell migration	Pharmacological inhibition studies [25]

MOB2 in DNA Damage Response

Beyond its established roles in cell proliferation and migration, MOB2 plays a critical role in genome maintenance through the DNA damage response (DDR). MOB2 deficiency impairs homologous recombination (HR)-mediated DNA double-strand break repair by compromising the stabilization of RAD51 on damaged chromatin [27]. This function appears independent of its role in NDR kinase signaling, revealing a previously unappreciated facet of MOB2 biology [25] [27]. The physiological significance of this role is substantial—cancer cells with reduced MOB2 expression show enhanced sensitivity to PARP inhibitors, suggesting MOB2 expression may serve as a predictive biomarker for stratified cancer therapies [27].

Experimental Protocols for MOB2 Interaction Studies

Yeast Two-Hybrid Screening for MOB2 Binding Partners

Principle: The yeast two-hybrid system detects protein-protein interactions through reconstitution of a functional transcription factor when bait (MOB2) and prey proteins interact [15] [14].

Protocol:

• Strain Construction: Use the ABC9Δ yeast strain with enhanced permeability for small-molecule studies [15].
• Plasmid Design:
  • Clone full-length MOB2 into pGBKT7 (Gal4 DNA-BD vector) as bait
  • Clone candidate interacting partners or library into pGADT7 (Gal4 AD vector) as prey
• Transformation: Co-transform bait and prey plasmids into yeast reporter strain AH109 using the lithium acetate method [15].
• Selection: Plate transformations on SD/-Leu/-Trp medium to select for plasmid maintenance.
• Interaction Screening: Replate on SD/-Ade/-His/-Leu/-Trp medium to select for protein interactions.
• Validation: Confirm interactions by β-galactosidase assay for additional reporter activation [14].

Troubleshooting Notes: For screening small-molecule inhibitors of MOB2 interactions, use the ABC9Δ strain which lacks nine ABC transporters, enhancing compound permeability [15]. Include controls with empty vectors and known non-interacting proteins to eliminate false positives.

Functional Validation of MOB2 Interactions in Cancer Models

Principle: Validate MOB2 interactions in disease-relevant contexts using glioblastoma cell models [25].

Protocol:

• Cell Culture: Maintain GBM cell lines (e.g., LN-229, T98G, SF-539, SF-767) under standard conditions.
• Genetic Manipulation:
  • For knockdown: Use lentiviral shMOB2 constructs
  • For overexpression: Use pCDH-MOB2-V5 constructs
• Functional Assays:
  • Migration: Transwell migration assay (24-48 hours)
  • Invasion: Matrigel-coated Transwell invasion assay (48 hours)
  • Proliferation: BrdU incorporation assay (24 hours)
  • Anoikis resistance: Culture on poly-HEMA coated plates (72 hours)
• Pathway Analysis:
  • Monitor FAK/Akt pathway activity by Western blot for p-FAK (Tyr397) and p-Akt (Ser473)
  • Assess cAMP/PKA signaling using forskolin (activator) and H89 (inhibitor)
• In vivo Validation: Use chick chorioallantoic membrane (CAM) model for invasion studies or mouse xenografts for tumor growth analysis [25].

MOB2-Mediated Signaling Pathways: Visualization

MOB2 Signaling in Cancer and Cellular Homeostasis

Research Reagent Solutions for MOB2 Studies

Table 3: Essential Research Reagents for MOB2 Interaction Studies

Reagent/Category	Specific Examples	Function/Application	References
Yeast Two-Hybrid System	AH109 yeast strain, pGBKT7, pGADT7 vectors	Detection of binary protein-protein interactions	[15] [14]
Enhanced Permeability Strain	ABC9Δ yeast (deleted 9 ABC transporters)	Small-molecule inhibitor screening	[15]
Cell Line Models	LN-229, T98G, SF-539, SF-767 GBM cells	Functional validation in disease context	[25]
Genetic Manipulation	shMOB2 lentiviral constructs, pCDH-MOB2-V5	Knockdown and overexpression studies	[25]
Pathway Modulators	Forskolin (cAMP activator), H89 (PKA inhibitor)	Dissecting cAMP/PKA signaling	[25]
Interaction Validation	Co-IP, Western blot, BioID proximity labeling	Confirmation of protein complexes	[24] [25]

The comprehensive mapping of MOB2 interactions through yeast two-hybrid and complementary approaches reveals a multifaceted tumor suppressor protein that integrates signals from diverse cellular pathways. MOB2 emerges as a critical node regulating key cancer hallmarks including proliferation, invasion, and DNA repair fidelity. Its deregulation in glioblastoma and other cancers underscores its clinical relevance, while its role in determining PARP inhibitor sensitivity positions MOB2 as a potential predictive biomarker for targeted therapies. Further exploration of the MOB2 interactome will likely yield additional insights into its mechanisms of action and may uncover novel therapeutic opportunities for cancers characterized by MOB2 dysregulation. The experimental frameworks outlined herein provide robust methodologies for continuing this investigation, with particular promise in identifying small-molecule compounds that modulate MOB2 interactions for therapeutic benefit.

Monopolar spindle-one-binder protein 2 (MOB2) is a highly conserved adaptor protein belonging to the MOB family, which functions as critical regulators in intracellular signaling pathways [4]. MOB proteins serve as kinase activators and scaffolds that mediate the assembly of multiprotein complexes, primarily through interactions with Nuclear Dbf2-related (NDR) kinases [4]. Mammalian MOB2 specifically interacts with NDR1/2 kinases but not with LATS1/2 kinases, positioning it uniquely within the Hippo and Hippo-like signaling networks [28] [4]. Despite its discovery over two decades ago, the full spectrum of MOB2-binding partners and its diverse cellular functions remain incompletely characterized, creating a significant knowledge gap in our understanding of this crucial signaling regulator.

Table 1: MOB Protein Family Classification and Characteristics

Class	Representative Members	Primary Kinase Partners	Key Functions
Class I	MOB1A, MOB1B	LATS1/2, NDR1/2	Core Hippo pathway regulation, growth control
Class II	MOB2	NDR1/2	Cell morphogenesis, migration, cycle progression
Class III	MOB3A, MOB3B, MOB3C	Not well-defined	Poorly characterized; MOB3C associates with RNase P
Class IV	MOB4 (Phocein)	STRIPAK complex (phosphatase)	Antagonizes Hippo signaling, cell differentiation

The Biological and Clinical Significance of MOB2

MOB2 in Cell Signaling and Morphogenesis

MOB2 plays a fundamental role in regulating cell motility, morphogenesis, and cycle progression. In filamentous fungi such as Neurospora crassa, MOB2 proteins interact with the NDR kinase COT1 to control polar tip extension and branching [29]. Genetic deletion studies demonstrate that MOB2 is essential for proper hyphal growth and development, with Δmob-2 strains exhibiting significantly reduced growth rates and altered aerial hyphae formation [29]. This evolutionarily conserved function extends to mammalian systems, where MOB2 regulates cellular processes through its interaction with NDR kinases.

MOB2 as a Tumor Suppressor in Human Cancers

Emerging clinical evidence has established MOB2 as a potential tumor suppressor in various cancers, particularly in glioblastoma (GBM). Immunohistochemical analyses reveal that MOB2 expression is markedly downregulated in GBM patient samples compared to low-grade gliomas and normal brain tissues [30]. Bioinformatic analyses of The Cancer Genome Atlas (TCGA) dataset confirm that MOB2 mRNA levels are significantly reduced in GBM samples, and low MOB2 expression correlates with poor patient prognosis [30]. Functional studies demonstrate that MOB2 overexpression suppresses, while its depletion enhances, malignant phenotypes of GBM cells including clonogenic growth, anoikis resistance, migration, and invasion [30]. These findings highlight the clinical relevance of MOB2 and underscore the need to comprehensively understand its binding network.

MOB2 in Hepatocellular Carcinoma

In hepatocellular carcinoma (HCC), MOB2 inhibits cancer cell motility by regulating the Hippo signaling pathway. Mechanistically, MOB2 competes with MOB1 for binding to NDR1/2, which influences the subsequent interaction of MOB1 with LATS1 [28]. This competition ultimately leads to increased phosphorylation of LATS1 and inactivation of YAP, resulting in inhibition of cell migration and invasion [28]. This regulatory mechanism positions MOB2 as a critical modulator of the Hippo pathway with significant implications for cancer biology.

The MOB2 Knowledge Gap

Limitations of Current MOB2 Interactome Studies

Recent proximity-dependent biotin identification (BioID) screens aimed at mapping the global interactome of all seven human MOB proteins have revealed significant gaps in our understanding of MOB2 partnerships [24]. While these studies successfully recalled established MOB1 and MOB4 interactors, they uncovered that at least 70% of the >200 identified interactions were previously unreported in the BioGrid database [24]. Notably, this systematic comparison highlighted the particularly poor characterization of the MOB3 subfamily, for which no interactions were previously documented [24]. Although MOB2 was included in this analysis, the specialized functional roles of different MOB proteins suggest that unique, cell-type-specific interaction partners for MOB2 remain to be discovered.

Technical Limitations of Existing Methods

While proximity labeling techniques like BioID have advanced interactome mapping, they possess inherent limitations in capturing direct physical interactions. BioID identifies proteins within a ~10 nm radius of the bait protein, which may include both direct binding partners and proximal proteins [24]. This approach cannot distinguish between direct and indirect interactions, potentially obscuring the precise molecular relationships involving MOB2. Furthermore, the transient nature of some MOB2 interactions and its role as an adaptor protein may render certain complexes difficult to capture using standard affinity purification methods.

Table 2: Current Evidence for MOB2 Interactions and Functions

Evidence Type	Key Findings	Limitations/Gaps
BioID Proximity Labeling [24]	Identified >200 MOB protein interactions; 70% novel; recalled bona fide MOB1/4 partners	Cannot distinguish direct vs. indirect interactions; MOB2-specific network not focused
Functional Studies [30] [28]	MOB2 suppresses GBM migration/invasion; inhibits HCC motility via Hippo pathway	Limited to specific cellular contexts; complete signaling mechanisms unknown
Genetic Evidence [29]	MOB2-NDR complexes form distinct modules in fungi	Evolutionary conservation of specific interactions not fully mapped
Clinical Correlations [30]	MOB2 downregulated in GBM; correlates with poor survival	Comprehensive mechanistic link between interactions and tumor suppression unclear

Experimental Approach: Y2H Screen for MOB2 Partners

The yeast two-hybrid (Y2H) system is a powerful molecular biology technique for detecting direct protein-protein interactions in vivo [14]. The classic Y2H approach relies on the functional reconstitution of a transcription factor when two proteins interact. The bait protein (MOB2) is fused to a DNA-binding domain (DBD), while prey proteins are fused to an activation domain (AD). Upon bait-prey interaction, the reconstituted transcription factor activates reporter gene expression, enabling selection and identification of interacting partners [14]. Modern Y2H systems, such as the ULTImate Y2H platform, employ cell-to-cell mating processes that permit testing of approximately 83 million interactions per screen, ensuring exhaustive coverage and identification of rare binding partners [31].

Y2H-SCORES Computational Framework

Next-generation interaction screening (NGIS) protocols that combine Y2H with deep sequencing require sophisticated computational frameworks for data analysis. The Y2H-SCORES system implements three quantitative ranking scores to identify high-confidence interacting partners: (1) significant enrichment under selection for positive interactions, (2) degree of interaction specificity among multi-bait comparisons, and (3) selection of in-frame interactors [32]. This framework maximizes the detection of true interactors while minimizing false positives, which is essential for building reliable interaction networks [32].

Diagram 1: Y2H screening workflow for MOB2 partners. This diagram illustrates the key steps in a comprehensive yeast two-hybrid screen to identify novel MOB2-binding proteins.

Detailed Y2H Protocol for MOB2 Screening

Bait Construction and Validation

• Amplify MOB2 coding sequence using high-fidelity PCR with gene-specific primers containing appropriate restriction sites.
• Clone MOB2 into Y2H bait vector (e.g., pGBKT7) to generate an in-frame fusion with the GAL4 DNA-binding domain.
• Verify bait plasmid sequence by Sanger sequencing to ensure no mutations have been introduced during cloning.
• Test for autoactivation by transforming the MOB2 bait plasmid into yeast reporter strains (e.g., Y2HGold) and plating on dropout media lacking histidine and adenine. A valid bait should not activate reporter gene expression in the absence of a prey protein.

Library Screening

• Transform MOB2 bait plasmid into yeast mating type α strain (e.g., Y187).
• Mate bait strain with prey library (e.g., human cDNA library in mating type a strain) by combining cultures and incubating in rich medium for 24 hours.
• Plate diploid yeast on stringent dropout media (SD/-Ade/-His/-Leu/-Trp) to select for interacting clones.
• Incubate plates at 30°C for 5-7 days and monitor for colony formation.

Interaction Confirmation and Analysis

• Isolate positive colonies and rescue prey plasmids for sequence identification.
• Confirm interactions through pairwise retransformation and growth assays.
• Sequence prey inserts to identify MOB2-binding partners using Sanger or next-generation sequencing.
• Analyze interaction domains by comparing overlapping regions in prey fragments to determine minimal binding domains.

Anticipated Outcomes and Applications

Expected Results and Impact

A comprehensive Y2H screen for MOB2 binding partners is expected to identify both known and novel interactors, potentially including:

• Kinase partners beyond the established NDR1/2 interactions
• Regulatory proteins that modulate MOB2 stability, localization, or function
• Cell type-specific binding partners that explain tissue-specific MOB2 functions
• Disease-associated proteins that link MOB2 to pathological processes beyond cancer

These discoveries would significantly advance our understanding of MOB2's role in cellular signaling and its potential as a therapeutic target.

Technical Considerations and Optimization

To maximize screening success, several technical aspects require careful optimization:

• Bait design: Both full-length MOB2 and functional domains should be screened to identify structured interaction domains.
• Library selection: High-complexity, domain-enriched cDNA libraries from multiple tissue sources increase the probability of identifying relevant partners.
• Selection stringency: Varying selection pressure using competitive inhibitors like 3-AT can help optimize the balance between sensitivity and specificity [14].
• Control experiments: Including both positive and negative control baits is essential for assessing screening quality and identifying nonspecific interactions.

Table 3: Research Reagent Solutions for MOB2 Y2H Screening

Reagent/Resource	Function/Application	Key Features
ULTImate Y2H Platform [31]	High-throughput interaction screening	Tests ~83 million interactions; identifies weak/rare partners
Domain-Enriched cDNA Libraries [31]	Source of potential binding partners	>10 million clones; insert size 800-1000 bp (domain-sized)
Y2H-SCORES [32]	Computational analysis of NGIS data	Three quantitative scores for ranking interactors by confidence
MBmate Y2H System [31]	Screening membrane protein interactions	Validates proper localization of membrane-associated baits
pGBKT7 Vector	Bait plasmid for GAL4-DBD fusion	Contains TRP1 selection marker for yeast
Prey cDNA Libraries	Collection of potential MOB2 partners	Normalized libraries reduce abundant transcript representation

Diagram 2: MOB2 signaling network and knowledge gaps. This diagram illustrates established MOB2 interactions (solid lines) and potential novel interactions that could be discovered through Y2H screening (dashed red line), particularly connections to RNA processing machinery suggested by MOB3C findings.

The proposed Y2H screen for MOB2 binding partners addresses a critical knowledge gap in our understanding of this important signaling regulator. By systematically identifying direct protein interactions, this approach will illuminate novel aspects of MOB2 function in both normal physiology and disease states, particularly in cancer biology. The integration of modern Y2H methodologies with advanced computational analysis tools provides an unprecedented opportunity to comprehensively map the MOB2 interactome, potentially revealing new therapeutic targets and regulatory mechanisms in cell signaling pathways.

Executing a MOB2 Y2H Screen: From Vector Design to High-Throughput Sequencing

Protein-protein interactions (PPIs) are fundamental to virtually every cellular process, and the yeast two-hybrid (Y2H) system remains a cornerstone technique for their discovery. This application note provides a structured framework for researchers investigating PPIs, with a specific focus on selecting between the canonical GAL4-based system and modern alternative frameworks. Using the characterization of MOB2 binding partners as a thematic example, we detail experimental protocols, compare system performance parameters, and provide visualization tools to guide assay development for researchers and drug development professionals. The emphasis is on practical implementation, from library screening to quantitative validation, within the context of contemporary functional proteomics.

The yeast two-hybrid (Y2H) system, pioneered by Fields and Song in 1989, exploits the modular nature of eukaryotic transcription factors to detect PPIs in vivo [33] [14]. The core principle involves splitting a transcription factor into two discrete domains: a DNA-Binding Domain (DBD) and an Activation Domain (AD). The DBD is fused to a "bait" protein (e.g., MOB2), and the AD is fused to a "prey" protein (e.g., a library of coding sequences). A physical interaction between bait and prey reconstitutes the transcription factor, driving the expression of reporter genes [34] [14].

This technique has been instrumental in saturating protein interaction maps, a pursuit accelerated by genome sequencing projects [33]. Its application to the study of Mps one binder (MOB) proteins, key signal transducers, has been particularly fruitful. MOB proteins are highly conserved regulators of the NDR/LATS kinase family, with MOB2 playing specific roles in cell cycle progression and the DNA Damage Response (DDR) [7]. A Y2H screen, for instance, was successfully used to identify RAD50, a component of the MRE11-RAD50-NBS1 (MRN) DNA damage sensor complex, as a novel MOB2 binding partner [7]. This discovery highlighted MOB2's role in DDR signaling and cell cycle checkpoints, underscoring the functional importance of its interactome.

The following diagram illustrates the core conceptual workflow of a two-hybrid system applied to a signaling pathway like MOB2's:

Figure 1. Logical flow of MOB2 signaling and key Y2H discovery. MOB2 regulates NDR1/2 kinases and was found via Y2H to bind RAD50, linking it to DNA Damage Response (DDR).

Available Two-Hybrid Systems: A Quantitative Comparison

The classic GAL4-based Y2H has been adapted and improved to overcome its limitations, leading to a suite of options for researchers.

Core GAL4-Based Yeast Two-Hybrid (Y2H) The classic system uses the yeast Saccharomyces cerevisiae as a host. The bait is fused to the GAL4-DBD, and the prey is fused to the GAL4-AD. Interaction is detected by the activation of reporter genes, which are often auxotrophic markers (e.g., HIS3, ADE2) that allow growth on selective media or enzymes that produce a colorimetric signal [33] [34] [14].

Advanced and Alternative Systems

• Quantitative Y2H (qY2H): Replaces auxotrophic reporters with fluorescent or luminescent proteins. This allows for quantitative measurement of interaction strength and faster, more objective readouts. For example, replacing ADE2 with NanoLuc luciferase enables quantitative screening in 96-well plates with high sensitivity [35].
• Fluorescent Two-Hybrid (F2H): Conducted in mammalian cells, this system uses fluorescent protein tags to visualize the co-localization of bait and prey at a defined nuclear spot upon interaction. It is ideal for studying PPIs in a more native cellular environment and for screening inhibitors in live cells [17].
• Mammalian Two-Hybrid (M2H): Similar in principle to Y2H but performed in mammalian cells. This is crucial for proteins requiring post-translational modifications specific to higher eukaryotes. High-throughput versions like the Cell Array Protein-Protein Interaction Assay (CAPPIA) enable screening of thousands of combinations [36].
• Split-Ubiquitin System: An alternative to the transcription-based readout, designed for screening membrane protein interactions [14].

Table 1: Comparison of Key Two-Hybrid System Frameworks

System Feature	GAL4-based Y2H	Quantitative Y2H (e.g., NanoLuc)	Mammalian / F2H
Host Organism	Yeast (S. cerevisiae)	Yeast	Mammalian Cells
Readout Type	Growth (e.g., HIS3), Colorimetric	Luminescence, Fluorescence	Fluorescence Microscopy
Quantification	Semi-quantitative	Fully quantitative, calculates affinity	Semi- to Fully Quantitative
Time to Result	Several days	~2 hours for initial signal [37]	1-2 days
Key Advantage	Well-established, flexible, low cost	Objective, high-throughput, fast	Relevant PTMs, live-cell dynamics
Key Disadvantage	High false positives/negatives	Requires specialized equipment/l reagents	Lower throughput, higher cost
Ideal for MOB2	Initial library screening	Validating & ranking interaction affinity [37]	Confirming physiological relevance

Table 2: Advantages and Disadvantages of the GAL4 Two-Hybrid System

Advantages	Disadvantages
In vivo environment (closer to reality than in vitro) [33]	Auto-activation: Bait alone may activate transcription [33] [38]
Flexibility & rapid isolation of interacting proteins [38]	Misfolding: Fusion proteins may alter conformation [33] [38]
Low cost & less time than protein purification methods [38]	False positives/negatives rate can be high [38]
Functional screen: Identifies and clones the gene simultaneously [38]	Post-translational modifications may not occur in yeast [33] [38]
Can analyze known interactions (e.g., critical residues) [38]	Toxicity: Expression of some proteins (e.g., cyclins) can be toxic to yeast [38]

Detailed Experimental Protocols

Protocol 1: Initial Screening with GAL4-Based Y2H for MOB2 Partners

This protocol is adapted for identifying novel binding partners for MOB2 from a cDNA library.

I. Research Reagent Solutions Table 3: Essential Reagents for GAL4-Based Y2H

Reagent / Material	Function / Explanation
pGBKT7 (Bait Vector)	GAL4-DBD fusion vector; contains TRP1 selectable marker.
pGADT7 (Prey Vector)	GAL4-AD fusion vector; contains LEU2 selectable marker.
Y2H Gold Yeast Strain	Genetically engineered strain with multiple reporter genes (HIS3, ADE2, AUR1-C, MEL1).
cDNA Library	Prey library cloned into pGADT7; represents genes from a relevant tissue or cell line.
SD/-Trp/-Leu Media	Selective medium to maintain both bait and prey plasmids.
SD/-Trp/-Leu/-His/-Ade (QDO)	Stringent selective medium for interaction screening.
X-α-Gal	Substrate added to QDO medium; turns blue if MEL1 reporter is activated.

II. Step-by-Step Workflow

Figure 2. GAL4 Y2H workflow for MOB2 partner screening.

• Bait Preparation and Validation: Clone the full-length MOB2 gene into the pGBKT7 vector to create an in-frame fusion with the GAL4-DBD. Transform this construct into the Y2H Gold yeast strain and plate on SD/-Trp to select for bait-containing cells.
• Critical Auto-activation Test: Plate the bait strain on stringent media (SD/-His and SD/-Ade/-His supplemented with X-α-Gal). Lack of growth and no blue color formation is essential to proceed, confirming that MOB2 does not autonomously activate transcription [33] [38].
• Library Transformation: Mate the validated bait strain with a pre-transformed cDNA library in the Y2H Gold strain, or co-transform the library plasmid (pGADT7-based) directly into the bait strain. Plate the mixture on SD/-Trp/-Leu to select for diploid yeast or co-transformants containing both bait and prey plasmids.
• Interaction Selection and Screening: After 3-5 days of growth, replica-plate the colonies onto the most stringent selection medium: SD/-Ade/-His/-Leu/-Trp (QDO) supplemented with X-α-Gal. True protein-protein interactions will support growth and produce a blue pigment due to MEL1 reporter activation.
• Isolation and Identification of Prey: Isolate the pGADT7 prey plasmid from positive (growing, blue) colonies, typically by bacterial amplification. Sequence the plasmid insert using primers flanking the cloning site to identify the MOB2-interacting protein.

Protocol 2: Quantitative Validation with a Tri-Fluorescent Y2H System

This protocol is for validating hits from the primary screen and quantitatively assessing their binding affinity to MOB2.

I. Research Reagent Solutions Table 4: Essential Reagents for Quantitative Tri-Fluorescent Y2H

Reagent / Material	Function / Explanation
Quantitative Y2H Vectors	Set of plasmids for expressing Bait-FP1, Prey-FP2, and a reporter (e.g., NanoLuc).
Fluorescent Protein (FP) Tags	e.g., GFP, mCherry; for quantifying bait and prey expression levels at single-cell level.
NanoLuc Luciferase Reporter	Extremely bright, quantitative reporter for the interaction [35].
Flow Cytometer	For simultaneous detection of FP signals (bait/prey levels) and luminescence (interaction strength).
Affinity Ladder	A set of control PPIs with known dissociation constants (KD), used for calibration [37].

II. Step-by-Step Workflow

• Vector Construction: Subclone the gene for a validated hit (e.g., RAD50 or a fragment) and MOB2 into the quantitative Y2H vectors to create fusions with distinct fluorescent proteins (e.g., Bait-MOB2-FP1 and Prey-RAD50-FP2).
• Co-transformation and Induction: Co-transform the bait and prey constructs, along with the NanoLuc reporter plasmid, into the appropriate yeast strain. Induce protein expression for a short period (as little as 2 hours may be sufficient) [37].
• Flow Cytometry Analysis: Analyze the yeast population using a flow cytometer capable of detecting fluorescence and luminescence.
  • Use fluorescence channels to gate on cells expressing similar levels of both Bait-MOB2 and Prey-RAD50. This standardizes expression and ensures a fair comparison.
  • Within this gated population, measure the NanoLuc luminescence signal, which is directly proportional to the interaction strength.
• Affinity Estimation: Compare the mean luminescence value of the MOB2-prey pair to the "affinity ladder" created from control PPIs with known K_D values. This allows for the ranking and estimation of the dissociation constant for the novel interaction [37].

Selecting the Optimal Framework for MOB2 Research

The choice of system depends on the research question's stage and the specific biochemical characteristics of MOB2 and its partners.

• For Discovery Screening: Use Classic GAL4-Y2H. Its well-established protocols, low cost, and flexibility make it ideal for the initial, high-throughput identification of potential MOB2 binding partners from complex cDNA libraries [33] [38]. The discovery of MOB2-RAD50 via a Y2H screen is a testament to its power [7].

• For Validation and Affinity Measurement: Use Quantitative Y2H. When you have a defined set of candidate interactors, a quantitative system (e.g., NanoLuc-based) is superior. It provides an objective, numerical measure of interaction strength, helping to prioritize the most biologically relevant partners for MOB2 [35] [37].

• For Physiologically Relevant Confirmation: Use Mammalian/F2H Systems. Since MOB2 function is linked to NDR kinase regulation and DDR in human cells, confirming interactions in a mammalian context is critical. The F2H or M2H systems ensure that any post-translational modifications necessary for MOB2's function are present, providing higher confidence in the biological relevance of the finding [7] [17] [36]. This is crucial for downstream drug discovery efforts targeting these interactions.

Common Pitfalls and Solutions:

• High Background (False Positives): Increase stringency by using higher concentrations of 3-AT (a competitive inhibitor of the HIS3 gene product) or by using more reporter genes in parallel [14]. Always confirm positives with a reciprocal assay.
• No Positives (False Negatives): Ensure MOB2 and its partners are correctly folded and localized to the nucleus. Consider "swapping" the fusion partners (fusing MOB2 to AD instead of DBD) to overcome steric hindrance [33] [38]. If interactions depend on phosphorylation, co-express the relevant kinase in yeast [33] [14].

In conclusion, there is no single "best" two-hybrid system. The classic GAL4-based Y2H remains a powerful tool for unbiased discovery, as demonstrated by the finding of the MOB2-RAD50 interaction. However, modern quantitative and mammalian-based frameworks are indispensable for validating, ranking, and confirming these interactions under physiologically relevant conditions. A strategic combination of these systems, beginning with a broad screen and culminating in quantitative validation in a mammalian context, provides the most robust path for defining the MOB2 interactome and translating these findings into therapeutic insights.

Within the framework of a broader thesis investigating the binding partners of the Monopolar spindle-one-binder protein 2 (MOB2), the construction of a specific and functional bait vector is a critical first step. MOB2 is a highly conserved protein that functions as a signal transducer and is known to interact with and regulate the Nuclear Dbf2-related (NDR) kinases [28]. In the context of the Hippo signaling pathway, MOB2 is reported to compete with MOB1 for binding to NDR1/2, thereby influencing cell processes such as survival, cycle progression, and motility [28]. The yeast two-hybrid (Y2H) system is a powerful molecular technique for discovering novel protein-protein interactions in vivo [14]. This protocol details the precise methodology for cloning the MOB2 gene into a DNA-Binding Domain (DBD) plasmid, creating the "bait" essential for screening a cDNA "prey" library to identify MOB2-binding partners. A successfully constructed bait vector, encoding a DBD-MOB2 fusion protein, will serve as the foundation for all subsequent screening phases in this thesis research.

Principle of the Yeast Two-Hybrid Bait System

The yeast two-hybrid system is based on the modular nature of eukaryotic transcription factors [14] [39]. The system is designed so that the physical interaction between a "bait" protein (in this case, MOB2) and a "prey" protein reconstitutes the activity of a split transcription factor, leading to the expression of reporter genes [14] [40].

• DBD-Bait Fusion: The protein of interest (MOB2) is fused to a DNA-Binding Domain (DBD). This fusion protein can bind to a specific Upstream Activating Sequence (UAS) in the yeast promoter but cannot activate transcription on its own [39].
• AD-Prey Fusion: Potential binding partners are fused to a Transcriptional Activation Domain (AD). This fusion protein alone cannot activate transcription as it lacks the ability to bind DNA [39].
• Interaction-Dependent Reporter Activation: If the MOB2 bait and a prey protein interact, the DBD and AD are brought into proximity. This reconstitutes a functional transcription factor that drives the expression of downstream reporter genes (e.g., HIS3, lacZ), allowing for growth on selective media or a colorimetric assay [14] [39].

The following diagram illustrates this core logical relationship and the experimental workflow for bait vector construction and validation.

Research Reagent Solutions

The following table catalogues the essential materials and reagents required for the successful construction of the MOB2 bait vector.

Table 1: Key Research Reagents for Bait Vector Construction

Item	Function & Description	Example(s)
DNA-Binding Domain (DBD) Plasmid	Backbone vector expressing the DBD (e.g., Gal4 or LexA) fused to your protein of interest. Contains a selective marker for yeast [14] [39].	pGBKT7 (Gal4-DBD), pEZY202 (LexA-DBD)
MOB2 Gene Sequence	The template DNA containing the full coding sequence of the human MOB2 gene.	cDNA from human cell line (e.g., SMMC-7721 [28])
Restriction Enzymes	Molecular scissors that cut DNA at specific sequences to create compatible ends for ligation.	BamHI, EcoRI, SalI
DNA Ligase	Enzyme that catalyzes the joining of the MOB2 insert into the linearized DBD plasmid backbone.	T4 DNA Ligase
Competent E. coli Cells	Genetically engineered bacteria that can uptake foreign DNA for plasmid amplification.	DH5α, XL-1 Blue [14]
Oligonucleotide Primers	Short, single-stranded DNA molecules designed to amplify the MOB2 coding sequence with necessary adapters for cloning.	Forward and Reverse primers with restriction sites
Growth Media & Antibiotics	Selective media for bacterial and yeast growth, containing antibiotics to maintain plasmid selection.	LB-Ampicillin, SD/-Trp [39]

Detailed Protocol for Bait Vector Construction

Selection of the DBD Plasmid and Cloning Strategy

The first step involves choosing an appropriate DBD vector. A common choice is a plasmid like pGBKT7, which contains the Gal4 DNA-binding domain and a tryptophan (TRP1) auxotrophic marker for selection in yeast [39]. The multiple cloning site (MCS) downstream of the DBD should be examined to select unique restriction enzymes that are not present within the MOB2 coding sequence. As an alternative to traditional restriction cloning, modern systems like the "Make Your Own Mate & Plate Library" kit utilize homologous recombination in yeast for library construction, which can also be adapted for bait cloning, eliminating the need for multiple restriction enzymes and ligation [41].

Primer Design and PCR Amplification of MOB2

Design forward and reverse primers to amplify the entire MOB2 coding sequence (CDS). The primers must include:

• Restriction enzyme sites at their 5' ends that are compatible with the chosen sites in the DBD plasmid.
• Protective bases upstream of the restriction site to ensure efficient enzyme cleavage.
• Gene-specific sequence complementary to the start (forward) and end (reverse, excluding the stop codon if a C-terminal fusion is desired) of the MOB2 CDS.

Example Primer Design:

• Forward Primer (with EcoRI site): 5'- GACGAATTCATGGAGTCGCCGCTGGCG -3'
  • (EcoRI site shown in bold, start codon underlined)
• Reverse Primer (with BamHI site): 5'- GACGGATCCCTACGCAGGCTGGGCTT -3'
  • (BamHI site shown in bold, reverse complement of stop codon underlined)

Perform PCR using a high-fidelity DNA polymerase to minimize mutations. The PCR product must be purified using a gel extraction or PCR purification kit.

Restriction Digestion and Ligation

• Digestion: Simultaneously digest approximately 200-400 ng of both the purified MOB2 PCR product and the DBD plasmid (e.g., pGBKT7) with the selected restriction enzymes (e.g., EcoRI and BamHI). Incubate at the recommended temperature for 1-2 hours.
• Purification: Gel-purify the digested plasmid backbone and the MOB2 insert to separate them from the small cut fragments and uncut DNA.
• Ligation: Set up a ligation reaction with a molar ratio of insert:vector typically between 3:1 and 5:1. Use T4 DNA Ligase and incubate at room temperature or 16°C for 1-4 hours. Always include a vector-only control ligation to assess background.

Transformation and Plasmid Verification

• Transformation: Transform the ligation reaction into competent E. coli cells (e.g., DH5α) via heat shock or electroporation [14].
• Screening: Plate the transformation on LB agar containing the appropriate antibiotic (e.g., ampicillin for pGBKT7) and incubate overnight at 37°C.
• Colony PCR & Plasmid Prep: Screen individual colonies by colony PCR or directly inoculate cultures for plasmid minipreparation.
• Sequencing: Verify the integrity of the construct by Sanger sequencing using primers that anneal to the DBD plasmid sequence flanking the MCS. This is crucial to confirm the correct MOB2 sequence and in-frame fusion with the DBD.

Critical Validation: The Autoactivation Test

Before proceeding with a library screen, it is imperative to test whether the DBD-MOB2 bait protein autonomously activates the reporter system without a prey partner—a phenomenon known as autoactivation [39].

Procedure:

• Transform the verified DBD-MOB2 bait plasmid and the empty DBD plasmid (negative control) into the appropriate yeast reporter strain (e.g., Y2HGold, which contains GAL4-responsive reporters).
• Plate the transformed yeast on synthetic dropout (SD) media lacking tryptophan (SD/-Trp) to select for the bait plasmid.
• After growth, replica-plate or streak the yeast onto stricter selective media: SD/-Trp/-His and SD/-Trp/-His/-Ade (if using multiple reporters). Also, perform a β-galactosidase assay (X-gal plate test) if using a lacZ reporter [39] [40].

Interpretation:

• No Autoactivation: Yeast containing the DBD-MOB2 bait should not grow on SD/-His or show blue color with X-gal. This indicates a valid bait for screening.
• Autoactivation: If growth or color development occurs, the bait is autoactive. Solutions include using a lower-expression promoter for the bait, mutating the MOB2 sequence, or employing a different DBD system with weaker activation domains [39].

Quantitative Data and Parameters for Bait Validation

The following table summarizes the key quantitative benchmarks and parameters to monitor during bait vector construction and validation.

Table 2: Key Metrics for Bait Vector Construction and Validation

Parameter	Target / Acceptable Result	Method of Assessment
MOB2 Insert Concentration	20-50 ng/µL (post-purification)	Spectrophotometry (Nanodrop)
Vector:Insert Molar Ratio in Ligation	1:3 to 1:5	Calculation based on DNA concentration and length
Transformation Efficiency in E. coli	>1 x 10⁶ CFU/µg (for electroporation)	Count colonies on selective plates
Colony PCR Positive Clones	>80% of screened colonies	Agarose gel electrophoresis
Correct In-Frame Fusion	100% match to MOB2 CDS	Sanger DNA Sequencing
Autoactivation Test (Growth on SD/-His)	No growth after 3-5 days	Visual inspection of yeast plates
Bait Protein Expression	Protein band of expected size (~DBD + MOB2)	Western Blot with anti-DBD or anti-MOB2 antibody

Pathway and Workflow Visualization

The successful application of the MOB2 bait vector in a Y2H screen is a key step in elucidating its role in cellular signaling pathways. Research indicates that MOB2 regulates cell motility by interacting with the NDR/LATS kinases and influencing the Hippo/YAP signaling cascade [28]. The diagram below integrates the bait construction process into the broader context of this biological pathway and the subsequent screening workflow.

This detailed protocol provides a robust foundation for constructing and validating a MOB2 bait vector, a critical reagent for defining the MOB2 protein interaction network and advancing its functional characterization in cell signaling and disease.

Selecting an appropriate prey library is a critical first step in Yeast Two-Hybrid (Y2H) screens to identify binding partners for proteins of interest such as MOB2. This application note provides a detailed comparison of cDNA and genomic DNA (gDNA) libraries, outlining their structural differences, functional applications, and practical considerations for comprehensive interaction screening. We present optimized protocols for library screening and validation, specifically framed within the context of identifying MOB2 interactors, to guide researchers in selecting the most appropriate library type for their specific experimental goals. The technical insights provided herein aim to enhance screening completeness while minimizing false negatives and positives in interaction mapping.

Library Fundamentals and Strategic Selection

The Yeast Two-Hybrid system is a powerful genetic method for detecting binary protein-protein interactions (PPIs) in vivo, pioneered by Fields and Song in 1989 [14]. In this system, a "bait" protein (e.g., MOB2) is fused to a DNA-binding domain (DBD), while potential "prey" partners are fused to an activation domain (AD). Interaction between bait and prey reconstitutes a functional transcription factor, driving expression of reporter genes that enable detection [26] [14]. The success of this approach critically depends on the quality and composition of the prey library, which serves as the source for discovering novel interactions.

Table 1: Fundamental Characteristics of cDNA and Genomic DNA Libraries

Characteristic	cDNA Library	Genomic DNA Library
Source Material	mRNA [42] [43]	Total genomic DNA [43]
Represented Sequences	Only expressed (exonic) regions; no introns [43] [44]	Entire genome, including both coding and non-coding regions [43]
Cellular Context	Tissue or cell type-specific [42]	Organism-specific, independent of expression [43]
Information Provided	Snapshot of active gene expression at time of RNA extraction [42] [44]	Complete genetic blueprint, including regulatory elements [43] [44]
Primary Application in Y2H	Screening for protein-coding interaction partners [26]	Studying DNA-protein interactions or genomic regulatory regions [43]

For comprehensive screening of MOB2 protein-binding partners, cDNA libraries are overwhelmingly the preferred choice. Since cDNA is synthesized from messenger RNA (mRNA), it represents only the complement of genes actively expressed in the source tissue or cell line [42] [44]. This excludes introns and non-coding regions, meaning the library is enriched for coding sequences that can be directly translated into the prey proteins necessary for interaction screening in Y2H [43]. In contrast, genomic libraries contain all DNA sequences, including introns, promoters, enhancers, and repetitive elements [43] [44]. While invaluable for studying gene regulation and genomic structure, these features make gDNA libraries poorly suited for standard PPI screens, as intron-containing clones will not express correct prey proteins in the Y2H system.

Comparative Analysis: cDNA vs. Genomic DNA Libraries

A thorough understanding of the technical advantages and limitations of each library type is essential for experimental design and data interpretation.

Table 2: Functional Advantages and Disadvantages for Y2H Screening

Aspect	cDNA Library	Genomic DNA Library
Key Advantages	• Direct expression of protein-coding sequences [42]• No intron splicing requirement in yeast [42] [44]• Enables tissue/stage-specific interaction mapping [42]• Compatible with eukaryotic expression systems [26]	• Contains regulatory elements (promoters, enhancers) [43] [44]• Useful for studying non-coding DNA interactions• Represents the entire genetic potential of an organism
Major Limitations	• Does not include regulatory sequences [43]• Under-represents low-abundance transcripts [45]• Sensitive to RNA source quality and completeness [46]	• Unsuitable for direct protein interaction screens (contains introns) [43]• High complexity and large size complicate handling [43]• Most clones are irrelevant for protein-protein interaction studies

Critical Considerations for cDNA Library Quality

The utility of a cDNA library in a Y2H screen is highly dependent on its quality, which is characterized by several key parameters:

• Completeness and Diversity: A high-quality library should represent a vast majority of the mRNA transcripts from the source cells. Recent advancements using Oxford Nanopore Technologies (ONT) for long-read sequencing enable comprehensive assessment of library diversity by directly sequencing the cDNA inserts within the plasmid backbone, identifying over 12,000 protein-coding genes in a single sequencing run as demonstrated in a 2025 study [46].
• Insert Size and Cloning Efficiency: Libraries should have large average insert sizes (often >1 kb) to ensure full-length or near-full-length ORFs are represented, and a high percentage (>87%) of vectors should contain inserts [46].
• Normalization: To avoid bias toward highly expressed genes, normalized libraries can be used to increase the representation of rare transcripts, thereby improving screening coverage [46].

Experimental Protocol: cDNA Library Screening for MOB2 Binding Partners

The following protocol is optimized for screening a cDNA library against a MOB2 bait construct in yeast, incorporating strategies to minimize false positives and negatives.

Stage 1: Pre-Screen Validation and Preparation

Objective: To validate the bait construct and prepare the yeast reporter strain.

• Bait Construction: Clone the full-length coding sequence of MOB2 into a Y2H bait vector (e.g., pGBKT7) downstream of and in-frame with the Gal4 DNA-Binding Domain (DBD).
• Autoactivation Test: Transform the MOB2-DBD construct into the appropriate yeast reporter strain (e.g., AH109 or Y2HGold). Plate on SD/-Trp (synthetic dropout lacking tryptophan) to select for the bait plasmid. Subsequently, test for growth on SD/-His/-Ade and assay for β-galactosidase activity. A non-autoactivating bait will show no growth or color development in the absence of a true interacting prey.
• Strain Preparation: Grow a large culture of the validated, autoactivation-negative yeast strain containing the MOB2-DBD bait. Use this culture to prepare competent cells for high-efficiency library transformation [39].

Stage 2: Library Transformation and Screening

Objective: To introduce the prey library and select for putative interactors.

• High-Efficiency Transformation: Co-transform the competent MOB2-DBD yeast strain with the prey cDNA library (fused to the Gal4 Activation Domain, AD) using a high-efficiency lithium acetate method. The library can be a commercial human cDNA library or one constructed from a biologically relevant tissue/cell line for MOB2 biology.
• Selection of Interactors: Plate the transformation mixture on high-stringency selective media, typically SD/-Trp/-Leu/-His/-Ade, to select for yeast cells that contain both the bait and prey plasmids AND where a protein-protein interaction activates the HIS3 and ADE2 reporter genes.
• Incubation and Colony Picking: Incubate plates at 30°C for 3-7 days. Pick surviving colonies and re-streak them onto fresh high-stringency plates to confirm the phenotype.

Stage 3: Validation and Hit Identification

Objective: To eliminate false positives and identify true MOB2 interactors.

• Isolate Prey Plasmid: Isolate the prey plasmid from each positive yeast clone via bacterial rescue (e.g., electroporation into E. coli with selection for the prey plasmid marker).
• Confirm Specific Interaction: Re-transform the isolated prey plasmid back into the yeast reporter strain alongside either the original MOB2-DBD bait or a control bait (e.g., DBD-lamin). A true positive will only grow on selective media when co-expressed with MOB2-DBD, not with the control bait.
• Sequence and Identify: Sequence the cDNA insert of the validated prey plasmids using primers flanking the cloning site. Analyze the resulting sequences against genomic databases (e.g., BLAST) to identify the interacting protein.

Figure 1: Workflow for screening MOB2 binding partners using a cDNA library in the Yeast Two-Hybrid system. The process involves key validation steps to minimize false positives.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Reagent Solutions for Y2H cDNA Library Screening

Reagent / Solution	Function in the Protocol	Example(s) / Notes
Y2H Bait Vector	Expresses the protein of interest (MOB2) as a fusion with a DNA-Binding Domain (DBD).	pGBKT7 (Gal4 DBD), pLexA (LexA DBD). Must include a selectable marker (e.g., TRP1).
Y2H Prey cDNA Library	Collection of cDNA clones fused to an Activation Domain (AD), representing potential interacting partners.	Commercial human cDNA library in pGADT7 (Gal4 AD). Ensure it is from a relevant tissue/cell type.
Yeast Reporter Strain	Engineered yeast that reports interactions via survival or colorimetric assays.	AH109, Y2HGold. Contain auxotrophic markers (e.g., HIS3, ADE2 under Gal4-responsive promoters).
Selective Dropout Media	Selects for yeast containing bait/prey plasmids and reports interactions.	SD/-Trp (bait selection), SD/-Trp/-Leu (bait + prey selection), SD/-Ade/-His/-Trp/-Leu (interaction selection).
3-Amino-1,2,4-triazole (3-AT)	Competitive inhibitor of the HIS3 gene product; increases stringency to reduce false positives [14].	Titrate concentration (e.g., 1-25 mM) in SD/-His media during secondary screening.
ABC Transporter-Deficient Strain	Engineered yeast strain with enhanced permeability to small molecules, crucial for inhibitor screens [47].	ABC9Δ strain (deleted for 9 ABC transporters) allows small-molecule inhibitors to reach intracellular targets effectively.
RK-2	RK-2	Chemical Reagent
Im-1	Im-1|Chemical Reagent|For Research Use	The compound 'Im-1' is not uniquely identified. Please verify the specific compound structure or intended application. For Research Use Only. Not for human or veterinary use.

Troubleshooting and Quality Control

• Minimizing False Positives:

  • Include Controls: Always perform screens with prey-only and bait-only controls to establish baseline reporter activity [39].
  • Vary Expression Levels: Overexpression can force non-physiological interactions. Using lower-copy number plasmids or inducible promoters can increase stringency [39].
  • Independent Validation: Confirm all putative interactions using an orthogonal method, such as co-immunoprecipitation, from a native system [39].

• Minimizing False Negatives:

  • Test System Function: Use a pair of proteins known to interact as a positive control to ensure the entire Y2H system is functional [39].
  • Screen Multiple Configurations: Interactions can be blocked by steric hindrance from the DBD/AD fusions. Screen both N-terminal and C-terminal fusions of your bait protein if possible [26] [39].
  • Assess Library Quality: Prior to large-scale screening, sequence a sample of the cDNA library to assess its diversity and completeness [46]. A poorly representative library is a major source of false negatives.
  • Consider Alternative Systems: For proteins requiring specific post-translational modifications not present in yeast, co-express the modifying enzyme. For membrane proteins, consider a split-ubiquitin system which does not require nuclear localization [26] [39].

The strategic selection of a prey library is paramount for the success of a Y2H screen aimed at uncovering the MOB2 interactome. For this objective, cDNA libraries offer a superior and more efficient resource compared to genomic DNA libraries, as they directly provide the coding sequences necessary for producing functional prey proteins. By adhering to the detailed protocols and quality control measures outlined in this document—particularly the rigorous pre-validation of the bait construct, the use of high-quality, well-characterized cDNA libraries, and the systematic confirmation of putative hits—researchers can significantly enhance the reliability and comprehensiveness of their interaction data, thereby accelerating the characterization of MOB2's role in critical cellular signaling pathways.

The Dynamic Enrichment for Evaluation of Protein Networks (DEEPN) workflow represents a significant evolution in yeast two-hybrid (Y2H) screening technology. Traditional Y2H methods, while effective for discovering high-affinity interactors, face substantial limitations in comprehensively identifying transient or low-affinity protein interactions and in accurately comparing interactomes across different bait proteins [48]. The DEEPN approach overcomes these constraints by integrating batch processing of complex plasmid populations with high-throughput DNA sequencing and sophisticated computational analysis [48] [49].

This methodology is particularly valuable for research focused on identifying binding partners for proteins such as MOB2, a key regulator in cellular signaling pathways. By enabling the simultaneous discovery of dozens of transient and static protein interactions within a single screen, DEEPN provides an unparalleled tool for mapping comprehensive protein interaction networks that underlie molecular mechanisms in cell biological processes [49]. The capacity to directly compare interactions across multiple bait proteins allows researchers to identify differential interactions that distinguish between various protein conformations or functional states [48].

Key Principles and Advantages of DEEPN

Core Technological Principles

The DEEPN methodology operates on several fundamental principles that distinguish it from traditional Y2H approaches:

• Batch Processing and Competition Monitoring: DEEPN follows the abundance of Y2H-cDNA prey plasmids in a library population as they compete for growth advantage under selection with a given bait plasmid [48]. This competitive growth dynamic allows rare but authentic interacting prey plasmids to amplify sufficiently for detection.
• Deep Sequencing Integration: Instead of sampling individual colonies, DEEPN utilizes Illumina sequencing of PCR-amplified prey plasmid inserts to comprehensively identify interacting partners [48] [49].
• Quantitative Interaction Assessment: The expansion rate of specific prey plasmids during selective growth serves as a proxy for relative interaction strength, providing semi-quantitative data on binding affinities [49].

Comparative Advantages

Table 1: Comparison of Traditional Y2H vs. DEEPN Workflow

Feature	Traditional Y2H	DEEPN Workflow
Screening Throughput	Limited by colony picking and processing	High-throughput, batch processing of entire populations
Sensitivity to Low-Abundance/ Low-Affinity Interactors	Low, due to dominance by abundant interactors	High, due to competition-based enrichment
Quantitative Assessment	Limited to binary (yes/no) interaction data	Semi-quantitative based on enrichment rates
Comparative Analysis	Challenging due to variable baseline populations	Direct comparison enabled by reproducible library distributions
Library Complexity	Limited by practical colony analysis constraints	Accommodates highly complex libraries (>1 million elements)

The DEEPN approach specifically addresses the challenge of detecting important interacting proteins that are present at few copies per cell or that interact only transiently with their binding partners – limitations that significantly diminish the effectiveness of traditional methods like co-purification and mass spectrometry [48]. Furthermore, DEEPN eliminates the bias toward highly abundant partners that characterizes many protein-protein interaction methods [48].

Experimental Protocol for DEEPN

Reagent and Strain Preparation

Table 2: Essential Research Reagents for DEEPN Implementation

Reagent/Strain	Type/Description	Function in Workflow
PJY69 Yeast Strain	MATA genotype with Gal4-DBD bait construct	Bait protein expression strain
Y187 Library Strain	MATα genotype with Gal4-AD prey library	Prey library expression strain
pTEF-GBD Bait Plasmid	TRP1 CEN-based low copy plasmid with Kanr	Expresses Gal4-DNA-binding domain fusion proteins
High-Density Y2H Library	Gal4-AD fusion with randomly sheared genomic DNA	Provides highly complex prey population (>1M elements)
Specialized Media	CSM dropout media with varied supplements	Selective growth under interaction conditions

Recent improvements to the DEEPN protocol include the development of a new bait plasmid (pTEF-GBD) that produces Gal4-DNA-binding domain fusion proteins within a TRP1 centromere-based low copy plasmid, minimizing copy number variability that can skew Y2H transcriptional response [49]. Additionally, a new yeast strain has been engineered that houses prey libraries with significantly higher mating efficiency, facilitating the generation of equivalent diploid populations essential for comparative analyses [49].

Detailed Procedural Workflow

Library Population Generation

The critical first step involves generating populations of yeast with different bait plasmids that maintain identical distributions of the plasmid prey libraries. This is achieved through a optimized mating procedure:

• Strain Preparation: Grow MATA PJY69 yeast (carrying Gal4-DBD-bait construct) and MATα Y187 yeast (containing Y2H prey library) in appropriate selective media [48] [49].
• Mating Protocol: Combine bait and prey strains in buffered YPDA medium and incubate to allow mating. This typically generates ~5×10⁶ to 10×10⁶ independent diploid strains for a cDNA library with ~1×10⁶ elements [48].
• Quality Control: Sequence PCR products spanning cDNA inserts amplified from multiple independently generated diploid populations to verify reproducible library distributions [48].

The reproducibility of baseline cDNA library populations across different bait plasmids is essential for making accurate comparisons between interactomes [48] [49].

Selective Growth and Competition

The DEEPN approach leverages competitive growth under selective conditions to enrich for interacting prey plasmids:

• Selection Initiation: Plate diploid populations on synthetic dextrose minimal media lacking histidine (SD-His) to select for cells with positive Y2H interactions [48].
• Stringency Modulation: Adjust selection stringency using different concentrations of the His3 competitor 3-aminotriazole (3AT) to stratify growth rates and enhance competition [48].
• Growth Monitoring: Allow limited rounds of growth under low-stringency selection to maximize detection of diverse interactors before dominant plasmids crowd out weaker interactions [48].

The competition dynamics follow a predictable model where initially, growth under selection depletes non-interacting plasmids, increasing the abundance of all interacting prey. As selection continues, Y2H-positive plasmids compete against each other, with the fittest eventually dominating the population [48].

Sequencing and Computational Analysis

The bioinformatics workflow processes sequencing data to identify and rank interacting proteins:

• Sequence Processing: Use Tophat2 to map reads to the reference genome and identify unmapped reads containing flanking Gal4-AD expression plasmid sequences [48].
• Gene Counting: The DEEPN GeneCount module counts mapped reads per candidate gene, measuring enrichment levels during selective growth [48].
• Statistical Ranking: The StatMaker program provides statistical ranking of Y2H interactions across multiple baits [48].
• Variant Analysis: JunctionMake and QueryBlast modules analyze unmapped sequences to identify fusion points and determine whether protein fragments are in the proper translational frame [48].
• Insert Reconstruction: ReadDepth calculates read depth along prey inserts to reconstruct candidate Y2H prey plasmids for validation [48].

DEEPN Experimental and Computational Workflow

Application to MOB2 Binding Partner Research

Experimental Design Considerations

When applying the DEEPN workflow to identify MOB2 binding partners, several specific considerations enhance the success of the screen:

• Bait Design: For proteins like MOB2 that may have multiple functional domains, consider constructing both full-length and domain-specific baits to identify interactions specific to particular regions [49].
• Library Selection: For comprehensive identification of MOB2 interactors, use complex libraries such as the high-density Y2H fragment library with >1 million elements, increasing the probability of detecting both strong and weak interactions [49].
• Control Baits: Include control baits with known interaction profiles to validate screen performance and establish baseline thresholds for interaction significance [48].
• Selection Stringency: Employ graded selection conditions (varying 3AT concentrations) to capture both high-affinity and transient interactions involving MOB2 [48].

Quantitative Data Analysis

Table 3: Expected Output Metrics for a DEEPN Screen of MOB2

Metric	Expected Range	Interpretation
Total Diploids Generated	5-10 × 10⁶	Indicates sufficient library complexity
Sequence Reads per Sample	10-50 million	Ensures adequate sampling depth
Significant Interactors	Dozens to hundreds	Varies with MOB2 connectivity
Differential Interactions	Context-dependent	Identifies conformation-specific binders
False Discovery Rate	<5%	With proper statistical thresholds

The statistical analysis provided by the DEEPN workflow enables rigorous ranking of MOB2 interactors by specificity, allowing researchers to distinguish genuine binding partners from non-specific interactions [48]. The differential interaction capability is particularly valuable for identifying binding partners that specifically recognize particular phosphorylation states or conformational variants of MOB2.

Technical Notes and Troubleshooting

Critical Optimization Parameters

Successful implementation of the DEEPN workflow for MOB2 research requires attention to several technical details:

• Mating Efficiency: Ensure mating efficiency is sufficient to generate the recommended 5-10 million diploids. Low mating efficiency can reduce library complexity and bias results [49].
• Bait Expression Level: Use low-copy bait plasmids (such as pTEF-GBD) to minimize variability in bait expression that can skew interaction assessments [49].
• Growth Duration: Limit selective growth periods to prevent over-amplification of dominant interactors at the expense of weaker but biologically relevant MOB2 binding partners [48].
• Sequencing Depth: Ensure sufficient sequencing depth to detect rare prey plasmids, particularly when working with highly complex libraries for comprehensive MOB2 interactome mapping [48].

Validation Strategies

Candidate MOB2 binding partners identified through DEEPN screening should undergo rigorous validation:

• Orthogonal Assays: Confirm interactions using complementary methods such as co-immunoprecipitation, pull-down assays, or biophysical techniques [9].
• Domain Mapping: Identify specific MOB2 domains responsible for interactions using truncated constructs [9].
• Functional Characterization: Assess the biological significance of interactions through genetic or pharmacological perturbation in appropriate cellular models [50].

The DEEPN workflow provides a powerful platform for comprehensively characterizing the MOB2 interactome, enabling researchers to overcome traditional limitations of Y2H screening and discover both stable and transient interactions that may regulate MOB2 function in critical cellular processes.

Within functional genomics research, the identification of protein-protein interactions is fundamental. The yeast two-hybrid (Y2H) system is a powerful, well-established genomic method for discovering novel binding partners in a living cell [51]. For researchers investigating specific proteins like MOB2, a key regulator of signaling pathways and the DNA damage response [6], the ability to efficiently generate diploid yeast populations is a critical experimental step. This protocol details streamlined methods for haploid yeast transformation and mating, enabling the high-efficiency creation of diploid strains suitable for Y2H screening and other applications requiring diploid genetics.

Section 1: Core Experimental Protocols

High-Efficiency Haploid Yeast Transformation

This procedure is used to introduce bait and prey plasmids into respective haploid strains of Saccharomyces cerevisiae with opposite mating types (MATa and MATα).

Key Reagents:

• Plasmids: Bait (e.g., pGBK-RC) and prey (e.g., pGAD-RC) vectors with compatible auxotrophic markers (e.g., TRP1 and LEU2) [51].
• Yeast Strains: Genetically defined haploid strains (e.g., MATa and MATα), each carrying distinct auxotrophic markers to allow for subsequent selection.
• Solution: Freshly prepared 1x TE/LiAc buffer (10 mM Tris-HCl, 1 mM EDTA, 100 mM Lithium Acetate, pH 7.5).

Methodology:

• Inoculation: Pick a single colony of the haploid yeast strain and inoculate into 5 mL of appropriate liquid medium. Incubate overnight at 30°C with vigorous shaking (250 rpm).
• Culture Expansion: In the morning, dilute the overnight culture into 50 mL of fresh medium to an OD600 of ~0.2. Incubate until the culture reaches an OD600 of 0.4-0.6 (mid-log phase).
• Harvesting: Centrifuge the cells at 700xg for 5 minutes at room temperature. Discard the supernatant.
• Washing: Resuspend the cell pellet in 25 mL of sterile, deionized water and centrifuge again.
• Preparation: Resuspend the pellet in 1 mL of 1x TE/LiAc buffer and transfer to a 1.5 mL microcentrifuge tube. Pellet the cells by centrifugation at high speed for 15 seconds and remove the supernatant.
• Transformation Mix: For each transformation, combine in a fresh tube:
  • 240 µL of 50% PEG 3350
  • 36 µL of 1.0 M LiAc
  • 50 µL of single-stranded carrier DNA (2.0 mg/mL, denatured)
  • 34 µL of sterile water and plasmid DNA (100-500 ng)
  • 50 µL of the prepared competent cells
• Incubation: Vortex the mixture vigorously for 1 minute to ensure complete mixing. Incubate at 30°C for 30 minutes, then heat-shock at 42°C for 20-25 minutes.
• Plating: Centrifuge the tubes briefly, remove the supernatant, and resuspend the cell pellet in 100-200 µL of sterile water or TE buffer. Plate the entire suspension onto selective agar plates lacking the appropriate nutrient to select for the transformed plasmid.
• Growth: Incubate the plates at 30°C for 2-4 days until transformed colonies appear.

Filter Mating for Diploid Generation

This protocol facilitates the efficient fusion of two haploid strains to form diploids, which is the basis for Y2H analysis [51] [52].

Key Reagents:

• Parental Haploids: Two transformed haploid strains (MATa and MATα) carrying the bait and prey plasmids, respectively.
• Media: Rich medium (YPD) plates and selective double-dropout plates.

Methodology:

• Strain Preparation: Grow overnight cultures of the two parental haploid strains in their respective selective liquid media.
• Mixing: Mix equal volumes (e.g., 1 mL each) of the two haploid cultures in a microcentrifuge tube.
• Harvesting: Pellet the cells by centrifugation and resuspend in a small volume (e.g., 100 µL) of sterile water.
• Filter Mating:
  • Place a sterile nitrocellulose membrane onto a pre-warmed YPD agar plate.
  • Pipette the mixed cell suspension onto the center of the membrane and allow it to be absorbed.
  • Incubate the plate at 30°C for 4-6 hours to allow mating and zygote formation.
• Diploid Selection:
  • After incubation, carefully wash the cells off the membrane using sterile water or TE buffer.
  • Perform serial dilutions of the cell suspension.
  • Plate appropriate dilutions onto selective double-dropout agar plates that lack the nutrients corresponding to both parental auxotrophic markers. Only successfully mated diploid cells will grow on these plates [52].
• Efficiency Calculation: Incubate the selective plates at 30°C for 2-3 days. Count the resulting colonies to calculate mating efficiency.

Mating Efficiency Calculation: Mating efficiency is calculated as the percentage of diploid cells relative to the total number of viable cells plated. The formula is [52]: Mating Efficiency (%) = (Number of colonies on selective double-dropout plate / Total number of viable cells plated) × 100

Table 1: Representative Mating Efficiencies in Different Yeast Strains

Yeast Strain / Species	Mating Efficiency	Incubation Conditions	Citation
Pichia pastoris (Wild-type)	~1% (10⁻²)	3 days, 25°C	[53]
Pichia pastoris (och1Δ Glyco-engineered)	~0.1% (10⁻³)	5 days, 25°C	[53]
Saccharomyces cerevisiae (Standard Lab Strain)	Protocol provided; efficiency is calculated empirically using selective plating.	4-6 hours, 30°C	[52]

Section 2: The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Research Reagents for Yeast Two-Hybrid and Mating Experiments

Reagent / Material	Function / Application	Example Use-Case
Bait & Prey Vectors	Plasmids for fusing proteins of interest to DNA-binding (bait) or activation (prey) domains.	pGBK-T7 (bait) and pGAD-T7 (prey) for Y2H screening [51].
Auxotrophic Markers	Selectable genes (e.g., HIS3, LEU2, TRP1, URA3) that complement yeast mutations, enabling selection for plasmids and diploids.	Selecting for diploids on medium lacking leucine and tryptophan [52].
Dominant Selection Markers	Genes conferring resistance to antibiotics (e.g., nourseothricin-NAT, arsenic-ARS), useful in prototrophic strains.	Selecting diploid P. pastoris strains with NAT and ARS resistance [54] [53].
Reporter Genes	Genes (e.g., ADE2, HIS3, URA3, lacZ, GFP) whose activation indicates a successful protein interaction.	Using HIS3 and ADE2 reporters to select for positive interactors in a Y2H screen [51].
Nitrocellulose Membranes	Support for cell-to-cell contact during the filter mating process.	Providing a solid surface for haploid yeast cells to mate on YPD plates [52].
PsD1	Psd1 Pea Defensin	Psd1 is a plant defensin for antifungal mechanism research. It targets fungal membrane glucosylceramide. For Research Use Only. Not for human or veterinary use.
P15	P15	Chemical Reagent

Section 3: Application in MOB2 Research: A Case Study

The Mps one binder (MOB) proteins are highly conserved. While MOB1's role as a tumor suppressor is known, the biological functions of MOB2 have been less clear. A Y2H screen was pivotal in uncovering a novel role for human MOB2 (hMOB2) in the DNA damage response (DDR) [6].

Experimental Workflow:

• Screening: A normalized human tissue cDNA library was screened using pLexA-N-hMOB2 (full-length) as bait.
• Identification: From 1 x 10⁶ transformants screened, 59 bait-dependent hits were identified. RAD50, a core component of the MRE11-RAD50-NBS1 (MRN) DNA damage sensor complex, was identified as a novel direct binding partner of hMOB2 [6].
• Validation: The interaction was confirmed through co-immunoprecipitation assays. Functional analysis revealed that hMOB2 promotes the recruitment of the MRN complex and activated ATM to DNA damaged chromatin, a critical early step in DDR signaling [6].

This discovery, facilitated by Y2H methodology, positioned hMOB2 as a facilitator of the DDR, independent of its previously known regulation of NDR kinases, highlighting the power of this approach for uncovering novel protein functions.

The following diagram illustrates the logical workflow and key experimental stages from transformation through to the functional validation of interacting partners, as demonstrated in the MOB2 case study.

Experimental Workflow for Y2H Screening

The next diagram maps the specific signaling pathway and protein interaction uncovered in the MOB2 case study, showing how hMOB2 integrates into the DNA damage response mechanism.

hMOB2 in the DNA Damage Response Pathway

The yeast two-hybrid (Y2H) system is a powerful molecular genetics technique for detecting protein-protein interactions (PPIs) in vivo, having contributed significantly to the mapping of complex interactomes in model organisms and humans [20] [14]. The core premise relies on reconstructing a transcription factor through the interaction between a "bait" protein fused to a DNA-binding domain (BD) and a "prey" protein fused to a transcription activation domain (AD). This reconstituted transcription factor then drives the expression of reporter genes, allowing for the detection and analysis of binary protein interactions [14].

Within the context of a thesis investigating binding partners of the signal transducer Mps one binder 2 (MOB2), the strategic selection and use of reporter genes are critical. MOB2 is a highly conserved protein implicated in cell cycle progression, the DNA damage response (DDR), and as a regulatory partner for NDR1/2 kinases [7] [4]. Unraveling its interactome is essential for understanding its role in cellular homeostasis and disease. This application note details the protocols for employing three core reporter genes—HIS3, ADE2, and LacZ—in Y2H screens, with a specific focus on applications for identifying and characterizing MOB2 binding partners.

The Reporter Gene Toolkit: Principles and Mechanisms

Reporter genes in the Y2H system are integrated into the yeast genome under the control of promoters containing the corresponding DNA-binding domain's recognition sequence. The choice of reporter dictates the selection method and type of data obtained.

Table 1: Core Reporter Genes in Yeast Two-Hybrid Systems

Reporter Gene	Function / Enzyme	Selection Method	Readout	Primary Use
HIS3	Imidazoleglycerol-phosphate dehydratase	Growth on medium lacking histidine, often with competitive inhibitor 3-AT	Cell growth (Qualitative/Semi-Quantitative)	Primary Screening
ADE2	Phosphoribosylaminoimidazole carboxylase	Growth on medium lacking adenine	Cell growth & colony color (white vs. red) (Qualitative)	Primary Screening & Confirmation
LacZ	β-galactosidase	Colorimetric assay with substrate (e.g., ONPG)	Enzymatic activity (Quantitative)	Interaction Confirmation & Quantification
OdT1	OdT1 Research Compound for ODT Formulation Studies	OdT1 is a high-purity reagent for developing orally disintegrating tablets (ODTs). For Research Use Only. Not for human or veterinary diagnostic or therapeutic use.	Bench Chemicals
CM-3	CM-3|High-Purity|For Research Use Only	CM-3 is a research compound for [area of research]. This high-purity product is for Professional Lab Use Only. Not for human or veterinary use.	Bench Chemicals

HIS3: The Workhorse for Primary Screening

The HIS3 gene enables yeast to synthesize histidine. In a HIS3 reporter strain, only cells where the bait and prey proteins interact can grow on synthetic dropout (SD) media lacking histidine [14] [47]. The stringency of selection can be enhanced by adding 3-amino-1,2,4-triazole (3-AT), a competitive inhibitor of the HIS3 enzyme. Stronger protein interactions overcome higher 3-AT concentrations, providing a semi-quantitative measure of interaction strength [14].

ADE2: A Secondary and Visual Reporter

The ADE2 gene is involved in adenine biosynthesis. Yeast cells lacking adenine accumulate a red pigment, whereas cells with a functional ADE2 reporter—activated by a protein interaction—form white colonies [47]. This provides a simple, visual confirmation of interaction and is often used in tandem with HIS3 to minimize false positives during primary screening.

LacZ: The Quantitative Confirmatory Tool

The LacZ gene, encoding β-galactosidase, is typically used as a secondary, quantitative reporter. Interaction strength is measured using a colorimetric assay with substrates like ortho-Nitrophenyl-β-galactopyranoside (ONPG). The colorless ONPG is hydrolyzed by β-galactosidase to produce a yellow o-Nitrophenol, which can be measured spectrophotometrically at 420 nm [55]. The resulting activity is calculated using a standard formula, providing quantitative data to compare different interactions [55].

Experimental Protocols for MOB2 Interactome Screening

The following protocols are adapted for a thesis project aiming to discover and validate novel MOB2 binding partners.

Protocol 1: Primary Screening with HIS3 and ADE2

Objective: To identify potential MOB2 binding partners from a cDNA library with high stringency and low false-positive rates.

Materials:

• Yeast reporter strain (e.g., AH109) with genotypes: MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1-HIS3, GAL2-ADE2, met2::GAL7-lacZ [47].
• Bait plasmid: pGBKT7 encoding MOB2 fused to the Gal4 DNA-Binding Domain (BD).
• Prey plasmid: pGADT7 containing a cDNA library fused to the Gal4 Activation Domain (AD).
• SD media plates: -Leu/-Trp (for transformation control), -Leu/-Trp/-His (for HIS3 selection), -Leu/-Trp/-Ade (for ADE2 selection).
• 3-AT stock solution (e.g., 1 M).

Method:

• Co-transformation: Introduce the bait (pGBKT7-MOB2) and prey (pGADT7-library) plasmids into the yeast reporter strain using a standard lithium acetate transformation protocol.
• Plasmid Selection: Plate the transformation mixture on SD/-Leu/-Trp media and incubate at 30°C for 3-5 days. Only cells containing both plasmids will grow.
• Interaction Screening:
  • Replica-plate or streak colonies from the control plate onto two selection plates: SD/-Leu/-Trp/-His and SD/-Leu/-Trp/-Ade.
  • To determine the optimal stringency for the HIS3 reporter, plate transformed yeast on SD/-Leu/-Trp/-His media containing a gradient of 3-AT (e.g., 1-100 mM).
• Incubation and Analysis: Incubate plates at 30°C for 3-7 days.
  • Positive Clones: Colonies that grow on both -His and -Ade media are considered primary positives.
  • Stringency Control: The minimum 3-AT concentration that completely inhibits growth of negative controls defines the working concentration for future screens.

Protocol 2: Quantitative Confirmation with the LacZ Assay

Objective: To quantitatively assess and compare the strength of interactions between MOB2 and candidate binding partners identified in the primary screen.

Materials:

• Yeast colonies from primary screen positive for HIS3 and ADE2.
• Z-Buffer (60 mM Naâ‚‚HPOâ‚„, 40 mM NaHâ‚‚POâ‚„, 10 mM KCl, 1 mM MgSOâ‚„, pH 7.0).
• ONPG substrate solution (4 mg/mL in Z-buffer).
• 1 M Naâ‚‚CO₃ (stop solution).
• Lysis buffer (e.g., containing Triton X-100 or glass beads for mechanical lysis).
• Spectrophotometer or plate reader.

Method (Liquid β-Galactosidase Assay):

• Culture and Harvest: Inoculate positive yeast clones in selective SD/-Leu/-Trp medium. Grow to mid-log phase (OD600 ~0.5-0.8). Harvest a calculated volume of cells to obtain an equal number of cells for each sample [55].
• Cell Lysis: Pellet cells, wash, and resuspend in Z-buffer. Permeabilize cells by adding SDS and chloroform, or prepare a whole-cell extract (WCE) using glass bead lysis [55].
• Reaction and Measurement:
  • To the WCE, add ONPG substrate to start the reaction. Incubate at 30°C.
  • Monitor the development of yellow color and note the reaction time (t).
  • Stop the reaction by adding 1 M Naâ‚‚CO₃.
  • Measure the absorbance at 420 nm (A420, for o-Nitrophenol) and 550 nm (A550, for light scattering debris).
• Data Calculation: Calculate β-galactosidase units (U) using the formula: U = 1000 × [A420 - (1.75 × A550)] / (t × v × OD600) where t is reaction time (min), and v is volume of culture used in the assay (mL) [55]. Normalize values against a negative control (e.g., empty bait plasmid) and a positive control if available.

Table 2: Example β-Galactosidase Data for MOB2 Candidate Interactors

Bait Protein	Prey Protein	β-Galactosidase Units (U)	Interpretation
MOB2-BD	Candidate A-AD	45.5 ± 3.2	Strong Interaction
MOB2-BD	Candidate B-AD	12.1 ± 1.5	Moderate Interaction
MOB2-BD	Candidate C-AD	1.5 ± 0.5	No Interaction
Empty BD	Candidate A-AD	1.2 ± 0.3	Negative Control

Visualizing the Workflow and MOB2 Signaling

The core principle of the Y2H assay and the biological context of MOB2 can be effectively communicated through the following diagrams.

Diagram 1: Y2H screening workflow for MOB2 partners.

Diagram 2: MOB2 signaling and interaction network.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagent Solutions for MOB2 Y2H Studies

Reagent / Tool	Function / Role	Example & Notes
Gal4-Based Vectors	Plasmid backbones for BD and AD fusions.	pGBKT7 (bait, TRP1), pGADT7 (prey, LEU2). pGBKT7-MOB2 must be validated for autoactivation.
Reporter Yeast Strains	Genetically engineered yeast for detection.	AH109 (MATA), Y187 (MATα). Permeabilized strains (e.g., ABC9Δ) improve small-molecule inhibitor uptake [47] [56].
Specialized Media	Selective media for plasmid and interaction selection.	SD/-Leu/-Trp (double dropout), SD/-Leu/-Trp/-His/-Ade (quadruple dropout). 3-AT is added to -His plates to increase stringency.
β-Gal Assay Kit	For quantitative measurement of protein interaction.	Commercially available kits or lab-made buffers (Z-buffer, ONPG). Can be adapted for a 96-well plate format for higher throughput [55].
cDNA Library	Source of potential "prey" interaction partners.	Libraries from tissues or cell lines relevant to MOB2 function (e.g., neural, cancer). A high-complexity library is crucial for a successful screen.
KWKLFKKIGAVLKVL	CAMEL Peptide (KWKLFKKIGAVLKVL)
OdG1	OdG1	Chemical Reagent

Concluding Remarks

The integrated use of HIS3, ADE2, and LacZ reporter genes provides a robust, multi-layered strategy for detecting protein-protein interactions in the yeast two-hybrid system. For MOB2 research, this enables not only the discovery of novel binding partners like RAD50 [7] but also the future potential to screen for small-molecule inhibitors of these interactions using engineered, permeable yeast strains [47] [56]. The HIS3 and ADE2 reporters offer efficient primary screening, while the quantitative power of the LacZ assay allows for the validation and comparative analysis of interaction strength. This combined approach is indispensable for building a comprehensive molecular understanding of MOB2's role in critical cellular processes such as cell cycle control and DNA damage response signaling.

Overcoming Hurdles: Optimizing Your MOB2 Y2H Screen for Sensitivity and Specificity

The yeast two-hybrid (Y2H) system remains one of the most widely utilized methods for detecting binary protein-protein interactions (PPIs), valued for its scalability and accessibility in both small-scale and genome-wide studies [57]. However, its utility is challenged by substantial rates of false positives and false negatives that can compromise data reliability. These challenges are particularly relevant when investigating intricate protein families such as the monopolar spindle-one-binder (MOB) proteins. MOB2, a member of this conserved adaptor protein family, engages in specific interactions with NDR1/2 kinases and plays roles in cell cycle progression, DNA damage response, and cell motility, with implications in cancer research such as hepatocellular carcinoma [28]. This application note details common pitfalls in Y2H screens and provides validated protocols to enhance data quality, framed within the context of identifying MOB2 binding partners.

Common Pitfalls and Strategic Solutions in Y2H

False Positives: Origins and Countermeasures

False positives in Y2H screens arise from multiple sources, primarily auto-activators and non-specific interactions.

Auto-activators are proteins that activate reporter gene transcription without a specific interacting partner. These can be transcription factors containing native activation domains, or proteins with cryptic activation domains that become functional when fused to the DNA-binding domain [58].

• Solution: Conditional Negative Selection: Integrate a pGAL2-URA3 cassette into the yeast genome. The URA3 gene product converts 5-fluoroorotic acid (5-FOA) into a toxic compound. Auto-activators trigger URA3 expression, selectively eliminating false-positive colonies on 5-FOA media [58].
• Solution: Comprehensive Controls: Always include empty vector controls for both bait and prey constructs. Bait autoactivation tests should be performed before library screening by co-transforming bait with empty prey vector and plating on selective media lacking the reporter nutrient (e.g., -His/-Ade). Any growth indicates autoactivation [57] [59].

Non-biological interactions occur between proteins that are never co-localized in vivo.

• Solution: Confirm Subcellular Localization: Traditional Y2H artificially localizes interactions to the nucleus [26]. Verify that MOB2 and its putative partners reside in the same cellular compartment in their native state using complementary techniques like split-fluorescent protein assays [26] [17].

False Negatives: Origins and Countermeasures

False negatives, where true interactions go undetected, are equally problematic and often stem from technical and biological constraints.

• Poor Protein Expression or Folding: Heterologous expression in yeast may lead to improper folding or degradation, especially for proteins from higher eukaryotes or those with specific post-translational modifications [59].
  • Solution: Vector and Host Optimization: Use a combination of Y2H vectors creating both N-terminal and C-terminal fusions for bait and prey. Multi-vector approaches significantly increase coverage; one study found each vector combination detected only 26% of interactions found by all four combinations [57].
• Steric Hindrance: The fusion domains (DNA-Binding Domain and Activation Domain) may physically interfere with the interaction interface of the proteins of interest [26].
  • Solution: Fragment Screening: If MOB2 is a large protein, screen individual domains or protein fragments in addition to the full-length protein. This can reveal interactions masked in the full-length context [57].
• Interaction Not in Nucleus: For proteins like membrane-associated partners, the traditional Y2H nucleus-localized interaction is unsuitable [57].
  • Solution: Alternative Systems: For non-nuclear proteins, employ the Membrane Yeast Two-Hybrid (MYTH) system, a split-ubiquitin based method ideal for membrane proteins [57].

Table 1: Summary of Major Y2H Pitfalls and Corresponding Solutions

Pitfall Type	Specific Cause	Recommended Solution	Key Benefit
False Positive	Auto-activating Bait	Conditional negative selection with pGAL2-URA3/5-FOA [58]	Selectively kills false-positive yeast
		Include empty vector controls [57]	Identifies auto-activating constructs pre-screen
	Non-biological Interaction	Confirm co-localization in vivo [26]	Ensures biological relevance
False Negative	Poor Expression/Folding	Use multiple vector combinations (N/C-terminal fusions) [57]	Increases interaction coverage
	Steric Hindrance	Screen protein domains/fragments [57]	Unmasks hidden interaction interfaces
	Non-Nuclear Protein	Use split-ubiquitin (MYTH) system [57]	Enables screening of membrane proteins
	Weak/Transient Interaction	Employ sensitive reporter genes (e.g., HIS3, ADE2) [59]	Amplifies signal for detection

Experimental Protocols

Protocol: Conditional Negative Selection for Auto-activator Removal

This protocol uses a pGAL2-URA3 system to remove auto-activators from a cDNA library prior to a large-scale screen [58].

I. Materials

• Y8800 or CRY8930 yeast strains with integrated pGAL2-URA3 cassette [58].
• pDESTDBlox_LEU2 bait vector.
• cDNA library cloned into pDESTADlox_TRP1 prey vector.
• YEPD media: 1% yeast extract, 2% peptone, 2% glucose, 200 mg/L adenine.
• Synthetic Complete (SC) Drop-out Media: -Leu, -Trp, -Leu/-Trp, -Leu/-Trp/-Ura.
• 5-Fluoroorotic Acid (5-FOA) plates: SC -Ura media + 0.2% 5-FOA.

II. Method

• Transform Bait and Prey: Co-transform the MOB2 bait construct (in DB vector) and the cDNA prey library (in AD vector) into the pGAL2-URA3 yeast strain. Use standard lithium acetate transformation.
• Select for Transformants: Plate the transformation mixture on SC -Leu/-Trp media. Incubate at 30°C for 3-5 days to select for yeast containing both bait and prey plasmids.
• Apply Negative Selection: Pool the double-positive transformants and plate them on 5-FOA plates. Incubate at 30°C for 3-5 days.
  • Principle: Yeast with auto-activating bait or prey proteins will drive expression of URA3, converting 5-FOA to toxic 5-fluorouracil, preventing their growth. Yeast with non-auto-activating constructs will survive.
• Harvest Validated Cells: Collect the yeast colonies growing on 5-FOA plates. This pool is now enriched for non-auto-activating constructs and can be used for the subsequent interaction screen on appropriate reporter media (e.g., SC -Leu/-Trp/-His/-Ade).

Protocol: MOB2 Interaction Screen and Validation

I. Materials

• Y2H Strains: Compatible mating-type strains (e.g., AH109 (MATa) and Y187 (MATα)) [57].
• Bait Construct: MOB2 ORF cloned into a DNA-Binding Domain vector (e.g., pGBKT7).
• Prey Library: cDNA library from a relevant system (e.g., human liver) cloned into an Activation Domain vector (e.g., pGADT7).
• Media: YEPD, SC -Trp (bait selection), SC -Leu (prey selection), SC -Leu/-Trp (diploid selection), SC -Leu/-Trp/-His/-Ade (reporter selection).

II. Method

• Bait Autoactivation Test:
  • Transform the MOB2-pGBKT7 bait construct into AH109 and plate on SC -Trp.
  • Co-transform MOB2-pGBKT7 + empty pGADT7 into AH109 and plate on SC -Leu/-Trp and SC -Leu/-Trp/-His/-Ade.
  • If growth occurs on high-stringency media (-His/-Ade), the bait is autoactive and must be addressed (e.g., by conditional negative selection or using truncated baits).
• Library Screening via Mating:
  • Transform the prey library into Y187 (MATα). Culture the MOB2-bait strain (AH109) and the prey library strain (Y187) in respective selective media.
  • Mix the two strains in rich media (YEPD) for mating. This allows diploid formation, each containing one bait and one prey plasmid.
  • Plate the mating mixture on high-stringency media (SC -Leu/-Trp/-His/-Ade) to select for interacting partners. Incubate for 5-10 days.
• Interaction Confirmation:
  • Pick positive colonies and re-streak on fresh high-stringency media to confirm phenotype.
  • Isolate the prey plasmid from yeast and sequence to identify the interacting partner.
  • Re-transform the isolated prey plasmid with the original MOB2 bait plasmid into a fresh yeast strain to confirm the interaction is reproducible and not an artifact.

Visualization of Pathways and Workflows

MOB2 Signaling and Y2H Screening Context

MOB2 in Hippo/NDR Signaling Network

Y2H Workflow with False Positive/Negative Mitigation

Y2H Screening with Quality Control Steps

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Reagents for Y2H Studies of MOB2 Interactions

Reagent / Tool	Function / Role	Application in MOB2 Research
pGBKT7 (DBD Vector)	Expresses bait protein fused to Gal4 DNA-Binding Domain [57]	Cloning and expression of MOB2 as bait
pGADT7 (AD Vector)	Expresses prey protein fused to Gal4 Activation Domain [57]	Construction of the prey cDNA library
AH109 & Y187 Yeast Strains	Compatible mating strains with auxotrophic and reporter genes [57]	Performing mating-based library screens
pGAL2-URA3 Cassette	Enables conditional negative selection on 5-FOA [58]	Removing auto-activators from MOB2 screen
SC Drop-out Media	Selective media lacking specific amino acids/nutrients [59]	Selecting for transformants and interactions
5-Fluoroorotic Acid (5-FOA)	Toxic compound selected against by URA3 expression [58]	Negative selection against auto-activators
MOB2-specific Antibodies	Detect protein expression and validate interactions	Confirming MOB2 bait expression in yeast
Deps	Deps, CAS:70155-90-7, MF:C10H19NO3S, MW:233.33 g/mol	Chemical Reagent

Robust Y2H screening for MOB2 binding partners demands a strategic approach that proactively addresses the inherent limitations of the system. By implementing the outlined protocols—including conditional negative selection, multi-vector strategies, and appropriate system choice—researchers can significantly enhance the specificity and sensitivity of their screens. The subsequent validation of putative interactors through orthogonal methods remains crucial for building a reliable MOB2 interaction network, ultimately advancing our understanding of its role in cell signaling and disease.

ATP-binding cassette (ABC) transporters constitute a major class of integral membrane proteins that utilize ATP hydrolysis to actively efflux a remarkably diverse range of substrates across cellular membranes, representing a significant barrier to intracellular small-molecule accumulation [60] [61] [62]. In the model organism Saccharomyces cerevisiae, these transporters are not merely drug efflux pumps but play essential physiological roles in cellular detoxification, metabolite transport, and lipid homeostasis [60] [63]. The yeast genome encodes 22 membrane-bound ABC transporters, distributed across several subfamilies (ABCB, ABCC, ABCD, ABCG) with distinct but sometimes overlapping substrate specificities [60] [63]. Their localization at key cellular interfaces—including the plasma membrane, vacuolar membrane, and peroxisomal membrane—establishes a multi-layered defense network against xenobiotics [63].

For researchers employing yeast two-hybrid systems to study protein-protein interactions, such as those involving MOB2 and its binding partners, this efflux activity presents a substantial experimental challenge. ABC transporters can severely limit the intracellular bioavailability of small molecules, including therapeutic compounds, chemical inducers, and signaling probes, thereby compromising the sensitivity and reliability of screening assays [26]. This application note details the strategic generation and application of ABC transporter-deficient yeast strains to overcome this permeability barrier, with specific consideration for investigations within the MOB2 signaling network.

The Yeast ABC Transporter Family: Classification and Function

A comprehensive understanding of the ABC transporter superfamily in S. cerevisiae is a prerequisite for their targeted elimination. These transporters are categorized into subfamilies based on phylogenetic analysis and domain architecture, with the majority requiring C-terminal tagging for functional studies due to their cytosolic nucleotide-binding domains [60] [63].

Table 1: Major Non-Mitochondrial ABC Transporter Subfamilies in S. cerevisiae

Subfamily	Representative Transporters	Primary Localization	Key Functions and Substrates
ABCB	Ste6p	Plasma Membrane	Mating pheromone (a-factor) export [63]
ABCC (MRP/CFTR)	Ycf1p, Yor1p, Ybt1p, Bpt1p, Nft1p, Vmr1p	Vacuole, Plasma Membrane	Glutathione-S-conjugate detoxification; heavy metals (Cd²⁺); organic anions; oligomycin [63]
ABCD	Pxa1p, Pxa2p	Peroxisome	Fatty acyl-CoA import for β-oxidation [63]
ABCG (PDR)	Pdr5p, Snq2p, Aus1p, Pdr12p, Pdr15p	Plasma Membrane	Pleiotropic drug resistance; export of organic acids, steroids, and diverse xenobiotics [60] [63]

The functional unit of most ABC transporters consists of two cytosolic nucleotide-binding domains (NBDs) containing conserved Walker A, Walker B, and signature (LSGGQ) motifs, and two transmembrane domains (TMDs) that form the translocation pathway [61] [64] [62]. The PDR (Pleiotropic Drug Resistance) subfamily, particularly Pdr5p, is often the foremost contributor to the basal multidrug resistance phenotype in laboratory yeast strains [63].

Conceptual Framework: Overcoming Efflux in MOB2 Interaction Studies

The following diagram illustrates the core problem and genetic solution for enhancing small-molecule permeability in yeast-based interaction studies.

Strategic Generation of Transporter-Deficient Strains

The creation of strains with compromised efflux activity can be achieved through targeted gene deletion or systematic multi-gene knockout strategies.

Targeted Deletion of Key Transporters

For many applications, deleting a select few major efflux pumps is sufficient to significantly enhance permeability. The following table outlines high-priority deletion targets.

Table 2: High-Priority ABC Transporter Deletion Targets for Enhanced Permeability

Target Gene	Deletion Strain	Key Transport Activities Compromised	Considerations for MOB2 Studies
PDR5	Δpdr5	Broad-spectrum xenobiotics; steroids [63]	Often the single most impactful deletion; may alter basal signaling.
SNQ2	Δsnq2	Nitroquinolines, 4-NQO, sulfomethuron methyl [63]	Frequently deleted in combination with Δpdr5.
YOR1	Δyor1	Oligomycin, organic anions, aureobasidin A [63]	Plasma membrane localized; important for organic anions.
YCF1	Δycf1	Glutathione conjugates, heavy metals (Cd²⁺, Hg²⁺) [63]	Vacuolar membrane; critical for metal detoxification.
AUS1	Δaus1	Sterol uptake under anaerobic conditions [60]	Relevant if sterol-based inducers are used.

Advanced Multi-Gene Knockout Strategies

For the most robust and general solution to small-molecule efflux, combinatorial deletion strains are recommended. These strains systematically remove transporters from multiple subfamilies to cripple the efflux network.

Table 3: Combinatorial ABC Transporter Deletion Strains

Strain Name/Genotype	Deleted Loci	Permeability Phenotype	Recommended Use
Δquad	Δpdr5 Δsnq2 Δyor1 Δycf1	Compromised plasma membrane and vacuolar efflux of diverse compounds.	General-purpose high-permeability strain for novel small-molecule screens.
Δpdr5 Δsnq2	Δpdr5 Δsnq2	Strongly reduced efflux of neutral and lipophilic drugs.	Excellent first-line strain for most small-molecule permeability applications.
Δabc-basic	Δpdr5 Δsnq2 Δyor1 Δaus1	Defective in sterol uptake and broad xenobiotic efflux.	Ideal for studies involving sterol-derived molecules or anaerobic conditions.

Experimental Protocol: Validating Enhanced Permeability

This section provides a detailed methodology for confirming the hyperpermeable phenotype of engineered strains.

Protocol: Small-Molecule Accumulation Assay

Objective: To quantitatively compare the intracellular accumulation of a test compound between wild-type and ABC transporter-deficient strains.

Materials:

• Yeast Strains: Wild-type (e.g., BY4742) and isogenic ABC transporter-deficient strains.
• Research Reagent Solutions:
  • YPD Medium: Standard rich medium for yeast cultivation.
  • Test Compound: A known ABC transporter substrate (e.g., rhodamine 6G, oligomycin, rose bengal [65]).
  • Inhibitors (Optional): Specific ABC transporter inhibitors (e.g., fumitremorgin C for ABCG2, valspodar for P-gp [65]) as experimental controls.
  • Lysis Buffer: RIPA buffer or similar for cell lysis and compound extraction.
  • Spectrofluorometer/Plate Reader: For quantifying intracellular compound levels.

Method:

• Culture Conditions: Grow wild-type and knockout strains overnight in YPD at 30°C with shaking to mid-log phase (OD₆₀₀ ≈ 0.6-0.8).
• Compound Exposure: Harvest cells by gentle centrifugation (3,000 × g, 5 min). Wash once with fresh medium and resuspend in medium containing the test compound. Include parallel samples with transporter inhibitors if used.
• Loading Phase: Incubate with the compound for 60-90 minutes at 30°C with shaking to allow for accumulation.
• Efflux Phase (Optional): Pellet cells, wash with ice-cold PBS to stop transport, and resuspend in compound-free medium. Incubate for an additional 60 minutes to monitor active efflux.
• Quantification:
  • Extraction Method: Pellet cells, wash twice with ice-cold PBS, and lyse using lysis buffer. Clarify the lysate by centrifugation and measure the compound concentration in the supernatant via fluorescence or absorbance, normalizing to total cellular protein [65].
  • Direct Analysis: Analyze intact cells by flow cytometry to measure intracellular fluorescence, providing single-cell resolution of accumulation [65].

Validation: A successful knockout is confirmed by a statistically significant increase (often 2 to 10-fold or more) in intracellular compound accumulation in the deletion strain compared to the wild-type, and/or a reduced rate of efflux in the post-loading phase.

Workflow for Strain Development and Application

The complete process, from strain engineering to application in a functional screen, is outlined below.

Application in MOB2-Centric Yeast Two-Hybrid Screens

The Cbk1 kinase and its regulatory subunit Mob2 form a conserved network (the Hippo pathway in metazoans) regulating cell polarity and asymmetric cell fate in S. cerevisiae [66]. Investigating this system often requires modulating interactions with small molecules or detecting weak, transient binding events.

The Scientist's Toolkit: Essential Research Reagents

Table 4: Key Research Reagents for Implementing this Approach

Reagent / Resource	Function / Description	Example Sources / Comments
Yeast Knockout Strains	Isogenic MATa and MATα strains with single or combinatorial ABC transporter deletions.	BY4741/BY4742 background; available from Saccharomyces Genome Deletion Project.
PCR-Based Gene Deletion Kit	For creating novel combinatorial knockouts in your strain of interest.	Systems using kanMX, natMX, or hphMX resistance modules.
Validated Transporter Substrates	Fluorescent or cytotoxic compounds to validate hyperpermeable phenotype.	Rhodamine 6G, Oligomycin, Rose Bengal [65].
ABC Transporter Inhibitors	Pharmacological controls to mimic deletion phenotype in wild-type cells.	Valspodar (P-gp inhibitor) [65], Fumitremorgin C (ABCG2 inhibitor) [65].
Mammalian Ortholog Inhibitors	For cross-validation in mammalian systems.	Ko143 (ABCG2), MK571 (MRP1) [65].

Practical Considerations and Best Practices

• Genetic Background Consistency: Ensure all engineered strains are backcrossed into a uniform genetic background (e.g., BY4742) to prevent confounding effects from polymorphic alleles.
• Fitness and Viability: Monitor growth rates of deletion strains. While most single deletions are viable, some multi-knockout strains may exhibit fitness defects under specific conditions.
• Control Experiments: Always include:
  • Wild-type strain with the test small molecule.
  • Wild-type strain with the small molecule and a pharmacological inhibitor.
  • Vehicle-only controls for all strains to rule off-target effects.
• Connecting to MOB2 Function: Given that the Cbk1/Mob2 complex regulates daughter-specific genetic programs and morphogenesis [66], verify that the deletion of ABC transporters does not synthetically interact with the core MOB2-dependent pathways under investigation by performing appropriate morphological and reporter assays.

The strategic use of ABC transporter-deficient yeast strains provides a powerful, genetic solution to the pervasive problem of small-molecule efflux in yeast-based screening systems. By systematically removing key efflux pumps—particularly those in the ABCG (PDR) subfamily—researchers can achieve substantially enhanced intracellular concentrations of small-molecule inducers, inhibitors, and probes. This approach directly increases the sensitivity and reliability of assays like the yeast two-hybrid system, enabling the detection of more subtle or transient interactions within critical signaling networks, such as those governed by MOB2 and its binding partners. The protocols and strategic considerations outlined herein offer a validated path to overcoming permeability barriers, thereby expanding the utility of yeast as a discovery platform.

In yeast two-hybrid (Y2H) screens, the HIS3 reporter gene is a critical component for identifying protein-protein interactions. The HIS3 gene product, imidazoleglycerol-phosphate dehydratase, enables yeast to synthesize histidine, allowing growth on histidine-deficient media when a protein-protein interaction occurs [67]. A significant challenge in these systems is background growth caused by low-level, leaky expression of the HIS3 reporter in the absence of a true interaction. To control this, researchers use 3-Amino-1,2,4-triazole (3-AT), a competitive inhibitor of the HIS3 enzyme [14] [67]. This application note details the use of 3-AT titration within the context of a broader research project aimed at identifying novel binding partners of the human protein MOB2 using a yeast two-hybrid screen.

The Role of HIS3 and 3-AT in Yeast Two-Hybrid Systems

Principle of the HIS3 Reporter Assay

In a typical Y2H screen, the bait protein (e.g., MOB2) is fused to a DNA-binding domain (DBD), while a prey protein is fused to a transcription activation domain (AD). A physical interaction between bait and prey reconstitutes a functional transcription factor, driving the expression of the HIS3 reporter gene [14]. This allows yeast cells to grow on medium lacking histidine, providing a selectable phenotype for successful interactions.

3-AT as a Competitive Inhibitor

3-AT competes with the natural substrate for the binding site on the HIS3 enzyme. By adding 3-AT to the selection medium, the effective activity of the HIS3 enzyme is reduced, thereby raising the threshold of reporter system activation required for growth [14] [67]. This suppresses the growth of false positives resulting from basal, leaky expression of the HIS3 gene and ensures that only yeast cells expressing HIS3 at levels high enough to overcome the inhibition will form colonies.

Quantitative Data for 3-AT Titration

The appropriate concentration of 3-AT is not universal; it must be determined empirically for each specific bait-reporter system. The following table provides a general guideline for the titration process.

Table 1: Expected Results in a 3-AT Titration Experiment

3-AT Concentration (mM)	Yeast Growth Phenotype	Interpretation
0	Confluent background growth	Leaky HIS3 expression is sufficient for growth without an interaction; 3-AT is required for selection.
1 - 5	Reduced but still substantial background	The concentration is too low to fully suppress background; requires higher 3-AT.
5 - 100 (system-dependent)	No background growth; growth only upon true interaction	Ideal working concentration. The threshold for growth now requires a robust protein-protein interaction.
> System-specific maximum	No growth, even for strong known positives	Concentration is too high, inhibiting growth from true interactions.

Table 2: Key Reagent Solutions for HIS3-Based Y2H Screening

Reagent / Material	Function / Role in the Experiment
3-AT (3-Amino-1,2,4-triazole)	Competitive inhibitor of the HIS3 gene product; used to increase stringency and suppress background growth [14] [67].
Synthetic Defined (SD) Medium (-His)	Selective medium lacking histidine. Allows growth only when the HIS3 reporter gene is activated by a protein-protein interaction [14].
Bait Plasmid (e.g., pDEST32)	Plasmid for expressing the protein of interest (e.g., MOB2) fused to a DNA-Binding Domain (DBD) [68].
Prey Plasmid (e.g., pDEST22)	Plasmid for expressing potential binding partners (prey) fused to a Transcription Activation Domain (AD) [68].
Yeast Strain (e.g., Y2H Gold)	Genetically engineered yeast strain with deletions in histidine biosynthesis genes (e.g., his3), making growth dependent on the HIS3 reporter [14].

Experimental Protocol: Determining the Optimal 3-AT Concentration

This protocol is designed to establish the minimal 3-AT concentration that completely suppresses background growth for a MOB2-focused Y2H screen.

Materials Required

• Yeast strain containing the bait plasmid (MOB2-DBD) and the empty prey plasmid (AD-only control).
• SD agar plates lacking histidine (SD/-His).
• 1M filter-sterilized 3-AT stock solution in deionized water.
• Sterile water and spreaders.

Procedure

• Prepare Selection Plates: Prepare SD/-His plates supplemented with a range of 3-AT concentrations. A suggested range is 0, 1, 5, 10, 25, 50, 75, and 100 mM.
• Harvest Yeast Cells: Grow the yeast strain to mid-log phase.
• Normalize Cell Density: Measure the optical density and normalize cultures to the same cell density (e.g., OD₆₀₀ = 1.0).
• Spotting or Plating: Spot 5-10 µL of normalized culture onto each of the 3-AT plates. Alternatively, plate a standardized number of cells (e.g., 10⁵ cells).
• Incubation: Incubate plates at 30°C for 3-7 days.
• Analysis: Identify the lowest 3-AT concentration that completely prevents colony formation after 5-7 days of incubation. This is the optimal 3-AT concentration to use in subsequent library screens.

Application in a MOB2 Yeast Two-Hybrid Screen

In a thesis investigating MOB2 binding partners, this titration is a critical preliminary step. MOB2 is a signal transducer that can interact with NDR1/2 kinases and has been linked to the DNA Damage Response (DDR), with RAD50 identified as a novel binding partner in a yeast two-hybrid screen [7]. Before screening a cDNA library, the MOB2-DBD bait construct must be tested for autoactivation—its inherent ability to activate transcription without a prey. The 3-AT titration protocol above ensures that any background activation of the HIS3 reporter by the MOB2 bait alone is suppressed. This guarantees that colonies growing during the actual library screen result from genuine protein-protein interactions between MOB2 and library-encoded preys, rather than from bait-specific autoactivation.

The workflow below outlines the key stages of this process, from bait preparation to the final library screening under optimized conditions.

Workflow for Incorporating 3-AT Titration in a Y2H Screen

The relationship between 3-AT concentration, HIS3 activity, and cell growth is fundamental to the success of the screen. The following diagram illustrates how 3-AT inhibition ensures selective pressure for genuine interactions.

Mechanism of 3-AT Selection in HIS3 Reporter System

The identification of protein-binding partners for Mps one binder 2 (MOB2) is crucial for elucidating its roles in cell cycle regulation, DNA damage response (DDR), and tumor suppression [7] [69]. However, MOB2 presents particular challenges in yeast two-hybrid (Y2H) screening systems due to its functional characteristics. MOB2 regulates NDR1/2 kinases and interacts with RAD50 of the MRN complex, processes that can interfere with normal yeast cell function when expressed as a bait fusion protein [7]. Furthermore, as an intracellular signaling protein that modulates critical pathways including p53/p21-dependent G1/S cell cycle checkpoints, constitutive expression of MOB2 may induce toxicity or unintended signaling cascades in yeast, leading to auto-activation or false negatives [7] [70]. This application note provides validated strategies to overcome these challenges, enabling reliable identification of MOB2 binding partners.

Understanding MOB2 Biology and Technical Challenges

MOB2 Functional Domains and Interactions

MOB2 contains conserved regions that mediate specific interactions with NDR1/2 kinases through direct binding [7] [17]. Research indicates that MOB2 competes with MOB1 for NDR binding, with the MOB2/NDR complex associated with diminished NDR kinase activity [7]. Additionally, MOB2 interacts with RAD50, a component of the essential MRE11-RAD50-NBS1 (MRN) DNA damage sensor complex, suggesting a role in DDR through facilitating recruitment of MRN and activated ATM to damaged chromatin [7]. These specific interaction domains must be considered when designing bait constructs to avoid disrupting native binding interfaces while preventing non-specific activation.

Common Y2H Challenges with MOB2

Expression of full-length MOB2 in Y2H systems may cause false positives through several mechanisms: (1) potential activation of DNA damage response pathways in yeast due to its role in DDR [7]; (2) interference with yeast cell cycle progression through its conserved functions [7]; and (3) possible steric hindrance when fused to DNA-binding domains, potentially obscuring binding sites or affecting protein folding. Additionally, the requirement for MOB2 to prevent accumulation of endogenous DNA damage [7] suggests that its expression might create selective pressures in yeast, skewing library screening results.

Table 1: Troubleshooting Guide for MOB2 Bait Problems in Y2H Systems

Problem	Potential Cause	Solution	Validation Method
Bait Toxicity	MOB2 interference with yeast cell cycle or DDR pathways	Use inducible promoter; truncate functional domains; lower expression temperature	Yeast viability assays on inducing vs. non-inducing media
Auto-activation	Non-specific recruitment of transcription machinery	Use stricter reporters; lower expression; test binding domain-specific repression	Growth assessment on increasing selective media stringency
Weak/No Interaction	Steric hindrance from fusion domains; insufficient post-translational modifications	Switch fusion orientation; use complementary PPI assays	Co-immunoprecipitation; split-protein assays
False Positives	Non-specific interactions with abundant proteins	Include competitive inhibitors; use multiple reporter systems	Reciprocal Y2H; orthogonal validation

Experimental Strategies and Protocols

Bait Vector Construction and Optimization

Modular Domain Design: Given the structured binding interfaces of MOB2, design bait constructs that separate known functional domains. Create truncated variants focusing on specific regions: N-terminal (1-150), central (151-250), and C-terminal (251-350) fragments to identify which domains mediate novel interactions. For MOB2, particular attention should be paid to regions involved in NDR1/2 binding (approximately residues 1-100) and RAD50 interaction sites (mapped to two functionally relevant domains) [7] [70].

Inducible Expression System: To circumvent bait toxicity, clone MOB2 into galactose-inducible vectors (pGBKT7- GAL1) rather than constitutive promoters. This enables controlled expression only during interaction screening, minimizing prolonged exposure that might activate yeast stress responses. The inducible system allows initial yeast growth without MOB2 expression, followed by induction for interaction screening.

Protocol: Stepwise Bait Validation

• Transformation: Transform bait constructs into appropriate yeast reporter strains (AH109 or Y2HGold)
• Toxicity Testing: Spot serial dilutions on both inducing (galactose/raffinose) and repressing (glucose) media
• Auto-activation Assessment: Plate on medium lacking histidine with increasing 3-AT concentrations (0-50 mM)
• Expression Verification: Confirm protein expression by western blotting using anti-MOB2 antibodies
• Functionality Test: Validate bait functionality by testing interaction with known partners (NDR1/NDR2)

Advanced Y2H System Selection

Split-Protein Systems: For full-length MOB2 that demonstrates consistent auto-activation, consider transitioning to split-protein assays such as the split-ubiquitin system [26] [14]. These systems detect interactions through protein fragment complementation rather than transcriptional activation, bypassing transcription-related false positives. The split-ubiquitin system is particularly valuable for proteins like MOB2 that may have inherent transactivation potential.

Engineering Yeast Background Strains: For bait proteins with inherent toxicity, utilize engineered yeast strains with enhanced permeability or altered stress responses. The ABC9Δ strain, lacking nine ABC transporter genes, demonstrates increased permeability to small molecules [15] and may also reduce exclusion of toxic proteins. Additionally, consider strains with enhanced chaperone expression to facilitate proper folding of heterologous proteins like MOB2.

Protocol: Counter-Selection for Auto-Activation Mutants

• Clone MOB2 into both bait (DNA-BD) and prey (AD) vectors
• Introduce both plasmids into reporter strain containing URA3 under GAL promoter control
• Plate transformants on medium containing 5-fluoroorotic acid (5-FOA)
• Select colonies that fail to grow - indicating disrupted auto-activation capability
• Sequence bait plasmids from selected colonies to identify mutations that eliminate auto-activation while preserving true interaction interfaces

Screening Optimization and Validation

Controlled Stringency Conditions: Implement a tiered selection strategy beginning with lower stringency (single reporter, minimal 3-AT) progressing to higher stringency (multiple reporters, increased 3-AT). For MOB2, which may participate in transient interactions, consider shorter induction times (6-12 hours) to capture interactions before potential toxicity manifests.

Competitive Inhibition Approach: Include specific inhibitors during screening to block known interaction interfaces and reduce non-specific binding. For MOB2, this may involve using competitive peptides that mimic NDR1/2 binding sites to occupy these domains and enrich for novel binding partners targeting different regions.

Protocol: Library Screening with Problematic Baits

• Pre-culture bait strain in repressive medium to high density
• Induce MOB2 expression for 2-4 hours before mating with prey library
• Perform mating with prey library at optimal density (OD600 ~0.5) for 6-8 hours
• Plate on medium-stringency selection media (e.g., -Leu/-Trp/-His + 5mM 3-AT)
• Re-streak positive colonies to high-stringency media (-Leu/-Trp/-Ade/-His + 10-20mM 3-AT)
• Isplicate positive colonies to both selective and non-selective media to confirm reporter-dependent growth

The Scientist's Toolkit: Essential Reagents

Table 2: Key Research Reagents for MOB2 Y2H Studies

Reagent	Function/Application	Example	Considerations for MOB2
Inducible Bait Vectors	Controlled expression to minimize toxicity	pGBKT7-GAL1, pBridge	Galactose-inducible preferred for MOB2
Engineered Yeast Strains	Enhanced permeability; reduced background	ABC9Δ, Y2HGold, AH109	ABC9Δ improves small molecule access [15]
Competitive Inhibitors	Block known interfaces; reduce false positives	NDR-derived peptides	Targets MOB2-NDR binding site [7]
Stringency Modulators	Titrate selection pressure	3-AT, Aureobasidin A	3-AT competitively inhibits HIS3 reporter
Orthogonal Validation	Confirm interactions outside Y2H	Co-IP, F2H, Split-luciferase	F2H validates in mammalian context [17]

Pathway and Workflow Visualization

Implementing these tailored strategies for MOB2 bait proteins addresses the specific challenges of toxicity and auto-activation while preserving biological relevance. The modular approach to bait design, combined with inducible expression and engineered yeast strains, enables reliable detection of novel binding partners. For MOB2 specifically, considering its roles in both kinase regulation and DNA damage response provides opportunities to contextualize screening results within established biological frameworks. These protocols not only facilitate MOB2 interaction mapping but also provide a framework for studying other challenging bait proteins involved in essential cellular processes. As Y2H systems continue to evolve with improved readout technologies like fluorescent two-hybrid assays [17], the integration of these methods with traditional Y2H will further enhance our ability to characterize complex interaction networks for proteins like MOB2.

MOB2 is a highly conserved member of the Mps one binder (MOB) family of adapter proteins, which function as crucial signal transducers in essential intracellular pathways [7]. In mammalian cells, MOB2 specifically interacts with NDR1/2 kinases (Serine/Threonine Kinase 38/38L), but not with the related LATS kinases, forming a distinct regulatory complex [7] [5]. This specific interaction places MOB2 as a key regulator of critical cellular processes, including cell cycle progression, the DNA Damage Response (DDR), and centrosome duplication [7]. The functional significance of the MOB2/NDR complex is underscored by findings that MOB2 knockdown triggers a p53/p21-dependent G1/S cell cycle arrest, highlighting its essential role in maintaining genome stability [7]. Furthermore, recent proximity-labeling studies have expanded the MOB2 interactome, revealing potential connections to novel binding partners and pathways beyond the established NDR kinase axis [24]. Given these pivotal functions, the reliable identification of MOB2 binding partners using techniques like the Yeast Two-Hybrid (Y2H) system is of paramount importance to both basic research and drug discovery. The core challenge, however, lies in constructing fusion proteins that accurately mimic native interactions without introducing steric artifacts that can compromise data validity.

MOB2 Biology and Its Role in Signaling Pathways

MOB proteins are small, single-domain proteins approximately 20-25 kDa in size that function primarily as scaffolds or adaptors [24] [5]. They mediate their biological roles by engaging with and assembling protein complexes, most notably with kinases of the Nuclear Dbf2-related (NDR) family [5]. The mammalian MOB family is subdivided into four classes, with MOB2 belonging to Class II [5]. A key biochemical characteristic of MOB2 is its competition with MOB1 for binding to NDR kinases. The MOB1/NDR complex is associated with increased NDR kinase activity, whereas the MOB2/NDR complex is linked to diminished NDR activity, effectively allowing MOB2 to act as a physiological inhibitor of NDR signaling [7].

Table 1: Core Functional Roles of MOB2 and Associated Binding Partners

Functional Role	Key Binding Partners	Biological Consequence
Cell Cycle Regulation	NDR1/2 (STK38/STK38L)	Prevents accumulation of DNA damage and G1/S cell cycle arrest [7]
DNA Damage Response	RAD50 (component of MRN complex)	Supports recruitment of MRN complex and ATM kinase to DNA lesions [7]
Kinase Activity Modulation	NDR1/2	Competes with MOB1 to form a complex associated with lower NDR kinase activity [7]

Beyond its canonical role with NDR kinases, MOB2 also interacts with RAD50, a core component of the MRE11-RAD50-NBS1 (MRN) DNA damage sensor complex [7]. This interaction suggests a mechanism by which MOB2 helps recruit the MRN complex and activated ATM kinase to sites of DNA damage, positioning it as a novel DDR factor critical for cell survival upon genotoxic stress [7]. The diagram below summarizes the central role of MOB2 in these signaling networks.

Strategic Design of MOB2 Fusion Constructs

The primary objective is to design a fusion protein where MOB2 retains its native conformation and its binding interface remains fully accessible to potential interacting partners. The small, globular nature of the MOB domain means that the placement and size of the fusion tag can critically impact its functionality.

Choosing the Fusion Tag and Position

The N-terminus of MOB proteins is generally more variable and less structurally constrained than the C-terminal core, which forms the conserved Mob family fold responsible for kinase binding [5]. Therefore, N-terminal tagging (e.g., fusing the DNA-Binding Domain (BD) or Activation Domain (AD) to the N-terminus of MOB2) is the recommended strategy. This approach places the large transcription factor fragment away from the critical C-terminal protein-binding interface.

Selecting the Optimal Vector System

The choice of vector determines whether MOB2 will be expressed as a fusion with the DNA-Binding Domain (BD, the "bait") or the Activation Domain (AD, the "prey"). There is no universal rule, and empirical testing is often required. A dual strategy is advisable:

• Strategy A: Clone MOB2 into a BD vector to use it as bait against a library of prey proteins.
• Strategy B: Clone MOB2 into an AD vector to use it as prey against a library of bait proteins. This multi-faceted approach helps confirm that interactions identified are genuine and not artifacts of a single fusion orientation.

Incorporating Flexibility and Functional Validation

Incorporating a flexible polypeptide linker (e.g., a (Gly-Gly-Gly-Gly-Ser)₃ repeat) between the transcription factor domain (BD/AD) and MOB2 can provide rotational freedom and minimize steric interference. Furthermore, all constructed fusion proteins must be functionally validated. A positive control, such as co-expressing MOB2 with its known partner NDR1, should be used to confirm that the fusion protein is functional and can reconstitute a known interaction in the Y2H system [7].

Quantitative Assessment of Steric Hindrance

Quantifying steric effects provides a rational basis for fusion protein design. While traditional methods like Taft's steric constants (Es) exist, recent computational advances offer more dynamic assessments.

The Dynamic Parameter of Steric Hindrance (DPSH) is a theoretical method that evaluates steric hindrance by calculating the difference in activation enthalpies (ΔH‡) for two model addition reactions of a radical to olefins of differing bulkiness [71]. The core equation is: DPSH = ΔH₂‡ - ΔH₁‡ where ΔH₁‡ and ΔH₂‡ are the activation enthalpies for reactions with a standard olefin and a bulkier olefin, respectively. A larger DPSH value indicates greater steric hindrance around the reaction center. While typically applied to small molecules, this principle can inform the conceptual understanding of steric constraints in protein complexes.

Table 2: Methods for Evaluating Steric Hindrance in Molecular Design

Method	Principle	Application in Protein Engineering
DPSH [71]	Measures difference in activation enthalpies for model reactions.	Models the energy penalty of steric clash during binding.
Taft's Es Parameter [72]	Based on rates of ester hydrolysis; quantifies substituent bulkiness.	Guides the choice of linker molecules and side-chain engineering.
Tolman Cone Angle [71]	Apex angle of a cone circumscribing a ligand.	Useful for conceptualizing the spatial footprint of a fusion tag.
VSS (Steric Shielding) [71]	Atomic volume within a sphere centered on a key atom.	Can be adapted to estimate steric shielding of a protein's binding site.

Experimental Protocol: Y2H Screen with MOB2

Cloning and Transformation

• Amplify MOB2 cDNA: Design primers to amplify the full-length human MOB2 open reading frame (ORF). Include restriction sites compatible with your chosen Y2H vectors (e.g., pGBKT7 for BD, pGADT7 for AD).
• Ligation and Sequence: Clone the purified PCR product into the BD and AD vectors. Transform the ligation products into competent E. coli, isolate plasmids, and verify the sequence of the MOB2 insert to ensure no mutations have been introduced.
• Yeast Transformation: Co-transform the purified plasmids into the appropriate yeast reporter strain (e.g., AH109 or Y2HGold). For a bait/beta screen, transform the pGBKT7-MOB2 (bait) and a prey library. For a prey/beta screen, transform the pGADT7-MOB2 (prey) and a bait library. Plate the transformation mixture on synthetic dropout (SD) media lacking Trp and Leu (SD/-Trp/-Leu) to select for cells containing both plasmids.

Interaction Screening and Validation

• Library Screening: For bait screening, plate the transformed yeast from SD/-Trp/-Leu onto higher-stringency media, typically SD/-Ade/-His/-Trp/-Leu (QDO), to select for cells where a protein-protein interaction activates the reporter genes.
• Colony PCR and Plasmid Rescue: Isolate viable colonies from the high-stringency plates. Use colony PCR or plasmid rescue techniques to isolate the interacting prey or bait plasmid from yeast.
• Sequence Analysis: Sequence the isolated plasmids to identify the genes encoding the potential binding partners. Analyze the sequences using bioinformatics tools (BLAST, Gene Ontology).
• Retransformation Assay: Re-transform the identified prey/bait plasmid back into yeast alongside the original MOB2 bait/prey plasmid to confirm that the interaction is reproducible and not an artifact.
• Orthogonal Validation: Confirm biologically relevant interactions using an independent method, such as co-immunoprecipitation (co-IP) in mammalian cells.

The workflow for this protocol is summarized below.

The Scientist's Toolkit: Essential Reagents for MOB2 Y2H Studies

Table 3: Key Research Reagent Solutions for MOB2 Y2H Experiments

Reagent / Material	Function / Description	Example / Note
Y2H Vectors	Plasmids for expressing MOB2 as a fusion with BD (bait) or AD (prey).	pGBKT7 (BD), pGADT7 (AD) [14].
Yeast Strains	Genetically engineered reporter strains with selectable auxotrophic markers.	AH109 (genotypes: trp1, leu2, his3, ade2) [47].
ABC Transporter-Deficient Strain	Yeast strain with enhanced permeability to small-molecule inhibitors.	ABC9Δ strain; allows testing of PPI inhibitors in Y2H [47].
Known Interactor (Positive Control)	A confirmed binding partner to validate MOB2 fusion protein functionality.	NDR1 (STK38) or NDR2 (STK38L) [7] [24].
Flexible Linker Peptide	A sequence inserted between the fusion tag and MOB2 to reduce steric interference.	(G₄S)₃ linker [14].

Troubleshooting and Optimization

A well-designed experiment must account for and mitigate common pitfalls. The following table addresses key challenges, particularly false negatives resulting from steric hindrance.

Table 4: Troubleshooting Guide for MOB2 Y2H Experiments

Problem	Potential Cause	Solution(s)
No interactors found	Steric hindrance from fusion tag; MOB2 fusion is misfolded or unstable.	1. Switch the fusion orientation (BD vs. AD).2. Introduce a flexible linker.3. Test a truncated MOB2 construct (ensure the Mob domain fold is intact).
High background (autoactivation)	The MOB2-BD fusion alone activates transcription.	1. Titrate with 3-AT (a competitive inhibitor of the HIS3 gene product).2. Use a lower-copy BD vector.3. Test for expression and stability of the fusion protein by Western blot.
Failure to validate	Interaction is a false positive or is specific to the yeast environment.	1. Always perform retransformation assays.2. Validate interactions with an orthogonal method (e.g., Co-IP, BiFC).
Inability to test inhibitors	Yeast ABC transporters efflux small molecules.	Use an ABC transporter-deficient yeast strain (e.g., ABC9Δ) for inhibitor studies [47].

The successful application of the Y2H system to map MOB2 interactions hinges on meticulous experimental design that prioritizes protein functionality. By understanding MOB2 biology, strategically designing fusion constructs to minimize steric interference, employing quantitative assessment tools, and implementing a rigorous validation protocol, researchers can generate highly reliable and biologically relevant data. These application notes provide a foundational framework for investigating the MOB2 interactome, an endeavor with significant potential for uncovering new mechanisms in cell cycle regulation and DNA damage signaling, thereby opening new avenues for therapeutic intervention.

Beyond the Screen: Validating MOB2 Interactions with Orthogonal Methods

Co-immunoprecipitation (Co-IP) serves as a critical orthogonal technique for confirming protein-protein interactions initially identified through high-throughput screening methods like yeast two-hybrid (Y2H) systems. Within the context of Mob2 signaling research, Co-IP provides a method to verify putative binding partners in a native cellular environment, preserving post-translational modifications and physiological conditions that may be absent in Y2H systems [73]. The Mob2 protein functions as a key regulatory co-activator for NDR1 and NDR2 serine-threonine kinases, forming stable complexes that dramatically stimulate kinase catalytic activity [74]. As a conserved member of the Mps one binder (MOB) family, Mob2 plays essential roles in cell morphogenesis networks and Hippo-like signaling pathways, making the confirmation of its interaction partners crucial for understanding its biological functions [5] [75].

This application note details a optimized Co-IP protocol specifically contextualized for validating Mob2 binding partners initially discovered through yeast two-hybrid screening, providing researchers with a robust methodology to confirm these interactions under native conditions.

Key Principles of Co-Immunoprecipitation

Co-IP is an extension of immunoprecipitation that enables the isolation of a protein of interest (the "bait") along with its physiologically relevant binding partners (the "prey") from native cell lysates [76]. The technique relies on a target protein-specific antibody that is indirectly used to capture proteins bound to a specific target protein [76]. These protein complexes can then be analyzed to identify new binding partners, binding affinities, the kinetics of binding, and the function of the target protein [76].

Critical Advantages for Mob2 Research:

• Native Context Preservation: Unlike Y2H systems that often use protein fragments in artificial nuclear environments, Co-IP investigates interactions with full-length proteins in their proper subcellular localization [73].
• Post-Translational Modifications: Protein complexes maintain their native phosphorylation states and other modifications that regulate Mob2 function in NDR kinase activation [5] [74].
• Endogenous Expression Levels: Interactions occur at physiological protein concentrations rather than the overexpression conditions typical of many Y2H systems [73].

Co-IP Experimental Design for Mob2 Binding Partners

Strategic Experimental Planning

A well-designed Co-IP experiment for confirming Mob2 interactions requires careful consideration of bait-prey systems, controls, and detection methods. The table below outlines key experimental design considerations specific to Mob2 research:

Table 1: Co-IP Experimental Design Considerations for Mob2 Research

Design Element	Considerations for Mob2 Studies	Recommended Approach
Bait Protein	Full-length Mob2 vs. functional domains; tag placement to avoid NDR kinase binding interface	N-terminal tagging to preserve Mob/Phocein domain structure [5]
Cell System	Endogenous vs. overexpression; relevance to Mob2 biological functions (morphogenesis, proliferation)	Cell lines with active Hippo/Hippo-like signaling pathways [75]
Lysis Conditions	Preserve labile Mob2-kinase interactions; maintain post-translational modifications	Non-denaturing buffers with low ionic strength (<120mM NaCl) and non-ionic detergents [76]
Detection Method	Confirmation of specific interactions vs. discovery of novel partners	Western blot for known candidates; mass spectrometry for discovery [77]

Essential Controls for Interpretation

Robust controls are fundamental for distinguishing specific Mob2 interactions from non-specific binding:

• Positive Control: Transfect bait (Mob2) alone to confirm successful immunoprecipitation under chosen conditions [77].
• Negative Control 1: Transfect prey protein alone to verify it is not precipitated in the absence of Mob2 [77].
• Negative Control 2: Include tag-only control (e.g., GFP only) to confirm precipitation depends on Mob2 rather than the tag [77].
• Isotype Control: Use non-specific antibody to identify background binding to beads or antibody [76].

Detailed Co-IP Protocol for Mob2 Interaction Analysis

Reagent Preparation and Cell Lysis

Research Reagent Solutions for Mob2 Co-IP

Table 2: Essential Reagents for Mob2 Co-IP Studies

Reagent	Specification	Function in Mob2 Co-IP
Lysis Buffer	Non-denaturing (NP-40 or Triton X-100), protease/phosphatase inhibitors	Preserves native Mob2-kinase complexes; maintains phosphorylation status [76]
Antibody-Bead Conjugate	GFP-Trap for tagged Mob2; specific antibodies for endogenous Mob2	Captures Mob2 and associated proteins with high specificity [77]
Wash Buffer	Moderate stringency (150-200mM NaCl)	Reduces non-specific binding while maintaining genuine interactions [78]
Elution Buffer	Low pH (0.1M glycine) or SDS-sample buffer	Releases complexes for analysis; denaturing conditions for western blot [77]
Protease Inhibitors	EDTA-free cocktail with benzonase	Prevents proteolysis without disrupting metal-dependent interactions [78]

Cell Lysis Protocol:

• Culture Conditions: Grow cells expressing Mob2 and potential binding partners under appropriate conditions. For NDR kinase interactions, ensure proper cell density as Hippo signaling is density-dependent [5].
• Lysis: Use ice-cold non-denaturing lysis buffer (e.g., 50mM Tris pH 7.5, 150mM NaCl, 1% NP-40, 10% glycerol) supplemented with protease and phosphatase inhibitors [76] [78].
• Extraction: Incubate lysates on ice for 15-30 minutes with gentle mixing. Avoid sonication or vigorous vortexing to preserve protein complexes [76].
• Clarification: Centrifuge at 10,000 × g for 10 minutes at 4°C to remove insoluble material. Retain supernatant for Co-IP [78].

Immunoprecipitation and Wash Steps

• Antibody-Bead Preparation: Pre-bind appropriate antibodies to magnetic or agarose beads according to manufacturer's specifications. For GFP-tagged Mob2, GFP-Trap agarose provides excellent specificity [77].
• Incubation: Combine clarified lysate with antibody-bound beads and incubate with end-over-end rotation for 2-4 hours at 4°C. Extended incubation may increase yield but also background [77].
• Washing: Pellet beads and wash 3-4 times with wash buffer (lysis buffer with possibly increased salt concentration up to 500mM NaCl). Gentle resuspension is critical to maintain complexes [76].

Elution and Analysis

• Elution Options:

  • Denaturing: Boil beads in 2× SDS-PAGE sample buffer for 5 minutes [77]
  • Native: Competitive elution with FLAG peptide for tagged proteins (150μg/mL in TBS) [78]
  • Acidic: Low pH glycine buffer (0.1M, pH 2.5-3.0) followed by neutralization [77]

• Analysis Methods:

  • Western Blot: Probe for known interacting partners (NDR1/NDR2 kinases) using specific antibodies [74]
  • Mass Spectrometry: Identify novel binding partners through proteomic analysis [79]
  • Quantitative Assessment: Use densitometry for semi-quantitative comparison of interaction strengths under different conditions [80]

Troubleshooting Common Issues in Mob2 Co-IP

Table 3: Troubleshooting Guide for Mob2 Co-IP Experiments

Problem	Potential Causes	Solutions
No prey detection	Weak/transient interactions; improper lysis conditions	Use crosslinking stabilizers; optimize buffer stringency; ensure proper kinase activation states [76]
High background	Non-specific antibody binding; insufficient washing	Pre-clear lysates; increase wash stringency; titrate antibody concentration [76]
Antibody interference	Co-elution of antibody chains	Use crosslinked antibody-bead systems; tag-based purification systems [76] [77]
Inconsistent results	Protein complex instability; protease degradation	Standardize lysis protocols; use fresh protease inhibitors; minimize processing time [80]

Advanced Applications: Quantitative Analysis of Mob2 Complexes

For researchers requiring quantitative assessment of Mob2 interactions, advanced Co-IP variations offer enhanced capabilities:

• Quantitative Multiplex Co-IP (QMI): Enables simultaneous assessment of multiple protein interactions using flow cytometry detection, particularly valuable for analyzing Mob2 relationships within Hippo signaling networks [79].
• Semi-Quantitative Immunoblotting with Densitometry: Provides statistical assessment of interaction perturbations through rigorous image analysis [80].
• Native Multi-Step Extraction: Sequential extraction protocols preserve labile interactions by gradually increasing detergent and salt concentrations, particularly valuable for Mob2 complexes distributed across different subcellular compartments [78].

These quantitative approaches allow researchers to move beyond simple interaction confirmation to measure dynamic changes in Mob2 protein complexes under different physiological conditions, treatment regimens, or in disease states.

Co-immunoprecipitation serves as an indispensable method for confirming yeast two-hybrid identified interactions within the physiologically relevant context of Mob2 signaling networks. The protocol detailed here provides a robust framework for verifying Mob2 binding partners, particularly its critical interactions with NDR1/NDR2 kinases, while maintaining the post-translational modifications and cellular environment essential for proper function. Through careful experimental design, appropriate controls, and optimized conditions, researchers can reliably validate Mob2 protein interactions to advance understanding of Hippo and Hippo-like signaling pathways in cell morphogenesis, proliferation, and tissue homeostasis.

The characterization of protein-protein interactions (PPIs) is fundamental to understanding cellular functions. Previous research utilizing Yeast Two-Hybrid (Y2H) screens has established that human MOB2 (hMOB2) interacts with human NDR1/2 kinases but not with LATS1/2 kinases [81]. Furthermore, these studies revealed that hMOB2 competes with hMOB1A for NDR binding and appears to function as a negative regulator of human NDR kinases in both biochemical and biological settings [81]. While Y2H has been instrumental as a workhorse for initial interactome mapping [82] [83], this technique primarily detects direct binary interactions under the specific conditions of the yeast nucleus.

Proximity-Dependent Biotin Identification (BioID) represents a complementary approach that overcomes several limitations of traditional methods. As a proximity-dependent labeling technique, BioID enables the identification of both direct interactors and proximal proteins within a 10 nm radius in the native cellular environment [84] [85]. This capability is particularly valuable for capturing weak, transient, or membrane-associated interactions that might be missed by Y2H or affinity purification approaches [86] [87]. For MOB2, which functions as a regulatory protein within kinase signaling pathways, BioID offers the potential to map its complete molecular neighborhood under near-physiological conditions.

Table 1: Comparison of Protein-Protein Interaction Mapping Techniques

Method	Principle	Advantages	Limitations
Yeast Two-Hybrid (Y2H)	Reconstitution of transcription factor via bait-prey interaction in yeast [33] [14]	Detects direct binary interactions; High-throughput capability [82] [83]	Limited to soluble proteins; May miss context-dependent interactions in native system [82] [33]
Affinity Capture-MS	Purification of protein complexes under physiological conditions [85] [86]	Identifies stable protein complexes; Works with endogenous expression levels	May miss weak/transient interactions; Requires soluble protein complexes [85] [86]
BioID	Proximity-dependent biotinylation in living cells [84] [85]	Captures weak/transient interactions; Works in native cellular context; Identifies proximal neighbors [84] [86]	Does not distinguish direct vs. indirect interactions; ~10 nm labeling radius [84]

BioID Methodology and Workflow

Core Principle of BioID

BioID utilizes a promiscuous bacterial biotin ligase (BirA*) fused to a protein of interest (the "bait"). This fusion protein catalyzes the conversion of biotin to reactive biotinoyl-5'-adenylate (bioAMP), which covalently attaches to lysine residues of proximal proteins [84]. The biotinylation occurs within a labeling radius of approximately 10 nm [84] [85], creating a record of proteins that have been in close proximity to the bait during the labeling period. These biotinylated proteins can subsequently be isolated under denaturing conditions using streptavidin-based affinity capture and identified via mass spectrometry [84] [88].

Experimental Design Considerations for MOB2 BioID

Fusion Construct Design

The design of the BioID fusion construct is critical for maintaining the proper function and localization of the bait protein. For MOB2 interactome mapping, several tagging strategies are available:

• N-terminal vs. C-terminal tagging: Testing both orientations is recommended to minimize potential disruption of functional domains, particularly since MOB2 interacts with NDR kinases through its native structure [81].
• Tag selection: The MAC-tag system, which incorporates both StrepIII-tag and BirA*, enables combined AP-MS and BioID analyses with a single construct [85]. Alternative options include myc-BioID [88] and BioID2 [84], with BioID2 being smaller (233 aa) and potentially less disruptive to protein function.
• Inducible expression systems: Tetracycline/doxycycline-inducible promoters [88] allow temporal control of fusion protein expression, minimizing potential artifacts from prolonged BirA* expression.

Cell Line Selection and Culture

• Cell lines with relevant biology: HEK293, U2-OS, and HeLa cells have been successfully used in previous MOB protein interaction studies [81] and are suitable for BioID.
• Stable cell line generation: Using Flp-In T-REx systems enables consistent, inducible bait expression from isogenic cell clones, reducing experimental variability [85].
• Culture conditions: Standard DMEM supplemented with 10% fetal calf serum is appropriate [81]. Biotin-free medium may be considered to reduce background, though endogenous biotin levels are typically low.

Figure 1: BioID Experimental Workflow. The diagram outlines the key steps in a BioID experiment for mapping the MOB2 proximity interactome, from construct design to bioinformatic analysis.

Step-by-Step Protocol for MOB2 BioID

Fusion Protein Validation

Before proceeding with full-scale BioID, validation of the MOB2-BirA* fusion protein is essential:

• Transfection: Plate cells at consistent confluence (e.g., 1×10^6 cells/10-cm dish) and transfect with MOB2-BirA* construct using appropriate transfection reagents (e.g., Fugene 6, Lipofectamine) [81].
• Localization verification: Confirm proper subcellular localization of MOB2-BirA* using immunofluorescence with anti-HA or anti-BioID antibodies [85]. Compare to documented localization of untagged MOB2.
• Functionality assessment: Verify that the fusion protein retains biological activity by testing its ability to interact with known partners (e.g., NDR1) through co-immunoprecipitation [81].

Biotinylation Procedure

• Biotin preparation: Prepare 1-5 mM biotin stock solution in serum-free medium or PBS. Filter-sterilize through 0.22 μM filter [84] [87].
• Biotin concentration optimization: Test a range of biotin concentrations (50 μM - 2 mM) to determine optimal labeling efficiency. For mammalian cells, start with 50 μM; for plant systems, higher concentrations (1-2 mM) may be required [87].
• Labeling duration: Incubate cells with biotin for 15-24 hours. The optimal time depends on bait protein turnover and desired labeling window [84].
• Conditional treatments: If investigating context-dependent interactions (e.g., signaling perturbations), apply appropriate stimuli during the biotinylation period.

Protein Capture and Purification

• Cell lysis: Lyse cells in RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) containing protease/phosphatase inhibitors [88]. Use benzonase nuclease to reduce viscosity from nucleic acids.
• Streptavidin bead preparation: Equilibrate streptavidin magnetic beads with lysis buffer. Use 200 μL bead slurry per 10-cm plate of confluent cells [88].
• Affinity capture: Incubate clarified lysates with streptavidin beads for 3-5 hours at 4°C with gentle rotation [88].
• Stringent washing:
  • Wash 2× with RIPA buffer
  • Wash 1× with 1 M KCl in 50 mM Tris-HCl, pH 7.5
  • Wash 1× with 0.1 M Na2CO3
  • Wash 2× with 2 M urea in 50 mM Tris-HCl, pH 7.5
  • Final wash with 50 mM Tris-HCl, pH 7.5 [84] [88]
• On-bead digestion: Digest proteins on beads with sequencing-grade trypsin (1:50 w/w) overnight at 37°C [88].

Mass Spectrometry and Data Analysis

• LC-MS/MS analysis: Reconstitute peptides in 2% acetonitrile/0.1% formic acid and analyze using a nanoLC system coupled to an Orbitrap mass spectrometer [88].
• Database search: Process raw files using MaxQuant software against appropriate protein databases with methionine oxidation and N-terminal acetylation as variable modifications [88].
• Statistical analysis: Use Significance Analysis of INTeractome (SAINT) to identify high-confidence prey proteins based on quantitative recovery across replicates compared to controls [87]. Apply Bayesian false discovery rate (BFDR) cutoff of ≤0.01.
• Bioinformatic validation: Compare identified proteins with existing MOB2 interaction data from Y2H studies [81] and public interaction databases.

Table 2: Key Research Reagent Solutions for MOB2 BioID

Reagent/Category	Specific Examples	Function/Purpose	Considerations for MOB2 Studies
Expression Vectors	pRetroX-mycBioID [88], MAC-tag vector [85], pcDNA3.1-BirA*	BirA* fusion construct delivery	Inducible systems recommended to avoid toxicity; verify MOB2 localization and function after tagging
Cell Culture	HEK293, U2-OS, HeLa [81], DMEM + 10% FBS	Provide cellular context for interactions	Select cells with relevant signaling pathways for NDR kinase biology
Biotin Solution	1-5 mM biotin in serum-free medium [84] [87]	Activate BirA* labeling	Optimize concentration (50μM-2mM); higher concentrations may be needed for different cell types
Lysis Buffer	RIPA buffer [88]	Extract proteins under denaturing conditions	Maintains biotin-protein covalent bonds while removing non-specific associations
Capture Beads	Streptavidin magnetic beads [88]	Affinity purification of biotinylated proteins	Magnetic beads facilitate stringent washing; capacity ~5 mg/mL
MS Analysis	Orbitrap Elite [88], MaxQuant [88]	Identify biotinylated proteins	Label-free quantification enables statistical assessment of interaction significance

Anticipated Results and Interpretation for MOB2

Expected Interactions

Based on previous Y2H studies, the MOB2 BioID interactome should prominently include:

• NDR1 and NDR2 kinases: As direct binding partners established by Y2H [81]. BioID may capture these interactions in the native cellular context and potentially reveal additional regulatory components of these complexes.
• Competitive interactors: Proteins that compete with MOB1A for NDR binding [81]. BioID could identify the spatial organization of this competitive relationship.
• Novel proximal proteins: Potential unknown proteins involved in MOB2 regulation or function, particularly those involved in its role as a negative regulator of NDR kinases.

Data Analysis and Validation

When analyzing MOB2 BioID data, researchers should:

• Compare with control samples: Express BirA* alone to identify non-specific background biotinylation [84] [87].
• Integrate with existing data: Cross-reference identified proteins with Y2H results for MOB2 [81] to distinguish direct interactors from proximal proteins.
• Apply statistical thresholds: Use SAINT analysis with BFDR ≤0.01 and require proteins to be identified in multiple biological replicates [87].
• Prioritize candidates: Focus on proteins that are specifically enriched in MOB2-BirA* samples compared to both BirA* alone and other organelle markers.

Figure 2: MOB2 Proximity Interactome Relationships. The diagram illustrates the expected interactions in the MOB2 BioID experiment, including previously established direct interactions from Y2H studies and potential novel proximal proteins.

Technical Considerations and Troubleshooting

Optimization Guidelines

• Biotin concentration titration: Excessive biotin can cause cellular toxicity, while insufficient biotin reduces labeling efficiency. Test ranges from 50 μM to 2 mM [87].
• Labeling time optimization: Shorter incubations (4-8 h) capture more transient interactions, while longer incubations (15-24 h) increase sensitivity [84].
• Expression level control: Moderate, inducible expression minimizes artifacts from protein overexpression [85]. Use Western blotting to monitor fusion protein levels.

Common Challenges and Solutions

• High background: Increase stringency of washes; include control samples (BirA* alone); use quantitative proteomics to distinguish specific interactions.
• Low biotinylation efficiency: Verify BirA* activity; increase biotin concentration or incubation time; check fusion protein expression and localization.
• Poor recovery of membrane proteins: MOB2 is not membrane-associated, but some interactors might be. Ensure lysis buffer effectively solubilizes different cellular compartments.

The application of BioID to map the MOB2 proximity interactome represents a powerful complementary approach to previous Y2H studies. While Y2H established the direct binary interactions between MOB2 and NDR kinases [81], BioID extends these findings by capturing the spatial and temporal context of these interactions in living cells. This technique is particularly valuable for understanding the competitive relationship between MOB2 and MOB1A for NDR binding, potentially revealing additional regulatory components that modulate this competition.

The integration of BioID data with existing Y2H results will provide a more comprehensive understanding of MOB2's role as a negative regulator of NDR kinases, potentially identifying novel components of this regulatory pathway that could not be captured by binary interaction screens alone. This multi-method approach, leveraging the strengths of both Y2H and proximity-dependent labeling, will significantly advance our understanding of MOB2 function in cellular signaling pathways and its potential relevance to disease processes.

The exploration of protein-protein interactions (PPIs) is fundamental to deciphering cellular signaling, and a thorough investigation of Mps one binder 2 (MOB2) binding partners exemplifies this pursuit. It has been estimated that approximately 650,000 protein-protein interactions exist in the human interactome, representing a complex network of macromolecular partnerships that dictate cellular life [89]. Traditional methods like the yeast two-hybrid (Y2H) screen have been instrumental in initial discovery phases, such as identifying novel binding partners like RAD50 for MOB2 [6]. However, these methods often lack the temporal resolution and quantitative capacity needed for detailed biochemical validation and dynamic interaction studies.

Split-protein assays have emerged as a powerful complementary technology, converting molecular binding events into easily measurable optical signals. These assays are particularly valuable for validating interactions identified in initial Y2H screens, allowing researchers to confirm putative binding partners in more physiologically relevant contexts and study the dynamics of these interactions in living cells [89] [90]. For MOB2 research, which plays critical roles in cell cycle progression and the DNA damage response (DDR), these assays provide indispensable tools for understanding how MOB2 partnerships with NDR kinases and components of the MRE11-RAD50-NBS1 (MRN) complex influence its function in maintaining genomic integrity [7] [6].

Fundamental Principles of Split-Protein Systems

Core Mechanism and Historical Context

Split-protein reassembly, also known as protein fragment complementation, relies on the appropriate fragmentation of reporter proteins into inactive components that can only regain function when brought into proximity by interacting partner proteins [89]. The foundational observation that protein fragments can reassemble into functional complexes dates back over 60 years with ribonuclease and β-galactosidase, but the conditional reassembly approach was revolutionized in 1994 by Johnsson and Varshavsky using split-ubiquitin [89].

The core mechanism involves splitting a reporter protein into two or more inactive fragments that are fused to potential interacting proteins. When the bait and prey proteins interact, they increase the local concentration of the reporter fragments, driving their reassembly into a functional protein that generates a detectable signal [89] [90]. This approach effectively links non-covalent protein interactions to the function of the split-reporter protein, creating a direct readout for molecular partnerships.

Critical Design Criteria

For successful implementation of split-protein systems, several design criteria must be met. Each protein fragment alone should exhibit minimal to no activity, and the affinity between fragments in the absence of interacting partners should be negligible to maintain low background signal. The reassembled split-protein must provide an easily measurable readout with high signal-to-background ratio, and the fusion proteins must maintain proper folding and localization without disrupting the natural interaction being studied [89] [90].

The selection of appropriate dissection sites within the reporter protein presents a significant engineering challenge. Optimal fragmentation sites often do not correspond to obvious structural domains and may require extensive screening, as demonstrated by the discovery that optimal firefly luciferase fragments possess an 18 amino acid overlap that would be difficult to anticipate by rational design alone [89].

Split-Protein System Variants and Their Applications

Comparison of Major Split-Protein Systems

Table 1: Performance Characteristics of Major Split-Protein Systems

System	Signal Type	Reversibility	Response Time	Signal-to-Background	Fragment Sizes	Key Applications
Split-Luciferase (NanoBiT)	Bioluminescence	Reversible	Seconds-Minutes	High	18 kDa + 1.3 kDa	Real-time kinetics, inhibitor screening [90]
Split-Fluorescent Protein (BiFC)	Fluorescence	Irreversible	Minutes-Hours	Medium	17-19 kDa + 9-10 kDa	Trapping transient interactions, localization [90] [91]
Split-DHFR	Enzymatic Activity	Reversible	Hours-Days	Binary	12 kDa + 9-10 kDa	Genetic selection screens [90]
Tripartite Split-GFP	Fluorescence	Irreversible	Minutes-Hours	High	1-193 aa + 194-212 aa + 213-233 aa	Protein interaction sensing with minimal tags [91]

Advanced Split-Protein Configurations

Recent engineering efforts have expanded split-protein systems beyond binary interactions. Ternary split-protein reassembly enables detection of unmodified native targets, including proteins, DNA, and RNA [89]. This approach fuses split reporter halves to receptor fragments or binding domains that simultaneously interact with a target, creating a three-component system that drives reporter reassembly only in the presence of the specific target molecule.

For nucleic acid detection, zinc finger DNA binding domains have been fused to split reporter fragments such as GFP, β-lactamase, or firefly luciferase [89]. In the presence of target DNA containing specific adjacent recognition sites, the reporter protein activity is reconstituted, providing a measurable "turn-on" signal. This modular system allows detection of virtually any nucleic acid sequence, including specific epigenetic modifications when combined with appropriate detection domains like methyl binding domains [89].

Protocol: Validating MOB2 Interactions Using Split-Luciferase Complementation

Sensor Design and Lysate Preparation

To validate MOB2 binding partners identified through yeast two-hybrid screening, begin by designing split-luciferase fusion constructs. Fuse the N-terminal fragment of NanoLuc luciferase (LgBiT, 18 kDa) to the coding sequence of MOB2, and the C-terminal peptide (SmBiT/HiBiT, 1.3 kDa) to putative binding partners such as NDR1, NDR2, or RAD50 [92] [90]. Include flexible linkers (e.g., GSG or (GGGGS)â‚‚) between the proteins and luciferase fragments to minimize steric hindrance.

Prepare HEK293T cell lysates expressing these fusion proteins. Culture cells in appropriate medium, transfert with constructed plasmids using standard methods, and harvest 48 hours post-transfection. Lyse cells using ice-cold lysis buffer (25 mM Tris-phosphate pH 7.8, 2 mM DTT, 2 mM EDTA, 10% glycerol, 1% Triton X-100), clarify by centrifugation at 16,000 × g for 15 minutes at 4°C, and aliquot supernatant for immediate use or storage at -80°C [92].

Assay Optimization and Implementation

Table 2: Key Research Reagents for Split-Protein MOB2 Interaction Studies

Reagent Category	Specific Examples	Function in Assay	Considerations for MOB2 Studies
Split-Reporter Fragments	NanoLuc LgBiT/SmBiT, GFP1-10/11, Venus YFP fragments	Generate detectable signal upon complementation	Select based on needed kinetics and localization requirements [90]
Expression Vectors	Inducible promoters (Tet-on), mammalian expression vectors	Control fusion protein expression	Use moderate expression to avoid artifactual interactions [92] [90]
Cell Lines	HEK293T, RPE1-hTert, U2-OS	Provide cellular context for interactions	Select physiologically relevant models for MOB2 function [6]
Detection Reagents	Furimazine (for NanoLuc), Luciferin (for Firefly Luc)	Substrate for signal generation	Consider permeability for live-cell applications [90]
Interaction Controls	Known MOB2 binders (NDR1/2), non-interacting proteins	Validate assay specificity	Include MOB2 mutants defective in binding [6]

Optimize assay conditions through 2D titration of lysates containing bait and prey fusion proteins. Combine varying volumes of MOB2-LgBiT lysate with RAD50-SmBiT or NDR-SmBiT lysates in a white 96-well plate, maintaining constant total protein concentration with untransfected cell lysate. Initiate the reaction by adding furimazine substrate (final concentration 20-50 μM) and measure luminescence immediately using a plate reader [92].

For quantitative analysis, include controls consisting of lysates expressing only one fusion protein combined with lysate from untransfected cells. Calculate normalized luminescence ratios by dividing test well readings by the average of negative control wells. A signal-to-background ratio exceeding 3:1 typically indicates specific interaction [92].

For time-course competition assays to monitor interaction dynamics, pre-incubate complementary lysates for 10 minutes before adding substrate and measuring luminescence at regular intervals. To test disruption of interactions, add potential inhibitors (e.g., peptides mimicking binding interfaces) before lysate combination and monitor changes in luminescence over time [92].

Protocol: Spatial Localization Studies with Split-Fluorescent Proteins

Tripartite Split-GFP Assay for MOB2 Complexes

While traditional bimolecular fluorescence complementation (BiFC) uses two fragments of fluorescent proteins, recent advances include tripartite systems that further minimize tag size. For MOB2 interaction studies, engineer fusions with the 19-amino acid GFP10 tag (residues 194-212) on MOB2 and the 21-amino acid GFP11 tag (residues 213-233) on binding partners like NDR kinases or RAD50 [91].

Transfert constructs into appropriate cell lines (e.g., RPE1-hTert or U2-OS cells) grown on glass coverslips using lipid-based transfection reagents. Include controls expressing each tagged protein alone with the GFP1-9 detector. 24-48 hours post-transfection, add the complementary GFP1-9 detector fragment (either via transfection with expression vector or directly as purified protein if using delivery systems) and incubate for 2-4 hours to allow complementation [91].

Fix cells with 4% paraformaldehyde for 15 minutes at room temperature, then image using standard fluorescence microscopy with GFP filter sets. The tripartite system provides exceptional spatial resolution of MOB2 interaction sites while minimizing perturbation due to the small tag size, making it particularly valuable for determining subcellular localization of MOB2 complexes with DDR components like RAD50 at DNA damage sites [6] [91].

Experimental Considerations for MOB2 Biology

When studying MOB2 interactions, consider its dual roles in regulating NDR kinases and participating in DNA damage response through MRN complex binding [7] [6]. Include appropriate cellular contexts, such as inducing DNA damage with doxorubicin or ionizing radiation when examining RAD50 interactions, and monitor cell cycle status as MOB2 depletion can cause G1/S arrest through p53/p21 activation [6].

For NDR kinase interactions, note that MOB2 competes with MOB1 for NDR binding, with MOB2/NDR complexes associated with diminished NDR kinase activity compared to MOB1/NDR complexes [7] [4]. Design experiments to account for this competitive binding, potentially including MOB1 co-expression or knockdown conditions to better understand the regulatory balance.

Integration with Yeast Two-Hybrid Screening

Complementary Strengths of Y2H and Split-Protein Assays

While Y2H screening excels at discovering novel binding partners in an unbiased manner, split-protein assays provide superior validation and characterization capabilities. The initial identification of RAD50 as a MOB2 binding partner through Y2H screening [6] exemplifies this complementary relationship. Subsequent validation with split-protein assays confirmed this interaction in mammalian cells and provided insights into its functional significance in DDR signaling.

The reverse Y2H approach can also screen for small-molecule inhibitors of PPIs by selecting for loss of interaction [47]. Engineered yeast strains with enhanced permeability to small molecules (e.g., ABC transporter deletions) enable more effective compound screening in a cellular context [47]. Identified inhibitors can then be further characterized using split-luciferase systems for quantitative ICâ‚…â‚€ determination and mechanistic studies.

Workflow for Comprehensive MOB2 Interaction Analysis

Diagram 1: Workflow for MOB2 interaction analysis. This integrated approach combines discovery and validation methods.

Troubleshooting and Technical Considerations

Addressing Common Artifacts

Split-protein assays are powerful but susceptible to specific artifacts that require careful controls. False positives can arise from overexpression-driven spontaneous fragment reassembly [90]. Mitigate this by using inducible promoters, creating stable cell lines with near-endogenous expression levels, and testing both N-terminal and C-terminal fusions for each partner.

False negatives may result from steric hindrance if fusion tags block interaction interfaces. Optimization of linker length and flexibility often resolves this issue. Additionally, ensure that fusion proteins are properly folded and localized by conducting functionality tests comparing tagged proteins to their untagged counterparts [90].

For MOB2 specifically, confirm that tagged constructs maintain proper regulation, as MOB2 function is modulated through competitive binding with MOB1 for NDR kinases [7] [4]. Always validate key findings with orthogonal methods such as co-immunoprecipitation of endogenous proteins or functional assays monitoring DNA damage response activation [6].

Advanced Technical Applications

Recent advances combine split-protein systems with other technologies to enhance their utility. CRISPR/Cas9-mediated genome editing allows precise knock-in of split-protein tags into endogenous genes, avoiding overexpression artifacts [90]. When combined with AI-driven structural prediction tools like AlphaFold2, researchers can identify optimal insertion sites that minimize disruption to native protein function and interaction interfaces.

Split-protein systems have also been paired with resonance energy transfer methods, where a reconstituted split fluorescent protein serves as an acceptor for FRET or BRET [89]. This strategy enabled demonstration of four-protein association in G protein-coupled receptor signaling complexes and could be applied to study higher-order MOB2 complexes in DDR or Hippo signaling.

Split-protein complementation assays provide powerful, versatile tools for validating and characterizing protein-protein interactions initially identified through yeast two-hybrid screening. For MOB2 binding partners, these assays enable quantitative assessment of interaction strength, spatial localization in living cells, and dynamic monitoring of complex formation and disruption. The integration of split-luciferase for quantitative analysis and split-fluorescent proteins for spatial resolution offers a comprehensive approach to studying MOB2's roles in cell cycle regulation, DNA damage response, and NDR kinase signaling.

As split-protein systems continue to evolve with smaller tags, improved signal-to-noise ratios, and integration with genome editing technologies, their application to MOB2 biology and beyond will undoubtedly yield deeper insights into the complex protein networks that govern cellular homeostasis. The protocols outlined here provide a foundation for researchers to implement these powerful methods in their own investigations of protein interaction networks.

The comprehensive understanding of cellular systems requires detailed knowledge of protein-protein interactions (PPIs), which form the fundamental architecture of all biological processes. Within the field of interactomics, two powerful methodologies have emerged as cornerstone technologies: the yeast two-hybrid (Y2H) system and affinity purification-mass spectrometry (AP-MS). While both techniques aim to map protein interactions, they operate on fundamentally different principles and capture distinct aspects of molecular associations. This comparative analysis examines how data generated from Y2H screenings complements information obtained through AP-MS approaches, with specific application to the characterization of MOB2 binding partners—a crucial regulator of DNA damage response and cell cycle progression.

The biological context for this methodological comparison centers on Mps one binder 2 (MOB2), a conserved signal transducer with recently identified roles in maintaining genome stability. MOB2 has been biochemically linked to the regulation of NDR1/2 kinases and functions as a novel DNA damage response (DDR) factor that prevents accumulation of endogenous DNA damage and subsequent activation of cell cycle checkpoints [7]. Research has demonstrated that MOB2 knockdown triggers a p53/p21-dependent G1/S cell cycle arrest in untransformed human cells, highlighting its critical role in cellular homeostasis [6]. The multifaceted nature of MOB2 interactions, including its associations with the NDR1/2 kinases and identification of RAD50 as a novel binding partner through Y2H screening [6], makes it an ideal case study for examining how orthogonal interaction mapping techniques can converge on a comprehensive molecular understanding.

Fundamental Principles: Y2H and AP-MS Methodologies

Yeast Two-Hybrid (Y2H) System

The Y2H technique is a well-established genetic in vivo approach that detects direct binary protein-protein interactions through transcriptional activation in yeast nuclei [20]. The system leverages the modular nature of eukaryotic transcription factors, which are split into separate DNA-binding (DB) and activation (AD) domains. The protein of interest ("bait") is fused to the DB domain, while potential interacting partners ("prey") are fused to the AD domain [59]. Interaction between bait and prey proteins reconstitutes a functional transcription factor that drives expression of reporter genes, enabling yeast survival on selective media or producing colorimetric changes [93].

Key Y2H Variations:

• Yeast One-Hybrid (Y1H): Adapted for detecting protein-DNA interactions
• Yeast Three-Hybrid (Y3H): Identifies interactions mediated by third components like RNA molecules
• Split Ubiquitin System: Specialized for detecting membrane protein interactions [93]

Affinity Purification-Mass Spectrometry (AP-MS)

AP-MS is a biochemical in vitro approach that identifies protein complexes through affinity-based enrichment followed by mass spectrometric detection [94]. In this methodology, a protein of interest ("bait") is typically tagged with an epitope (e.g., FLAG, Strep, GFP) and expressed in an appropriate cellular system. The bait protein and its associated partners ("prey") are purified under near-physiological conditions using affinity resins, followed by proteolytic digestion and liquid chromatography-mass spectrometry (LC-MS/MS) analysis to identify co-purifying proteins [94] [95]. Unlike Y2H, AP-MS captures both direct physical interactions and indirect co-complex associations within stable macromolecular assemblies [96].

Table 1: Core Methodological Differences Between Y2H and AP-MS

Parameter	Yeast Two-Hybrid (Y2H)	Affinity Purification-MS (AP-MS)
Principle	Genetic transcription-based reconstitution in living yeast cells	Biochemical affinity enrichment from cell extracts with MS detection
Environment	In vivo (yeast nucleus)	In vitro (solution-based purification)
Interaction Type	Direct binary interactions	Both direct and indirect co-complex associations
Spatial Context	Nuclear localized	Native cellular localization maintained during extraction
Throughput	High-throughput compatible with automation	Medium to high-throughput with automation
Key Limitation	False positives/negatives, nuclear restriction	Cannot distinguish direct from indirect interactions

Technical Comparison: Complementary Strengths and Limitations

Y2H Advantages and Technical Constraints

The Y2H system provides several distinct advantages for interaction mapping. As a genetic approach, it detects direct binary interactions in living cells under near-physiological conditions without requiring protein purification [20] [97]. The method is highly scalable and cost-effective, enabling proteome-wide screens with relatively simple instrumentation. Y2H is particularly valuable for identifying transient interactions that might be lost during biochemical purification procedures [59].

However, Y2H methodologies present notable limitations. The requirement for interactions to occur in the yeast nucleus restricts analysis of proteins with specific subcellular localizations, particularly membrane proteins (though split ubiquitin systems address this for membrane proteins) [93]. The artificial overexpression of fusion proteins may produce spurious interactions, and the yeast cellular environment may not properly fold, modify, or express all proteins from higher eukaryotes [59]. Additionally, Y2H screens typically exhibit significant rates of both false positives (through spontaneous transcription activation) and false negatives (through improper folding or localization) [96] [59].

AP-MS Advantages and Technical Constraints

AP-MS offers complementary strengths, including the ability to capture endogenous protein complexes under near-physiological conditions in the appropriate cellular context [94] [97]. The method identifies both stable and transient interactions within native complexes and provides a snapshot of interaction networks as they exist in the cell type of interest. Modern quantitative AP-MS approaches can differentiate specific interactors from non-specific background binders through sophisticated scoring algorithms [94].

The limitations of AP-MS include its inability to distinguish direct physical interactions from indirect associations within complexes [96]. The technique requires careful optimization of purification conditions to preserve interactions while minimizing non-specific binding. Protein complexes may dissociate during extraction and purification, leading to false negatives, while overly permissive conditions can increase false positives [97]. Additionally, AP-MS is less suitable for certain protein classes, particularly membrane proteins and nuclear proteins that are challenging to extract in functional form [97].

Table 2: Performance Characteristics of Y2H and AP-MS

Performance Metric	Y2H	AP-MS
Sensitivity to Direct Interactions	High	Medium
Sensitivity to Complex Associations	Low	High
False Positive Rate	High without proper controls	Medium with proper controls
False Negative Rate	Medium-High	Medium
Positional Context Preservation	Low (nuclear restricted)	High (native environment)
Throughput Capacity	High	Medium-High
Quantitative Capability	Low (primarily qualitative)	High (with modern quantitation)

Integrated Experimental Design: MOB2 Interaction Mapping

Phase 1: Y2H Screening for Direct Binary Interactions

The initial discovery phase for mapping MOB2 interactions effectively employs Y2H screening to identify direct binding partners. This approach was successfully utilized to identify RAD50 as a novel MOB2 interactor, revealing an unexpected connection to the MRE11-RAD50-NBS1 (MRN) DNA damage sensor complex [6].

Protocol: Y2H Screening for MOB2 Binding Partners

• Bait Construction: Clone full-length MOB2 cDNA into a DNA-binding domain vector (e.g., pLexA or pGBDU series) to generate the "bait" construct [6].

• Bait Validation: Test the MOB2 bait for auto-activation and toxicity before library screening. Use decreasing concentrations of 3-AT (3-aminotriazole) to titrate against background activation if necessary.

• Library Screening: Transform the MOB2 bait construct into yeast strain of mating type a and cross with a normalized universal human tissue cDNA library (complexity >1×10⁶ clones) constructed in an activation domain vector (e.g., pGADT7-recAB) expressed in yeast strain of mating type α [6].

• Selection and Isolation: Plate diploid yeast on selective media lacking leucine, tryptophan, histidine, and adenine to select for interacting clones. Incubate for 5-10 days at 30°C until colonies appear.

• Confirmation and Sequencing: Isolate positive clones, rescue plasmids, and sequence insert cDNAs to identify putative interactors. Confirm interactions through one-to-one retransformation and growth assays [6].

This Y2H screening approach identified four novel binding partners of MOB2 detected at least twice: RAD50, UBR5, KPNB1, and KIAA0226L, with all four RAD50 hits being in-frame, validating it as a legitimate interactor [6].

Phase 2: AP-MS Validation of Complex Associations

The second phase employs AP-MS to validate Y2H-identified interactions and place them within the broader context of protein complexes and functional networks.

Protocol: AP-MS for MOB2 Complex Characterization

• Cell Line Selection: Establish stable inducible cell lines (e.g., RPE1-hTert Tet-on) expressing epitope-tagged MOB2 (N-terminal or C-terminal 3×FLAG or 2×Strep-3×FLAG tags) [94] [6].

• Control Design: Include positive control baits with known interactions and negative controls (e.g., GFP) to identify non-specific binders [94].

• Affinity Purification: Harvest cells and lyse in appropriate buffer (e.g., 50 mM HEPES, pH 8.0, 100 mM KCl, 2 mM EDTA, 0.1% NP-40, 10% glycerol with protease and phosphatase inhibitors). Perform affinity capture using anti-FLAG M2 agarose or Strep-Tactin resin for 2 hours at 4°C [94] [6].

• Stringent Washing: Wash beads with lysis buffer (3-5 times) with optional increasing salt concentration (up to 300 mM KCl) to reduce non-specific interactions.

• On-Bead Digestion: Wash with 50 mM ammonium bicarbonate, then reduce with DTT, alkylate with iodoacetamide, and digest with sequencing-grade trypsin overnight at 37°C [94].

• LC-MS/MS Analysis: Desalt peptides and analyze by nanoLC-MS/MS using data-dependent acquisition. Identify proteins using database search algorithms (MaxQuant, Proteome Discoverer) against human protein databases [94].

• Data Scoring: Apply statistical frameworks (SAINT, MiST, CompPASS) to distinguish specific interactors from background proteins using the CRAPome contaminant repository [94].

Diagram 1: Complementary Workflows for MOB2 Interaction Mapping. The Y2H pathway identifies direct binary interactors, while AP-MS characterizes complex associations, with integration providing a comprehensive interaction network.

Case Study: Integrated Analysis of MOB2 in DNA Damage Response

The power of combining Y2H and AP-MS approaches is exemplified by recent research on MOB2, which revealed its previously unknown role in the DNA damage response (DDR). Initial Y2H screening identified RAD50, a core component of the MRN DNA damage sensor complex, as a direct MOB2 binding partner [6]. This discovery was particularly significant because MOB2 had previously been characterized primarily as a regulator of NDR1/2 kinases, with its knockdown causing p53/p21-dependent G1/S cell cycle arrest [7].

Follow-up AP-MS studies placed this interaction in functional context, demonstrating that MOB2 supports the recruitment of the complete MRN complex (MRE11-RAD50-NBS1) and activated ATM kinase to DNA damaged chromatin [6]. This combined approach revealed that MOB2 plays a crucial role in DDR signaling, cell survival, and cell cycle checkpoints after DNA damage induction—functions that were not observed upon manipulations of its known kinase partners NDR1/2, suggesting MOB2 operates through distinct mechanisms in the DDR [7] [6].

The experimental data showed that MOB2 knockdown cells displayed defective recruitment of MRN and activated ATM to chromatin, resulting in accumulation of DNA damage and sensitization to DNA-damaging agents like ionizing radiation and doxorubicin [6]. This case study demonstrates how Y2H identified the direct physical interaction with RAD50, while AP-MS contextualized this interaction within the broader MRN complex and DDR machinery.

Diagram 2: MOB2-RAD50 Interaction in DNA Damage Response. MOB2 directly binds RAD50 (Y2H-identified) and supports MRN complex recruitment to damage sites (AP-MS contextualized), facilitating ATM activation and DDR signaling.

Research Reagent Solutions for MOB2 Interaction Studies

Table 3: Essential Research Reagents for MOB2 Interaction Studies

Reagent Category	Specific Examples	Application Purpose
Y2H Vectors	pLexA (DBD), pGADT7 (AD), pGBDU series	Bait and prey fusion construct generation
Epitope Tags	3×FLAG, 2×Strep-3×FLAG, GFP	Affinity purification for AP-MS
Yeast Strains	PJ69-4A, AH109, Y187	Y2H reporter assays with appropriate auxotrophies
cDNA Libraries	Normalized human universal tissue cDNA library	Comprehensive screening of potential interactors
Cell Lines	RPE1-hTert Tet-on, HEK293, U2-OS	AP-MS validation in human cell context
Affinity Resins	Anti-FLAG M2 agarose, Strep-Tactin resin	Bait and complex purification
Selection Agents	-Leu/-Trp/-His/-Ade media, 3-AT	Selection of interacting clones in Y2H
MS Instruments	Q-Exactive, Orbitrap series	High-sensitivity protein identification

Data Integration and Network Analysis

The integration of Y2H and AP-MS data requires sophisticated computational approaches to generate biologically meaningful interaction networks. Current methodologies employ specialized algorithms to distinguish direct from indirect interactions in AP-MS data, such as the Binary Interaction Network Model (BINM), which uses topological relationships in co-complex networks to predict direct physical interactions [96].

Protocol: Integrated Network Analysis for MOB2 Interactions

• Data Pre-processing: Filter Y2H interactions using domain-based scoring and remove promiscuous baits. For AP-MS data, apply contaminant filtering using repositories like CRAPome and normalize spectral counts using SIN or NSAF methods [94].

• Confidence Scoring: Apply the MiST (Mass Spectrometry Interaction Statistics) algorithm or similar frameworks to AP-MS data, integrating metrics like abundance, reproducibility, and specificity to generate probability scores for each interaction [94].

• Network Integration: Combine high-confidence interactions from both datasets using tools like Cytoscape, distinguishing direct Y2H interactions from co-complex AP-MS associations using different edge types [98].

• Topological Analysis: Identify network hubs, bottlenecks, and modules using built-in Cytoscape apps (cytoHubba, ClusterONE) to pinpoint functionally important nodes in the MOB2 interaction network [98].

• Functional Enrichment: Perform GO term, pathway, and domain enrichment analysis using tools integrated with Cytoscape (STRING, BiNGO) to extract biological meaning from the integrated network [98].

• Experimental Prioritization: Use network topology metrics (betweenness centrality, degree) combined with functional annotation to prioritize interactions for further validation.

This integrated approach to MOB2 interaction mapping has revealed its dual functionality: as a regulator of NDR kinases under normal conditions and as a facilitator of MRN complex recruitment in DNA damage response, explaining why MOB2 depletion causes accumulation of endogenous DNA damage and G1/S cell cycle arrest independent of its NDR regulatory functions [7] [6].

The complementary application of Y2H and AP-MS technologies provides a powerful framework for elucidating comprehensive protein interaction networks, as demonstrated in the characterization of MOB2 binding partners. Y2H excels at identifying direct binary interactions through genetic selection, while AP-MS captures the contextual complexity of protein assemblies in near-physiological conditions. The integration of these orthogonal approaches has been instrumental in revealing MOB2's novel role in DNA damage response through its direct interaction with RAD50 and functional contribution to MRN complex recruitment.

Future developments in interactomics will further enhance this synergistic relationship. Advances in mass spectrometry sensitivity and quantification, coupled with engineered proximity-labeling techniques, will provide increasingly comprehensive maps of protein interactions in their native cellular environments [95]. Similarly, improvements in Y2H methodologies, including specialized systems for membrane proteins and post-translationally modified proteins, will expand the scope of detectable interactions. For MOB2 research, the integrated application of these evolving technologies promises to further elucidate its multifunctional roles in cell cycle regulation, DNA damage response, and potential connections to cancer biology, ultimately contributing to a more comprehensive understanding of cellular signaling networks in health and disease.

Within the broader context of a thesis investigating Mps one binder 2 (MOB2) binding partners via yeast two-hybrid (Y2H) screening, this document details the functional validation of identified interactions, specifically focusing on the MOB2-NDR kinase complex. MOB proteins are highly conserved eukaryotic signal transducers that regulate essential intracellular pathways through interactions with serine/threonine kinases of the Nuclear Dbf2-related (NDR/LATS) family [7]. While MOB1 is a known activator of NDR kinases, MOB2 has been characterized as a potential inhibitor, competing with MOB1 for binding to the same N-terminal regulatory domain on NDR1/2 (also known as STK38/STK38L) [7] [28]. This protocol provides a framework for quantitatively assessing the biochemical and cellular consequences of MOB2 binding on NDR kinase activity, a interaction whose biological significance is still being elucidated [7].

Background and Significance

The MOB2-NDR Kinase Interaction

Biochemical studies have established that MOB2 forms a specific complex with NDR1/2 kinases, but not with the related LATS kinases [7]. The formation of a MOB1/NDR complex is associated with increased NDR kinase activity, whereas the MOB2/NDR complex is linked to diminished NDR activity [7] [6]. This suggests that MOB2 binding can effectively block NDR activation, possibly by preventing the association of the activating MOB1 partner [28]. The functional readout of this interaction is critical, as NDR kinases are involved in key cellular processes such as cell cycle progression, the DNA damage response (DDR), apoptosis, and cell morphology [7] [99].

Physiological Context of MOB2

Although initially characterized biochemically as an NDR inhibitor, recent research has revealed that MOB2's biological functions may extend beyond this role. MOB2 has been implicated in preventing endogenous DNA damage accumulation and is required for proper activation of cell cycle checkpoints in response to exogenous DNA damage [7] [6]. Intriguingly, these functions appear to operate independently of NDR kinase signaling, as NDR1/2 knockdown does not phenocopy the effects of MOB2 depletion [6]. Furthermore, a yeast two-hybrid screen identified RAD50, a component of the MRE11-RAD50-NBS1 (MRN) DNA damage sensor complex, as a novel MOB2 binding partner [6]. This interaction facilitates the recruitment of the MRN complex and activated ATM (ataxia telangiectasia mutated) to sites of DNA damage, providing a mechanism for MOB2's role in DDR that is distinct from its regulation of NDR kinases [6]. Additionally, MOB2 insufficiency has been shown to disrupt neuronal migration during cortical development [12], and it regulates the motility of hepatocellular carcinoma cells by influencing the LATS/YAP pathway of the Hippo signaling cascade [28]. These diverse roles underscore the importance of robust methods to validate and characterize MOB2 interactions.

The following diagram illustrates the complex signaling relationships and functional outcomes associated with MOB2 interactions.

Experimental Protocols

This section provides detailed methodologies for key experiments validating MOB2-NDR interactions and their functional consequences.

Quantitative Yeast Two-Hybrid (Y2H) Assay

The Y2H system is a powerful molecular biology technique for discovering and quantifying protein-protein interactions (PPIs) by testing for physical binding between two proteins [14]. A quantitative approach using a β-galactosidase (β-gal) reporter assay allows for the comparison of relative binding strength [55].

Plasmid Acquirement and Strain Generation

• Plasmids: Three plasmids are required [55].
  • Bait Plasmid: Encodes MOB2 fused to the DNA-binding domain (DBD) of a transcription factor (e.g., Gal4).
  • Prey Plasmid: Encodes NDR1 or NDR2 fused to the activation domain (AD) of a transcription factor (e.g., Gal4).
  • Reporter Plasmid: Contains the LacZ gene under the control of a promoter with an upstream activating sequence (UAS) for the DBD.
• Strain Generation: A suitable yeast strain (e.g., S. cerevisiae) is co-transformed with the bait, prey, and reporter plasmids. Transformants are selected on appropriate triple dropout media (e.g., -Leu/-Trp/-Ura) based on the auxotrophic markers present on the plasmids [55].
• Critical Control: Always include a strain with the reporter, prey (NDR), and an empty bait plasmid to determine baseline reporter gene expression and identify false positives [55].

Cell Growth, Reporter Induction, and β-galactosidase Assay

• Growth: Grow transformed yeast strains to mid-log phase in selective media containing glucose (represses reporter gene).
• Induction: Harvest cells, wash to remove glucose, and resuspend in induction media (selective media + galactose). Galactose induces the GAL promoter, leading to expression of the hybrid proteins and, if an interaction occurs, expression of the LacZ reporter [55].
• Cell Lysis: After induction for at least two doubling times, harvest and lyse cells to obtain a whole-cell extract (WCE).
• Quantification: Incubate WCE with the colorimetric substrate ortho-Nitrophenyl-β-D-galactopyranoside (ONPG). The colorless ONPG is hydrolyzed by β-galactosidase to produce a yellow o-Nitrophenol. Record the reaction time and measure absorbance at 420 nm (o-Nitrophenol) and 550 nm (light scattering by cell debris) [55].
• Calculation: Calculate units of β-galactosidase activity (U) using the formula [55]:
  • ( U = \frac{1000 \times [\textrm{Abs}{420} - (1.75 \times \textrm{Abs}{550})]}{t \times v \times \textrm{Abs}_{600}} )
  • Where: Abs~420~ = absorbance by o-Nitrophenol, Abs~550~ = absorbance by cell debris, t = reaction time (minutes), v = reaction volume (mL), and Abs~600~ = cell density of the culture, representing original cell concentration.

In Vitro Kinase Activity Assay

This assay directly measures the functional impact of MOB2 binding on NDR kinase phosphorylation of its substrates.

Protein Purification and Complex Formation

• Purification: Express and purify recombinant proteins (e.g., NDR2, MOB1A, MOB2) from E. coli or mammalian cell systems using appropriate tags (e.g., GST, HA) [100] [99].
• Complex Formation: Pre-incubate purified NDR2 kinase with either MOB1A (positive control for activation) or MOB2 (test condition for inhibition) in kinase reaction buffer.

Kinase Reaction and Detection

• Reaction Setup: Initiate the kinase reaction by adding ATP and a suitable substrate (e.g., myelin basic protein or a specific NDR peptide substrate). Include controls without substrate (to assess autophosphorylation) and without kinase (background control).
• Phosphorylation Detection:
  • Radioactive Method: Use [γ-³²P]ATP, separate proteins by SDS-PAGE, and visualize radioactive phosphate incorporation via autoradiography or phosphorimaging.
  • Non-Radioactive (Phospho-Specific Antibody) Method: Use cold ATP and detect phosphorylation of NDR itself or its substrate using phospho-specific antibodies. For NDR, key phosphorylation sites are Ser281/Ser282 (activation loop) and Thr444/Thr442 (hydrophobic motif), both required for full activity [99].

Functional Cell-Based Validation

Wound Healing/Cell Motility Assay

Given MOB2's reported role in inhibiting hepatocellular carcinoma cell migration [28], this assay tests the functional consequence of MOB2-NDR interaction.

• Cell Line and Transfection: Use SMMC-7721 or another relevant cell line. Generate stable lines with MOB2 knockout (using CRISPR/Cas9) or MOB2 overexpression (using lentiviral vectors) [28].
• Wounding: Seed cells onto 6-well plates to form a confluent monolayer. Create a scratch ("wound") with a sterile pipette tip.
• Imaging and Quantification: Wash cells to remove debris and acquire images at the wound edge immediately (0 h) and after an incubation period (e.g., 24-48 h). Calculate the relative migration distance or percentage of wound closure. MOB2 overexpression is expected to inhibit migration, while its knockout should promote it [28].

Data Analysis and Presentation

Table 1: Expected Outcomes from MOB2-NDR Functional Validation Experiments

Experimental Assay	Key Readout	Expected Result with MOB2-NDR Interaction	Supporting Citation
Quantitative Y2H	β-galactosidase Units (Binding Affinity)	Strong, quantifiable signal confirming direct physical interaction.	[6] [55]
In Vitro Kinase Assay	NDR Substrate Phosphorylation	Reduction in substrate phosphorylation compared to MOB1-activated NDR.	[7] [28]
Co-Immunoprecipitation	Protein Complex Formation	Co-precipitation of MOB2 with NDR1/2, but not with LATS1/2.	[7] [6]
Wound Healing Assay	Cell Migration Rate	MOB2 overexpression inhibits migration; MOB2 knockout enhances migration.	[28]
Western Blot (Signaling)	NDR & YAP Phosphorylation	MOB2 knockout increases NDR1/2 phosphorylation; decreases YAP phosphorylation.	[28]

Quantitative Y2H Data Analysis

When performing quantitative Y2H, the calculated β-galactosidase units for the MOB2-NDR interaction should be standardized against the negative control (empty bait) and compared to a known positive interaction (e.g., MOB1-NDR). The data can be presented as shown in the hypothetical graph below.

Table 2: Example Quantitative Y2H Data for MOB Protein Interactions with NDR2

Bait Protein	Prey Protein	Mean β-gal Units (U/mg protein)	Standard Deviation	Interpretation
Empty Vector	NDR2	10.5	± 2.1	No Interaction (Baseline)
MOB1	NDR2	450.0	± 35.5	Strong Interaction
MOB2	NDR2	380.0	± 28.9	Strong Interaction
MOB2	LATS1	15.2	± 3.3	No Interaction

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents for MOB2-NDR Functional Validation

Reagent / Material	Function / Application	Example / Specification
Y2H Plasmids	Expressing bait (MOB2) and prey (NDR) fusions.	pLexA (DBD), pGADT7 (AD); with selectable markers (e.g., LEU2, TRP1).
β-galactosidase Assay Kit	Quantifying protein interaction strength in Y2H.	Includes ONPG substrate, lysis buffer, and reaction stop solution.
Anti-NDR1/2 Antibodies	Detecting NDR kinase expression and phosphorylation.	Phospho-specific: anti-p-Ser281/282, anti-p-Thr444/442 [99].
Anti-MOB2 Antibodies	Detecting MOB2 expression and localization.	Validated for immunoprecipitation and Western blotting.
Recombinant MOB1/2 & NDR Proteins	For in vitro binding and kinase assays.	High-purity, active, tag-purified proteins from E. coli or insect cells.
CRISPR/Cas9 Knockout System	Generating MOB2-deficient cell lines for functional studies.	lentiCRISPRv2 vector with sgRNA targeting MOB2 [28].
Lentiviral Overexpression System	Generating stable MOB2-overexpressing cell lines.	LV-MOB2 and control (LV-C) vectors [28].

Visualizing the Experimental Workflow

The following diagram outlines the core workflow for validating MOB2 interactions and their functional impact on NDR kinase activity, integrating the protocols described above.

Conclusion

A meticulously executed yeast two-hybrid screen is a powerful starting point for deconvoluting the MOB2 interactome, revealing its critical role as a node in Hippo and Hippo-like signaling networks. By integrating foundational knowledge with advanced, high-throughput screening methodologies and rigorous orthogonal validation, researchers can transform a list of potential binding partners into biologically and clinically actionable insights. Future research should focus on characterizing the dynamics of these interactions in different cellular contexts and disease states, particularly in cancer, where MOB family proteins are increasingly implicated. The continued development of more sensitive and specific Y2H technologies promises to further illuminate the complex functional landscape of MOB2 and its binding partners.

References

• 1. MOB control: Reviewing a conserved family of kinase ... [https://www.sciencedirect.com/science/article/abs/pii/S0898656811001197]
• 2. Characterization and Evolution of the Cell Cycle-Associated ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2684140/]
• 3. MOB: Pivotal Conserved Proteins in Cytokinesis, Cell ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7761452/]
• 4. Mob Family Proteins: Regulatory Partners in Hippo and ... [https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2020.00161/full]
• 5. Mob Family Proteins: Regulatory Partners in Hippo and Hippo ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7096357/]
• 6. Regulation of DNA damage responses and cell cycle ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4276419/]
• 7. The Possible Crosstalk of MOB2 With NDR1/2 Kinases in Cell ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5321467/]
• 8. 1PI1: Crystal structure of a human Mob1 protein [https://www.rcsb.org/structure/1pi1]
• 9. Yeast two-hybrid screening for proteins that interact with ... [https://www.nature.com/articles/s41598-019-52030-x]
• 10. MOB (Mps one Binder) Proteins in the Hippo Pathway and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6627106/]
• 11. Monopolar spindle-one-binder protein 2 regulates the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5840656/]
• 12. Mob2 Insufficiency Disrupts Neuronal Migration in the ... [https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2018.00057/full]
• 13. NDR kinase SAX-1 controls dendrite branch-specific ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12259037/]
• 14. Two-hybrid screening [https://en.wikipedia.org/wiki/Two-hybrid_screening]
• 15. A yeast two-hybrid system for the screening and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5680816/]
• 16. Mapping the MOB proteins' proximity network reveals a ... [https://www.sciencedirect.com/science/article/pii/S0021925823021518]
• 17. The Fluorescent Two-Hybrid Assay to Screen for Protein– ... [https://www.sciencedirect.com/science/article/pii/S2472555222073579]
• 18. The NDR family of kinases: essential regulators of aging [https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2024.1371086/full]
• 19. Applications of Yeast - Two Hybrid Screening [https://www.news-medical.net/life-sciences/Applications-of-Two-Hybrid-Screening.aspx]
• 20. - Yeast , a Powerful Tool for Systems Biology - PMC Two Hybrid [https://pmc.ncbi.nlm.nih.gov/articles/PMC2705515/]
• 21. Tissue expression of MOB2 - Summary [https://www.proteinatlas.org/ENSG00000182208-MOB2/tissue]
• 22. Quantitative Interactor with next-generation Sequencing... Screening [https://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2164-13-8]
• 23. DoMY-Seq: A yeast two-hybrid–based technique for ... [https://www.sciencedirect.com/science/article/pii/S0021925820000095]
• 24. Mapping the MOB proteins' proximity network reveals a ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10480535/]
• 25. MOB2 suppresses GBM cell migration and invasion via ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7156523/]
• 26. from the Yeast Two-Hybrid System to the Mammalian Split ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3372256/]
• 27. hMOB2 deficiency impairs homologous recombination- ... [https://www.sciencedirect.com/science/article/pii/S0898656821001959]
• 28. Monopolar spindle-one-binder protein 2 regulates the ... [https://www.spandidos-publications.com/10.3892/ol.2018.7952]
• 29. Two NDR kinase–MOB complexes function as distinct ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4617822/]
• 30. MOB2 suppresses GBM cell migration and invasion via ... [https://www.nature.com/articles/s41419-020-2381-8]
• 31. Protein Interactions Discovery [https://www.hybrigenics-services.com/protein-interaction-discovery]
• 32. Next-generation yeast-two-hybrid analysis with Y2H-SCORES ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8046355/]
• 33. Yeast Two - Hybrid : State of the Art - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC140126/]
• 34. Yeast two-hybrid assay for studying protein-protein interactions [https://pubmed.ncbi.nlm.nih.gov/15153642/]
• 35. NanoLuc luciferase as a quantitative yeast two-hybrid reporter [https://pubmed.ncbi.nlm.nih.gov/34940882/]
• 36. High-throughput mammalian two - hybrid screening for protein-protein... [https://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2164-9-68]
• 37. A Quantitative Tri-fluorescent Yeast Two-hybrid System [https://www.sciencedirect.com/science/article/pii/S153594762035026X]
• 38. Screening: Advantages and Disadvantages Two Hybrid [https://www.news-medical.net/life-sciences/Two-hybrid-screening-advantages-and-disadvantages.aspx]
• 39. Tips for Screening with Yeast Two Hybrid Systems [https://blog.addgene.org/tips-for-screening-with-yeast-two-hybrid-systems]
• 40. yeast two hybrid system [https://www.bio.davidson.edu/courses/molbio/yeastwo/yeastwo.html]
• 41. Make your own library for yeast two-hybrid screening [https://www.takarabio.com/learning-centers/protein-research/matchmaker-gold-yeast-two-hybrid-systems/make-your-own-library-for-yeast-two-hybrid-screening?srsltid=AfmBOoqcZLjMHGcsWEqtFtjOvsHNtk5T8Lkbg1I4zxLgTChsS7YbgXT6]
• 42. cDNA Library Overview and Applications [https://www.creative-biogene.com/support/cdna-library-overview-and-applications.html]
• 43. DNA Library (Genomic, cDNA): Types, Preparation, Uses [https://microbenotes.com/dna-library-gene-library/]
• 44. cDNA vs. gDNA: Structure, Function, Biotech Apps, and ... [https://www.cd-genomics.com/blog/cdna-gdna-comparison-structure-function-application/]
• 45. A descriptive study using library screening in yeast [https://www.sciencedirect.com/science/article/pii/S1687157X24001306]
• 46. Host-pathogen protein interaction studies: quality control of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12124543/]
• 47. A yeast two-hybrid system for the screening ... - BMC Biology [https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-017-0446-7]
• 48. DEEPN as an Approach for Batch Processing of Yeast 2- ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5594928/]
• 49. A Yeast 2-Hybrid Screen in Batch to Compare Protein ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6101618/]
• 50. A single-cell resolved genotype-phenotype map using ... [https://www.nature.com/articles/s41467-025-57600-4]
• 51. A comprehensive two-hybrid analysis to explore the yeast ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC31875/]
• 52. Determination of the Mating Efficiency of Haploids in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7614933/]
• 53. Generation of diploid Pichia pastoris strains by mating and ... [https://microbialcellfactories.biomedcentral.com/articles/10.1186/1475-2859-11-91]
• 54. Generation of diploid Pichia pastoris strains by mating and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3503796/]
• 55. Quantitative yeast two-hybrid screening in 4 easy steps [https://bitesizebio.com/53949/quantitative-yeast-two-hybrid/]
• 56. A yeast two-hybrid system for the screening and ... [https://pubmed.ncbi.nlm.nih.gov/29121928/]
• 57. Making the right choice: Critical parameters of the Y2H ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11796303/]
• 58. Removing auto-activators from yeast-two-hybrid assays by ... [https://www.nature.com/articles/s41598-021-84608-9]
• 59. An Overview of Yeast Two-Hybrid (Y2H) Screening [https://bitesizebio.com/23607/an-overview-of-yeast-two-hybrid-y2h-screening/]
• 60. Mapping the functional yeast ABC transporter interactome [https://pmc.ncbi.nlm.nih.gov/articles/PMC3835492/]
• 61. Mechanisms of action of P-glycoprotein (ABCB1) [https://www.sciencedirect.com/science/article/abs/pii/S0928098705003313]
• 62. The Human ATP-Binding Cassette (ABC) Transporter ... - NCBI [https://www.ncbi.nlm.nih.gov/books/NBK3/]
• 63. ABC Transporters in Saccharomyces cerevisiae and Their ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2786581/]
• 64. A Structure-Based View on ABC-Transporter Linked to ... [https://www.mdpi.com/1420-3049/28/2/495]
• 65. Screening of photosensitizers-ATP binding cassette (ABC) ... [https://www.oaepublish.com/articles/cdr.2024.50]
• 66. Yeast Cbk1 and Mob2 Activate Daughter-Specific Genetic ... [https://www.sciencedirect.com/science/article/pii/S0092867401005967]
• 67. HIS3 - an overview [https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/his3]
• 68. Workflow to Select Functional Promoter DNA Baits and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11580771/]
• 69. suppresses GBM cell migration and invasion via regulation of... MOB 2 [https://www.nature.com/articles/s41419-020-2381-8?error=cookies_not_supported&code=f96c7814-da97-4fec-a1ac-e9bc3100ba9e]
• 70. Metal toxicity and opportunistic binding of Pb2+ in proteins [https://pmc.ncbi.nlm.nih.gov/articles/PMC3947799/]
• 71. A theoretical, dynamical evaluation method of the steric ... [https://www.nature.com/articles/s41598-019-56342-w]
• 72. Quantitative expression for steric hindrance [https://chemistry.stackexchange.com/questions/67049/quantitative-expression-for-steric-hindrance]
• 73. Integrated Membrane Yeast Two-Hybrid System for the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12378420/]
• 74. Human Mob Proteins Regulate the NDR1 and NDR2 ... [https://www.sciencedirect.com/science/article/pii/S0021925820665796]
• 75. MOB control: Reviewing a conserved family of kinase regulators [https://pmc.ncbi.nlm.nih.gov/articles/PMC3398134/]
• 76. Co-Immunoprecipitation (Co-IP) [https://www.thermofisher.com/us/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/co-immunoprecipitation-co-ip.html]
• 77. How to conduct a Co-immunoprecipitation (Co-IP) [https://www.ptglab.com/news/blog/how-to-conduct-a-co-immunoprecipitation-co-ip/?srsltid=AfmBOoqt_QPR6yUwzQgQGj4j8ShT-8yeCPI6qyrDsofmUWTOWAXKmHU0]
• 78. Native Co-immunoprecipitation Assay to Identify Interacting ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7842739/]
• 79. Quantitative Multiplex co-Immunoprecipitation [https://pmc.ncbi.nlm.nih.gov/articles/PMC8195492/]
• 80. Co-immunoprecipitation and semi-quantitative ... [https://www.sciencedirect.com/science/article/pii/S2666166721003518]
• 81. Differential NDR/LATS Interactions with the Human MOB ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2937529/]
• 82. Mammalian two-hybrids come of age - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC2783295/]
• 83. Interactome Data - CCSB - Center for Cancer Systems Biology [https://ccsb.dana-farber.org/interactome-data.html]
• 84. BioID as a Tool for Protein-Proximity Labeling in Living Cells [https://pmc.ncbi.nlm.nih.gov/articles/PMC6583792/]
• 85. An AP-MS- and BioID-compatible MAC-tag enables ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5864832/]
• 86. Proximity labeling and affinity capture compared [https://www.sciencedirect.com/science/article/pii/S0021925822011693]
• 87. In planta proximity dependent biotin identification (BioID) [https://www.nature.com/articles/s41598-018-27500-3]
• 88. 4.3. Proximity-Dependent Biotin Identification (BioID) Assay [https://bio-protocol.org/exchange/minidetail?id=7130245&type=30]
• 89. Split-Protein Systems: Beyond Binary ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3237955/]
• 90. Evolution of split-protein technologies in virology [https://pmc.ncbi.nlm.nih.gov/articles/PMC12513004/]
• 91. A New Protein-Protein Interaction Sensor Based on ... [https://www.nature.com/articles/srep02854]
• 92. Protocol for analyzing protein-protein interactions by split ... [https://www.sciencedirect.com/science/article/pii/S2666166724004933]
• 93. Yeast 2-Hybrid [https://www.singerinstruments.com/resource/yeast-2-hybrid/]
• 94. Affinity purification–mass spectrometry and network analysis ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4332878/]
• 95. Recent Advances in Mass Spectrometry-Based Protein ... [https://www.sciencedirect.com/science/article/pii/S1535947624001774]
• 96. Identifying binary protein-protein interactions from affinity ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4595009/]
• 97. Yeast Two-Hybrid (Y2H) vs. AP-MS in Protein Interaction ... [https://www.omicsempower.com/blog/yeast-two-hybrid-y2h-vs-apms/]
• 98. Affinity purification-mass spectrometry network analysis [https://cytoscape.org/cytoscape-tutorials/protocols/AP-MS-network-analysis/]
• 99. Regulation of NDR Protein Kinase by Hydrophobic Motif ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC1316964/]
• 100. Mechanism of activation of NDR (nuclear Dbf2-related) ... [https://pubmed.ncbi.nlm.nih.gov/15197186/]